610 Medizin und Gesundheit
Refine
Year of publication
Document Type
- Article (6127)
- Doctoral Thesis (1995)
- Preprint (283)
- Part of Periodical (245)
- Conference Proceeding (207)
- Book (175)
- Contribution to a Periodical (172)
- Review (58)
- Part of a Book (39)
- Working Paper (17)
Language
- English (6242)
- German (3039)
- Latin (26)
- mis (13)
- Multiple languages (13)
- French (11)
- Portuguese (1)
- Romanian (1)
- Russian (1)
- Spanish (1)
Has Fulltext
- yes (9349) (remove)
Keywords
- inflammation (98)
- COVID-19 (71)
- SARS-CoV-2 (55)
- apoptosis (42)
- cancer (41)
- Inflammation (40)
- glioblastoma (38)
- breast cancer (34)
- autophagy (32)
- Cancer (30)
- prostate cancer (30)
- Depression (27)
- Apoptosis (26)
- biomarker (26)
- ADHD (25)
- Epilepsy (25)
- aging (25)
- pain (25)
- quality of life (25)
- wassergefiltertes Infrarot A (wIRA) (25)
- macrophage (24)
- immunotherapy (23)
- Quality of life (22)
- Wundheilung (22)
- microRNA (22)
- Germany (21)
- Gewebetemperatur (21)
- Video (21)
- children (21)
- EEG (20)
- Gewebedurchblutung (20)
- HIV (20)
- chemotherapy (20)
- hypoxia (20)
- mitochondria (20)
- reactive oxygen species (20)
- Biomarker (19)
- MRI (19)
- Sauerstoffpartialdruck im Gewebe (19)
- Schmerz (19)
- Schmerzminderung (19)
- Stroke (19)
- data science (19)
- depression (19)
- epilepsy (19)
- fMRI (19)
- Breast cancer (18)
- prevention (18)
- water-filtered infrared-A (wIRA) (18)
- Entzündung (17)
- Human behaviour (17)
- Neuroscience (17)
- Treatment (17)
- angiogenesis (17)
- endothelial cells (17)
- glioma (17)
- tumor microenvironment (17)
- Genetics (16)
- Infektionsabwehr (16)
- Lebensqualität (16)
- Machine learning (16)
- Magnetic resonance imaging (16)
- Medizin (16)
- Outcome (16)
- Prävention (16)
- Surgery (16)
- cognition (16)
- mTOR (16)
- proliferation (16)
- stroke (16)
- treatment (16)
- Cirrhosis (15)
- cytokines (15)
- lung cancer (15)
- multiple sclerosis (15)
- radical prostatectomy (15)
- reduction of pain (15)
- tissue oxygen partial pressure (15)
- tissue temperature (15)
- Angiogenesis (14)
- Cell biology (14)
- Infrarot (14)
- Mitochondria (14)
- Parkinson’s disease (14)
- Radiotherapy (14)
- Sauerstoffversorgung (14)
- cirrhosis (14)
- diagnosis (14)
- epigenetics (14)
- mortality (14)
- obesity (14)
- schizophrenia (14)
- tissue blood flow (14)
- wound healing (14)
- Biomarkers (13)
- Capsule endoscopy (13)
- Diagnostik (13)
- Gene expression (13)
- Immunotherapy (13)
- Mammakarzinom (13)
- Mortality (13)
- NADPH oxidase (13)
- Oncology (13)
- attention (13)
- bladder cancer (13)
- cell death (13)
- coronavirus (13)
- epidemiology (13)
- macrophages (13)
- miRNA (13)
- neurodegeneration (13)
- proteomics (13)
- Epidemiology (12)
- HCV (12)
- Immunology (12)
- Mosambik (12)
- Mozambique (12)
- Moçambique (12)
- ROS (12)
- Sepsis (12)
- child (12)
- colorectal cancer (12)
- extracellular matrix (12)
- leukemia (12)
- machine learning (12)
- oxidative stress (12)
- prevalence (12)
- psoriasis (12)
- surgery (12)
- survival (12)
- targeted therapy (12)
- Chemotherapy (11)
- Diabetes mellitus (11)
- Endoscopy (11)
- Heart failure (11)
- PCR (11)
- Primary care (11)
- Prostate cancer (11)
- Seizure (11)
- Suicide (11)
- exercise (11)
- hepatitis C virus (11)
- hippocampus (11)
- integrins (11)
- invasion (11)
- macrophage polarization (11)
- magnetic resonance imaging (11)
- outcome (11)
- radiotherapy (11)
- therapy (11)
- trauma (11)
- ACLF (10)
- Atrial fibrillation (10)
- COPD (10)
- Diagnostic markers (10)
- Endothelial cells (10)
- Hepatocellular carcinoma (10)
- Krankheit (10)
- Macrophages (10)
- Pain (10)
- Research article (10)
- Small bowel (10)
- Survival (10)
- Trauma (10)
- artificial intelligence (10)
- atherosclerosis (10)
- curcumin (10)
- elderly (10)
- gene therapy (10)
- infection (10)
- innate immunity (10)
- liver (10)
- metabolism (10)
- migration (10)
- neuroblastoma (10)
- neuropathic pain (10)
- osteoarthritis (10)
- p53 (10)
- physical activity (10)
- risk factors (10)
- vaccination (10)
- Alzheimer’s disease (9)
- Bipolar disorder (9)
- Blood (9)
- Children (9)
- Diagnosis (9)
- Drug therapy (9)
- EGFR (9)
- Energieumsatz <Medizin> (9)
- General practice (9)
- Hemorrhage (9)
- Hepatitis C (9)
- Malaria (9)
- Medizinische Ausbildung (9)
- Metastasen (9)
- Molecular biology (9)
- Multimorbidity (9)
- NASH (9)
- Osteoporosis (9)
- Proteomics (9)
- Schizophrenia (9)
- TAVI (9)
- VEGF (9)
- Wunde (9)
- adhesion (9)
- adolescents (9)
- brain metastases (9)
- complications (9)
- development (9)
- differentiation (9)
- drug resistance (9)
- fibrosis (9)
- hepatocellular carcinoma (9)
- hereditary angioedema (9)
- human (9)
- metastasis (9)
- portal hypertension (9)
- sepsis (9)
- AML (8)
- Acute myeloid leukemia (8)
- Aging (8)
- Autophagy (8)
- Autopsy (8)
- Behandlung (8)
- Borrelia (8)
- Cardiovascular magnetic resonance (8)
- DNA methylation (8)
- Diagnostics (8)
- Energiebereitstellung (8)
- Epilepsie (8)
- Europe (8)
- Evaluation (8)
- Gender (8)
- Geschichte (8)
- HIV-1 (8)
- Hepatitis C virus (8)
- Hypertension (8)
- In vitro (8)
- Kongress (8)
- Liver diseases (8)
- MEG (8)
- Medical research (8)
- Prevention (8)
- Problemwunden (8)
- Prognosis (8)
- RNA (8)
- Rare diseases (8)
- Wundinfektion (8)
- Wundinfektionen (8)
- Wundsekretion (8)
- aortic stenosis (8)
- biomarkers (8)
- chronic kidney disease (8)
- energy supply (8)
- exosomes (8)
- gender (8)
- heart failure (8)
- liver transplantation (8)
- medical education (8)
- microglia (8)
- monocytes (8)
- mouse (8)
- oxygen supply (8)
- periodontitis (8)
- polytrauma (8)
- pregnancy (8)
- primary care (8)
- problem wounds (8)
- renal cell carcinoma (8)
- sphingosine-1-phosphate (8)
- transcranial magnetic stimulation (8)
- wound infections (8)
- AIDS (7)
- Autism spectrum disorder (7)
- Brustkrebs (7)
- Cancer treatment (7)
- Colorectal cancer (7)
- Deutschland (7)
- Exercise (7)
- Forensic entomology (7)
- HCC (7)
- HDAC (7)
- Heart (7)
- Herb induced liver injury (7)
- Hypoxia (7)
- Immunohistochemistry (7)
- Immunological methods (7)
- Immunologische Methoden (7)
- Kardiovaskuläre Krankheit (7)
- Kommunikation (7)
- Mechanisms of disease (7)
- Mental health and psychiatry (7)
- Multiple sclerosis (7)
- NK cells (7)
- Neurology (7)
- Obesity (7)
- Outcomes (7)
- PD-L1 (7)
- Pandemic (7)
- Patients (7)
- Polytrauma (7)
- Postural control (7)
- Prevalence (7)
- Rheumatoid arthritis (7)
- Risk factors (7)
- Sekretion (7)
- TRAIL (7)
- Therapie (7)
- Training (7)
- Transfusion (7)
- X-ray crystallography (7)
- antiviral therapy (7)
- asthma (7)
- bipolar disorder (7)
- cholesterol (7)
- cochlear implant (7)
- conduct disorder (7)
- diffusion tensor imaging (7)
- efficacy (7)
- gene expression (7)
- hematopoietic stem cell transplantation (7)
- iron (7)
- liver cirrhosis (7)
- machine-learning (7)
- medical students (7)
- metastases (7)
- microbiome (7)
- natural killer cells (7)
- particulate matter (7)
- polypharmacy (7)
- prognosis (7)
- prophylaxis (7)
- resistance (7)
- seizure (7)
- signal transduction (7)
- sphingolipids (7)
- thermal and non-thermal effects (7)
- thermische und nicht-thermische Effekte (7)
- thrombosis (7)
- toxicity (7)
- tumor-associated macrophages (7)
- ubiquitin (7)
- working memory (7)
- wound exudation (7)
- ATM (6)
- Adenocarcinoma (6)
- Allgemeinmedizin (6)
- Antiviral therapy (6)
- Atherosclerosis (6)
- Attention (6)
- Balloon enteroscopy (6)
- CDK4/6 (6)
- CRISPR/Cas9 (6)
- Cell signalling (6)
- Clinical trial (6)
- Cognition (6)
- Comorbidity (6)
- Complications (6)
- Consensus (6)
- Crohn’s disease (6)
- DMEK (6)
- Data science (6)
- Death rates (6)
- Dopamine (6)
- Elderly (6)
- Electroencephalography (6)
- Enteroscopy (6)
- Extracellular matrix (6)
- Gene regulation (6)
- Gesundheit (6)
- Gesundheitserziehung (6)
- Glioblastoma (6)
- Goethe-Universität Frankfurt am Main. Fachbereich Humanmedizin (6)
- HBV (6)
- Health economics (6)
- Hippocampus (6)
- Immunsuppression (6)
- Incidence (6)
- Liver transplantation (6)
- Medical education (6)
- Medizin und Gesundheit (6)
- Medizinstudium (6)
- Molecular neuroscience (6)
- Morbidity (6)
- Multivariate analysis (6)
- Musculoskeletal system (6)
- Non-small cell lung cancer (6)
- OSCE (6)
- Oral anticoagulation (6)
- PD1/PDL1 (6)
- PI3K (6)
- Parkinson's disease (6)
- Patient blood management (6)
- Physical activity (6)
- Pneumonia (6)
- Portal hypertension (6)
- Pregnancy (6)
- Psychiatric disorders (6)
- Radiomics (6)
- Randomized controlled trial (6)
- Reactive oxygen species (6)
- Rectal cancer (6)
- Regeneration (6)
- Registry (6)
- Status epilepticus (6)
- Studien (6)
- Surgical and invasive medical procedures (6)
- T cell (6)
- T cells (6)
- Targeted therapy (6)
- Translational research (6)
- Ultrasound (6)
- Vaccination (6)
- Viral load (6)
- Vitamin D (6)
- acute lymphoblastic leukemia (6)
- acute myeloid leukemia (6)
- acute wounds (6)
- acute-on-chronic liver failure (6)
- akute Wunden (6)
- anemia (6)
- atrial fibrillation (6)
- bevacizumab (6)
- chronische venöse Unterschenkel-Ulzera (6)
- clinical trial (6)
- colon cancer (6)
- cytotoxicity (6)
- dentate gyrus (6)
- diabetes (6)
- diabetes mellitus (6)
- disease (6)
- environmental tobacco smoke (6)
- fibroblasts (6)
- flow cytometry (6)
- growth (6)
- guideline (6)
- guidelines (6)
- health education (6)
- imaging (6)
- immunity (6)
- immunohistochemistry (6)
- infection defense (6)
- influenza (6)
- information theory (6)
- integrin (6)
- iron deficiency (6)
- lactate (6)
- liver fibrosis (6)
- long non-coding RNA (6)
- mass spectrometry (6)
- mathematical modeling (6)
- medizinische Ausbildung (6)
- melanoma (6)
- memory (6)
- mesenchymal stromal/stem cells (6)
- metabolomics (6)
- mice (6)
- multimorbidity (6)
- nitric oxide (6)
- ovarian cancer (6)
- overall survival (6)
- plasticity (6)
- predictive coding (6)
- qualitative research (6)
- radiation (6)
- rhabdomyosarcoma (6)
- safety (6)
- sphingosine 1-phosphate (6)
- stress (6)
- synaptic plasticity (6)
- systematic review (6)
- temperaturabhängige und temperaturunabhängige Effekte (6)
- thermic and non-thermic effects (6)
- ultrasound (6)
- vaccine (6)
- visuelle Analogskalen (VAS) (6)
- vitamin D (6)
- 5-lipoxygenase (5)
- ARDS (5)
- Allergie (5)
- Alzheimer's disease (5)
- Anemia (5)
- Anticoagulation (5)
- Aortic stenosis (5)
- Arteriosklerose (5)
- Artificial intelligence (5)
- Aspergillus (5)
- Ataxia telangiectasia (5)
- Attitude (5)
- Autism (5)
- B cells (5)
- BMC (5)
- BRD4 (5)
- Biochemistry (5)
- Brain (5)
- C-reactive protein (5)
- CRP (5)
- Calliphoridae (5)
- Candida (5)
- Cardiovascular disease (5)
- Cardiovascular diseases (5)
- Cell staining (5)
- Cell therapy (5)
- Clinical trials (5)
- Critical care (5)
- Cytokines (5)
- DAA (5)
- Decision making (5)
- Diabetes (5)
- Diagnose (5)
- Diseases (5)
- Drug induced liver injury (5)
- ELISA (5)
- Education (5)
- Emotions (5)
- Epigenetics (5)
- Everolimus (5)
- Evidence-based medicine (5)
- Ewing sarcoma (5)
- Experimental models of disease (5)
- Extracellular vesicles (5)
- Eye movements (5)
- GPCR (5)
- Gastric cancer (5)
- Glioma (5)
- Guidelines (5)
- HNSCC (5)
- Health care (5)
- Hepatitis (5)
- Hepatotoxicity (5)
- Herbal hepatotoxicity (5)
- Histology (5)
- Hodgkin lymphoma (5)
- Hyperthermie (5)
- IL-6 (5)
- Immunsystem (5)
- Infection (5)
- Kind (5)
- Kinematic analysis (5)
- Legs (5)
- Lymphozyt (5)
- MLL (5)
- MRT (5)
- Machine-learning (5)
- Melanoma (5)
- MicroRNAs (5)
- Migration (5)
- Mitochondrial dysfunction (5)
- Molecular medicine (5)
- Mouse models (5)
- NF-κB (5)
- NK cell (5)
- NK-92 (5)
- NKG2D (5)
- NMR-Tomographie (5)
- NO (5)
- NS5A (5)
- Neurons (5)
- Nitric oxide (5)
- Omicron (5)
- PTSD (5)
- Personalized medicine (5)
- Pharmacology (5)
- Physiology (5)
- Platelet-rich fibrin (5)
- Polypharmacy (5)
- Posttraumatic stress disorder (5)
- Prediction (5)
- Predictive markers (5)
- Proliferation (5)
- Psychology (5)
- Quelle (5)
- RUCAM (5)
- Reaction time (5)
- Rhabdomyosarcoma (5)
- Risiko (5)
- STAT3 (5)
- Safety (5)
- Schlaganfall (5)
- Screening (5)
- Signaling (5)
- Smac (5)
- Sportmedizin (5)
- Surgical oncology (5)
- Treatment outcome (5)
- Tumor microenvironment (5)
- Validation (5)
- Vision (5)
- acute coronary syndrome (5)
- adaptation (5)
- age (5)
- ataxia telangiectasia (5)
- auditory cortex (5)
- cardiac surgery (5)
- cardiovascular disease (5)
- cell therapy (5)
- ceramides (5)
- cervical cancer (5)
- chimeric antigen receptor (5)
- chronic venous stasis ulcers of the lower legs (5)
- complement (5)
- confinement (5)
- connective tissue (5)
- connectivity (5)
- critical care (5)
- dendritic cells (5)
- dental implant (5)
- dental implants (5)
- digital medicine (5)
- drug discovery (5)
- evaluation (5)
- everolimus (5)
- extracellular vesicles (5)
- functional magnetic resonance imaging (5)
- graph theory (5)
- histology (5)
- hyperglycemia (5)
- immune response (5)
- impulsivity (5)
- lipocalin-2 (5)
- lncRNA (5)
- mTORC1 (5)
- meningioma (5)
- natural killer cell (5)
- outcomes (5)
- pancreatic cancer (5)
- pandemic (5)
- patient blood management (5)
- patient safety (5)
- patients (5)
- perception (5)
- phagocytosis (5)
- phosphorylation (5)
- platelets (5)
- precision medicine (5)
- preeclampsia (5)
- prospective, randomized, controlled, double-blind studies (5)
- prospektive, randomisierte, kontrollierte, doppeltblinde Studien (5)
- prostaglandins (5)
- protein degradation (5)
- psychotherapy (5)
- public health (5)
- quantitative MRI (5)
- rapamycin (5)
- rat (5)
- regeneration (5)
- rheumatoid arthritis (5)
- screening (5)
- sleep (5)
- sulforaphane (5)
- tissue engineering (5)
- ubiquitination (5)
- valproic acid (5)
- vector (5)
- visual cortex (5)
- 177Lu-PSMA-617 (4)
- 3D printing (4)
- ABCB1 (4)
- Acute inflammation (4)
- Acute lymphoblastic leukemia (4)
- Adherence (4)
- Adhesion (4)
- Age groups (4)
- Alcohol (4)
- Alzheimer (4)
- Amblyopia (4)
- Angiography (4)
- Animal models (4)
- Antikörper (4)
- Anxiety (4)
- Aortic valve (4)
- Ascites (4)
- Aspergillus fumigatus (4)
- B-cell lymphoma (4)
- BCR/ABL (4)
- BRAF (4)
- Bacterial infection (4)
- Behavior (4)
- Biopsy (4)
- Bladder cancer (4)
- Blood pressure (4)
- Bone density (4)
- Bone marrow (4)
- Brain metastasis (4)
- Burden of illness (4)
- C. elegans (4)
- CIK cells (4)
- CT (4)
- CXCR4 (4)
- Cannabis (4)
- Cardiology (4)
- Cell proliferation (4)
- Cerebellum (4)
- Cesarean section (4)
- Chemoradiotherapy (4)
- Chronic kidney disease (4)
- Classification (4)
- Cochlear implant (4)
- Cognitive behavioral therapy (4)
- Cognitive impairment (4)
- Cohort studies (4)
- Communication (4)
- Complex I (4)
- Computational models (4)
- Computed tomography (4)
- Conduct disorder (4)
- Corona (4)
- Cryoelectron microscopy (4)
- DILI (4)
- DNA damage (4)
- DTI (4)
- Data processing (4)
- Dementia (4)
- Denosumab (4)
- Density equalizing mapping (4)
- Developmental biology (4)
- Diagnostic medicine (4)
- Dravet syndrome (4)
- ER stress (4)
- Emotion regulation (4)
- Endoscopic retrograde cholangiopancreatography (4)
- Endothelium (4)
- Epileptischer Anfall (4)
- European Union (4)
- Eyes (4)
- Flow cytometry (4)
- Functional connectivity (4)
- Functional magnetic resonance imaging (4)
- Genetics research (4)
- Geschlecht (4)
- Gesundheitsökonomie (4)
- Glioblastom (4)
- Glucose (4)
- HAE (4)
- Healthcare worker (4)
- Heart transplantation (4)
- Hematology (4)
- Hepatitis B (4)
- Hereditary angioedema (4)
- Homeostasis (4)
- IAP proteins (4)
- Ibo <Moçambique> (4)
- Immunologie (4)
- Impfung (4)
- Infections (4)
- Infrarot-Thermographie (4)
- IntelliCage (4)
- Intensive care (4)
- Intensive care units (4)
- Interleukin (4)
- Interleukin-6 (4)
- Ischemia (4)
- Knees (4)
- Labor and delivery (4)
- Lehrbuch (4)
- Lesenlernen (4)
- Liver cirrhosis (4)
- Liver fibrosis (4)
- Long non-coding RNAs (4)
- Lung failure (4)
- MRSA (4)
- MSD (4)
- MYC (4)
- Mass spectrometry (4)
- Medical risk factors (4)
- Medizindidaktik (4)
- Medizingeschichte (4)
- Medizinstudenten (4)
- Medizinstudierende (4)
- Microbiology (4)
- Mouse (4)
- Multidetector computed tomography (4)
- Musculoskeletal diseases (4)
- Mwani (4)
- Mwani <Sprache> (4)
- Myocardial infarction (4)
- NAFLD (4)
- Neonates (4)
- Neural networks (4)
- Neurochirurgie (4)
- Neutropenia (4)
- Next-generation sequencing (4)
- Nierentransplantation (4)
- Nox4 (4)
- NoxO1 (4)
- Nrf2 (4)
- Older adults (4)
- PSMA (4)
- Pandemie (4)
- Pathogenesis (4)
- Patient safety (4)
- Pediatric (4)
- Phagocytosis (4)
- Physicians (4)
- Plasticity (4)
- Preclinical research (4)
- Preventive medicine (4)
- Prophylaxis (4)
- Prostatakarzinom (4)
- Public health (4)
- Pulmonary embolism (4)
- Pädiatrie (4)
- Quality of care (4)
- Qualitätssicherung (4)
- Quantitative MRI (4)
- Register (4)
- Registries (4)
- Rehabilitation (4)
- Resistenz (4)
- Roussel Uclaf Causality Assessment Method (4)
- Schwangerschaft (4)
- Seltene Erkrankungen (4)
- Sensitivity (4)
- Sensitivity and Specificity (4)
- Sensory perception (4)
- Sex (4)
- Sex differences (4)
- Speech (4)
- Sport (4)
- Stem cell (4)
- Stem cells (4)
- Suicidality (4)
- Surveillance (4)
- Systematic review (4)
- TACE (4)
- Tacrolimus (4)
- Therapy (4)
- Thrombose (4)
- Thrombosis (4)
- Tiermodell (4)
- Tissue engineering (4)
- Transcription factors (4)
- Tumormarker (4)
- Ubiquitination (4)
- Ultraschall (4)
- Wound healing (4)
- XIAP (4)
- Zika virus (4)
- acetaminophen (4)
- acute kidney injury (4)
- adjuvant therapy (4)
- adjuvante Therapie (4)
- adverse events (4)
- aggression (4)
- alcohol (4)
- alirocumab (4)
- anaemia (4)
- animal (4)
- antibodies (4)
- antioxidants (4)
- augmentation (4)
- bibliometrics (4)
- bibliometry (4)
- bioinformatics (4)
- brachytherapy (4)
- breast (4)
- cGMP (4)
- cancer stem cells (4)
- cell biology (4)
- cell migration (4)
- cerebellum (4)
- cerebrospinal fluid (4)
- chemoradiotherapy (4)
- chemoresistance (4)
- classical Hodgkin lymphoma (4)
- classification (4)
- climate change (4)
- clinical study (4)
- co-infection (4)
- collagen (4)
- combination therapy (4)
- complication (4)
- computed tomography (4)
- contact-free method (4)
- cortex (4)
- cystic fibrosis (4)
- cytomegalovirus (4)
- dementia (4)
- dendrite (4)
- dentist (4)
- diagnostics (4)
- direct-acting antivirals (4)
- dopamine (4)
- doxorubicin (4)
- early breast cancer (4)
- electroencephalography (4)
- electrolytic cleaning (4)
- electrophysiology (4)
- entropy (4)
- epigenetic (4)
- ergonomics (4)
- executive function (4)
- external beam radiotherapy (4)
- faculty development (4)
- fatigue (4)
- forensic entomology (4)
- frühes Mammakarzinom (4)
- functional connectivity (4)
- gastric cancer (4)
- general practice (4)
- glycolysis (4)
- haemophilia treatment (4)
- health-related quality of life (4)
- hemodialysis (4)
- hemorrhage (4)
- hepatitis C (4)
- hepatitis C virus (HCV) (4)
- immune evasion (4)
- immune system (4)
- immunology (4)
- in vitro (4)
- inflammasome (4)
- inflammatory bowel disease (4)
- infrared thermography (4)
- kidney (4)
- kontaktfreies, verbrauchsmaterialfreies Verfahren (4)
- learning to read (4)
- leukocytes (4)
- levetiracetam (4)
- lipid metabolism (4)
- lipoxygenase (4)
- lung function (4)
- management (4)
- mesenchymal stromal cells (4)
- metabolic syndrome (4)
- metastatic prostate cancer (4)
- mitosis (4)
- modeling (4)
- motility (4)
- motor cortex (4)
- multiple myeloma (4)
- musculoskeletal disorders (4)
- mutual information (4)
- neoadjuvant therapy (4)
- neural oscillations (4)
- neurocognition (4)
- neuroimaging (4)
- nociception (4)
- observational study (4)
- oscillations (4)
- p21 (4)
- pediatric (4)
- periimplantitis (4)
- peripheral artery disease (4)
- pharmacokinetics (4)
- polypharmacology (4)
- prefrontal cortex (4)
- primary cilium (4)
- primary health care (4)
- primary immunodeficiency (4)
- primary visual cortex (4)
- prostaglandin (4)
- proteasome (4)
- psoriatic arthritis (4)
- quality assurance (4)
- questionnaire (4)
- receptor (4)
- registry (4)
- reliability (4)
- resting state (4)
- resveratrol (4)
- risk (4)
- senescence (4)
- sex differences (4)
- signaling (4)
- simulation training (4)
- skeletal muscle (4)
- smoking (4)
- spinal cord (4)
- spirochetes (4)
- status epilepticus (4)
- stem cell transplantation (4)
- strength training (4)
- temozolomide (4)
- temporal lobe epilepsy (4)
- text book (4)
- thermographic image analysis (4)
- thermographische Bildanalyse (4)
- thrombolysis (4)
- thymus (4)
- tooth loss (4)
- transcription factor (4)
- transfusion (4)
- transplantation (4)
- traumatic brain injury (4)
- treatment centres (4)
- trials (4)
- tumor growth (4)
- tumor progression (4)
- tyrosine kinase inhibitors (4)
- walking (4)
- weight reduction (4)
- (surface) partial differential equations (3)
- 3D rapid prototyping (3)
- ABC Transporter (3)
- ADAM15 (3)
- ADHS (3)
- ALL (3)
- ATP (3)
- Abdominal aortic aneurysm (3)
- Acute kidney injury (3)
- Adolescents (3)
- Adults (3)
- Adverse events (3)
- Antibiotics (3)
- Antibodies (3)
- Antigen Processing (3)
- Antiretroviral therapy (3)
- Anämie (3)
- Aortic valve replacement (3)
- Arbeitsgedächtnis (3)
- Ataxia-telangiectasia (3)
- Autismus (3)
- BAG3 (3)
- BDNF (3)
- BMI (3)
- Batten disease (3)
- Begriffsgeschichte <Fach> (3)
- Bibliometrics (3)
- Biographie (3)
- Biophysics (3)
- Blood-brain barrier (3)
- Bone defect (3)
- Bone regeneration (3)
- Bone tissue engineering (3)
- Borrelia burgdorferi (3)
- Brain tumor (3)
- Bronchialasthma (3)
- C1 inhibitor (3)
- CAD/CAM (3)
- CAR (3)
- CD19 (3)
- CD36 (3)
- COMP (3)
- COVID 19 (3)
- CRM (3)
- CTGF (3)
- CXCL12 (3)
- CXCR3 (3)
- Calcium (3)
- Cancer chemotherapy (3)
- Cancer detection and diagnosis (3)
- Cancer genetics (3)
- Cancer genomics (3)
- Cancer models (3)
- Cardiac surgery (3)
- Carotis (3)
- Case report (3)
- Catheter ablation (3)
- Cell culture (3)
- Cerebrospinal fluid (3)
- Chaperone (3)
- Chemical biology (3)
- Child (3)
- Cholesterin (3)
- Chromatin accessibility (3)
- Chronic diseases (3)
- Chronic hepatitis C (3)
- Ciclosporin (3)
- Citation analysis (3)
- Clinical Trials and Observations (3)
- Clinical competence (3)
- Clinical decision support systems (3)
- Clinical genetics (3)
- Cochlear implantation (3)
- Cognitive neuroscience (3)
- Collagen (3)
- Comorbidities (3)
- Complex II (3)
- Compliance (3)
- Computer software (3)
- Computer-assisted diagnosis (3)
- Connective tissue (3)
- Coping (3)
- Coronary heart disease (3)
- Coronavirus (3)
- Costs (3)
- Covid-19 (3)
- Crystal structure (3)
- Cystic fibrosis (3)
- Cytokine (3)
- Cytoskeleton (3)
- D-wave (3)
- DNA damage response (3)
- DNA mismatch repair (3)
- DNase1-seq (3)
- Decision (3)
- Decorin (3)
- Deep brain stimulation (3)
- Delegation (3)
- Dental implant (3)
- Dental students (3)
- Dentistry (3)
- Development (3)
- Digitalisierung (3)
- Dose response (3)
- Drug hepatotoxicity (3)
- Drug resistance (3)
- Drugs (3)
- E-Learning (3)
- ECMO (3)
- EEG microstates (3)
- Eccentric fixation (3)
- Edema (3)
- Efficiency (3)
- Ejection fraction (3)
- Emergency room (3)
- Encephalopathy (3)
- Endocrinology (3)
- Endovascular repair (3)
- Entscheidungsassistenz (3)
- Epidemiologie (3)
- Epigenetik (3)
- Epileptische Anfälle (3)
- Evidence based medicine (3)
- Exosomes (3)
- FFLU (3)
- FGFR (3)
- FTY720 (3)
- Fasting (3)
- Feasibility (3)
- Feedback (3)
- Fibronectin (3)
- Fibrosis (3)
- Fingolimod (3)
- Finite Volumes (3)
- Fistula (3)
- Forensic medicine (3)
- Fourier analysis (3)
- Freud, Sigmund (3)
- Frühgeburt (3)
- Functional clustering (3)
- G-CSF (3)
- Gait analysis (3)
- Gene Regulation (3)
- Gene fusion (3)
- Gene therapy (3)
- Genome-wide association studies (3)
- Gesundheitsförderung (3)
- Gesundheitspolitik (3)
- Gesundheitswesen (3)
- Gewichtsabnahme (3)
- Global health (3)
- Goldstein, Kurt (3)
- Guideline (3)
- H1N1 (3)
- HER2 (3)
- HER2/neu (3)
- HIF (3)
- HPV (3)
- HSCT (3)
- Head and neck cancer (3)
- Health services research (3)
- Healthcare costs (3)
- Healthy adults (3)
- HepG2 (3)
- Hepatitis-C-Virus (3)
- Hirnforschung (3)
- HoLEP (3)
- Homosexualität (3)
- Hospitals (3)
- Human genetics (3)
- Hämodynamik (3)
- I-wave (3)
- IBD (3)
- ICD (3)
- ICU (3)
- IFT (3)
- IL-1β (3)
- Image processing (3)
- Immunchemie (3)
- Immune cells (3)
- Immune system (3)
- Immunosuppression (3)
- Impfstoff (3)
- Induction chemotherapy (3)
- Infectious diseases (3)
- Inflammatory bowel disease (3)
- Inflammatory diseases (3)
- Influenza (3)
- Infrarot-A-Strahlung (3)
- Injury (3)
- Innate immunity (3)
- Insulin (3)
- Interleukin-22 (3)
- Ixodes ricinus (3)
- Jaw (3)
- Kidney transplantation (3)
- Kinder (3)
- Kinderheilkunde (3)
- Kinderwunsch (3)
- Knochenersatzmaterial (3)
- Knowledge (3)
- Kolonkarzinom (3)
- Körper (3)
- Körperliche Aktivität (3)
- LCMV (3)
- LPS (3)
- Langerhans cell histiocytosis (3)
- Language (3)
- Leberzirrhose (3)
- Lehre (3)
- Lehrqualifikation (3)
- Leitlinien (3)
- Lesions (3)
- Leukemia (3)
- Leukozyt (3)
- Leukämie (3)
- Linear regression analysis (3)
- Liver Transplantation (3)
- LncRNA (3)
- Long-term care (3)
- Low back pain (3)
- Lumbar spine (3)
- Lyme disease (3)
- MCAK (3)
- MCAO (3)
- Macrophage polarization (3)
- Major depressive disorder (3)
- Makrophagen (3)
- Manner of death (3)
- Masquelet technique (3)
- Membrane proteins (3)
- Mental health (3)
- Mesenchymal stem cells (3)
- Messenger RNA (3)
- Meta-analysis (3)
- Metaanalysis (3)
- Metabolic diseases (3)
- Metabolic syndrome (3)
- Metabolism (3)
- Metabolomics (3)
- Methicillin-resistant Staphylococcus aureus (3)
- Microbiome (3)
- Microwave ablation (3)
- Monitoring (3)
- Morphogenesis (3)
- Morphology (3)
- Motor control (3)
- Multianalyte detection (3)
- Multiplate (3)
- Musculoskeletal disorder (3)
- Myalgia (3)
- NADH dehydrogenase (3)
- NIRS (3)
- NMR spectroscopy (3)
- NSCLC (3)
- Nerve fibers (3)
- Neuroblastom (3)
- Neurodegeneration (3)
- Neuroinflammation (3)
- Neurotransmitter (3)
- Nivolumab (3)
- Non-REM sleep (3)
- Nox (3)
- OSPE (3)
- OXA-48 (3)
- Obduktion (3)
- Observational study (3)
- Occlusion treatment (3)
- Occupational health (3)
- Offene Versorgung (3)
- Open repair (3)
- Optogenetics (3)
- Oxidative phosphorylation (3)
- Oxidativer Stress (3)
- PARK2 (3)
- PBPK (3)
- PDGFRβ (3)
- PSA (3)
- Pediatric patients (3)
- Pediatrics (3)
- Penile carcinomas (3)
- Peri-implantitis (3)
- Periodontitis (3)
- Persistence (3)
- Pflege (3)
- Phosphorylation (3)
- Platelets (3)
- Portal veins (3)
- Pre-analytics (3)
- Preterm birth (3)
- Primary health care (3)
- Primärversorgung (3)
- Prognostic markers (3)
- Progranulin (3)
- Prostataspezifisches Antigen (3)
- Protease inhibitor therapy (3)
- Psoriasis (3)
- Psychiatrie (3)
- Pulmonary hypertension (3)
- Questionnaire (3)
- Questionnaires (3)
- RCT (3)
- RITA (3)
- RNA interference (3)
- RNA sequencing (3)
- RNA therapeutics (3)
- Ratgeber (3)
- Ratte (3)
- Rechtsmedizin (3)
- Regression analysis (3)
- Relaxometry (3)
- Reliability (3)
- Reliabilität (3)
- Renal cell carcinoma (3)
- Research Article (3)
- Respiration (3)
- Rezidiv (3)
- Risk assessment (3)
- S1P (3)
- SARS (3)
- SF-36 (3)
- SNP (3)
- SUDEP (3)
- SUMO (3)
- SVR (3)
- Sarcoma (3)
- Seizures (3)
- Sensitivität und Spezifität (3)
- Serodiagnosis (3)
- Sexualität (3)
- Simulated patients (3)
- Sleep (3)
- Sphingolipids (3)
- Spiel (3)
- Spine (3)
- Sports and exercise medicine (3)
- Sprachstörung (3)
- Squamous cell carcinoma (3)
- Stammzelltransplantation (3)
- Statistical data (3)
- Stereotactic body radiation therapy (3)
- Strength training (3)
- Streptococcus pneumoniae (3)
- Sudden cardiac death (3)
- Surgeons (3)
- Synapses (3)
- Synaptic plasticity (3)
- Systematic reviews (3)
- TGF-β (3)
- TGFβ (3)
- TIPS (3)
- TKI (3)
- TSC (3)
- Target identification (3)
- Teaching (3)
- Tele-EEG (3)
- Telemedicine (3)
- Temozolomide (3)
- Tensiomyography (3)
- Thoracic trauma (3)
- Thrombozytenkonzentrat (3)
- Thyroid (3)
- Todesart (3)
- Torque (3)
- Toxicity (3)
- Transarterial chemoembolization (3)
- Type 2 diabetes (3)
- USP28 (3)
- Undergraduate medical education (3)
- Upper body posture (3)
- Validity (3)
- Variant histology (3)
- Vergütung (3)
- Versorgungsqualität (3)
- Wnt (3)
- Women (3)
- Zoonosis (3)
- absent expenditure of material (3)
- accident (3)
- acetylcholine (3)
- actin (3)
- acupuncture (3)
- acute coronary syndromes (3)
- acute decompensation (3)
- acute leukemia (3)
- adenosine (3)
- adherence (3)
- adjuvant chemotherapy (3)
- adult (3)
- aged (3)
- albumin (3)
- alcohol use disorder (3)
- allogeneic stem cell transplantation (3)
- alveolar ridge augmentation (3)
- anal cancer (3)
- animal model (3)
- animal models (3)
- anti-angiogenic therapy (3)
- antiviral (3)
- anxiety (3)
- aptamer (3)
- arteriogenesis (3)
- ascites (3)
- aspirin (3)
- astrocytes (3)
- atezolizumab (3)
- attention-deficit/hyperactivity disorder (3)
- autism spectrum disorder (3)
- autologous stem cell transplantation (3)
- automation (3)
- bacteria (3)
- bereavement (3)
- biocompatibility (3)
- bleeding (3)
- blood (3)
- blood transfusion (3)
- body mass index (3)
- bone (3)
- bone regeneration (3)
- bortezomib (3)
- brain cancer (3)
- brain imaging (3)
- brain metastasis (3)
- brain stimulation (3)
- brainstem (3)
- burden of illness (3)
- callous-unemotional traits (3)
- calprotectin (3)
- calretinin (3)
- cancer immunotherapy (3)
- cancer specific survival (3)
- carbapenemases (3)
- cardiac (3)
- caregivers (3)
- cartilage (3)
- caspase-2 (3)
- caspase-8 (3)
- catheter ablation (3)
- cell cycle (3)
- cell proliferation (3)
- chemokines (3)
- chronic myeloid leukemia (3)
- cisplatin (3)
- clinical benefit (3)
- clinical research (3)
- clinical trials (3)
- cochlea (3)
- colon (3)
- comorbidities (3)
- comorbidity (3)
- compartmental neuron model (3)
- complex I (3)
- complexome profiling (3)
- computational model (3)
- computational neuroscience (3)
- computational virology (3)
- continuous performance test (3)
- corona (3)
- cortisol (3)
- critical size defect (3)
- critically ill patients (3)
- cycling (3)
- cytokine-induced killer cells (3)
- decision making (3)
- dental education (3)
- dental profession (3)
- dexamethasone (3)
- diabetic nephropathy (3)
- diagnostic algorithm (3)
- didactic (3)
- diet (3)
- disintegration (3)
- dissolution (3)
- drug induced liver injury (3)
- drug release (3)
- eNOS (3)
- echocardiography (3)
- education (3)
- endocannabinoids (3)
- endoplasmic reticulum (3)
- epidermal growth factor receptor (3)
- episodic memory (3)
- evolution (3)
- fascia (3)
- feedback (3)
- fenfluramine (3)
- focal adhesion (3)
- follow-up (3)
- functional outcome (3)
- fusion (3)
- gamma (3)
- gene regulation (3)
- genetics (3)
- glucose (3)
- growth inhibition (3)
- haemophilia care (3)
- head and neck cancer (3)
- health (3)
- healthcare worker (3)
- heart (3)
- heart rate (3)
- hematopoiesis (3)
- hematopoietic stem and progenitor cells (3)
- hematopoietic stem cells (3)
- hepatitis B (3)
- herb induced liver injury (3)
- histone acetylation (3)
- homeostasis (3)
- hyperactivity (3)
- immune cells (3)
- immune checkpoint inhibitors (3)
- immune escape (3)
- immune reconstitution (3)
- immunmodulierende Effekte (3)
- immunologische Methoden (3)
- immunomodulatory effects (3)
- immunosuppression (3)
- inertial motion capture (3)
- infectious diseases (3)
- infrared-A radiation (3)
- insulin resistance (3)
- interleukin-22 (3)
- interleukins (3)
- invasive fungal disease (3)
- invasive fungal infection (3)
- iron metabolism (3)
- irradiation (3)
- kidney transplantation (3)
- leptin (3)
- lipidomics (3)
- lipids (3)
- liver injury (3)
- local recurrence (3)
- lockdown (3)
- long-term prophylaxis (3)
- lyme disease (3)
- lymphoma (3)
- mRNA (3)
- magnetoencephalography (3)
- massively parallel multigrid solvers (3)
- meta-analysis (3)
- metastatic (3)
- metformin (3)
- miRNAs (3)
- microdialysis (3)
- microwave ablation (3)
- mild cognitive impairment (3)
- mitochondrial disease (3)
- mitochondrial dysfunction (3)
- mitochondrial respiration (3)
- molecular mechanisms (3)
- monoclonal antibody (3)
- morbidity (3)
- morphology (3)
- mouse model (3)
- multi-scale modeling (3)
- multidrug resistance (3)
- musculoskeletal (3)
- mycophenolic acid (3)
- myocarditis (3)
- nanoparticles (3)
- necroptosis (3)
- neoadjuvant chemotherapy (3)
- neonate (3)
- neoplasms (3)
- neural network (3)
- neurocritical care (3)
- neuromodulation (3)
- neuropathy (3)
- neurophysiology (3)
- neutralization (3)
- neutralizing antibodies (3)
- newborn (3)
- next-generation sequencing (3)
- non-coding RNA (3)
- occupational infections (3)
- oncology (3)
- online survey (3)
- optogenetics (3)
- osteoporosis (3)
- overweight (3)
- oxidative phosphorylation (3)
- p47phox (3)
- pediatric patients (3)
- pentose phosphate pathway (3)
- perforant path transection (3)
- perfusion (3)
- peri-implantitis (3)
- pericarditis (3)
- pharmacodynamics (3)
- pharmacogenetics (3)
- physiotherapy (3)
- plasmid (3)
- platelet-rich fibrin (3)
- pneumonia (3)
- postoperative complications (3)
- postoperative pain (3)
- posttraumatic stress disorder (3)
- predictor (3)
- primary prostate cancer (3)
- primary sclerosing cholangitis (3)
- prognostic factors (3)
- prolonged grief disorder (3)
- protein synthesis (3)
- proteoglycan (3)
- proteome (3)
- proteostasis (3)
- pulmonary hypertension (3)
- radical prostatecomy (3)
- realistic geometries (3)
- relapse (3)
- relaxometry (3)
- remodelling (3)
- renal cell cancer (3)
- renal function (3)
- reproducibility (3)
- resistance mutation (3)
- resolution (3)
- rituximab (3)
- salvage therapy (3)
- scientometrics (3)
- seizures (3)
- serum (3)
- severe acute respiratory syndrome coronavirus 2 (3)
- sex (3)
- simulation (3)
- soft tissue sarcoma (3)
- sphingolipid (3)
- squamous cell carcinoma (3)
- stress response (3)
- supportive periodontal therapy (3)
- surgical procedures (3)
- synchrony (3)
- systematic biopsy (3)
- systemic antibiotics (3)
- therapeutics (3)
- therapy monitoring (3)
- tobacco prevention (3)
- toll-like receptor (3)
- trafficking (3)
- training (3)
- transcriptome (3)
- transient elastography (3)
- triglycerides (3)
- tumor angiogenesis (3)
- type 1 diabetes (3)
- tyrosine kinase inhibitor (3)
- validity (3)
- vemurafenib (3)
- viral dynamics (3)
- virus (3)
- visual analog scales (VAS) (3)
- visual analogue scales (VAS) (3)
- visual attention (3)
- von Willebrand factor (3)
- working conditions (3)
- zinc (3)
- Ähnlichkeit (3)
- - (2)
- 17-AAG (2)
- 3D spatio-temporal resolved mathematical models (2)
- 5′-UTR (2)
- 6-shogaol (2)
- A/D transition (2)
- ABCC1 (2)
- ABCG2 (2)
- ACL (2)
- AF4 (2)
- AKI (2)
- AKT (2)
- ALK (2)
- AMH (2)
- AMPK (2)
- APP processing (2)
- ARFI (2)
- ATP-citrate lyase (2)
- Abdominelles Aortenaneurysma (2)
- Abort (2)
- Absorption (2)
- Academic medicine (2)
- Access (2)
- Accidental reaction (2)
- Acinetobacter baumannii (2)
- Acne inversa (2)
- Acoustics (2)
- Action potentials (2)
- Activities of daily living (2)
- Acuris (2)
- Acute Myeloid Leukemia (AML) (2)
- Acute decompensation (2)
- Acute leukemia (2)
- Acute lymphocytic leukaemia (2)
- Acute myeloid leukaemia (2)
- Acute seizure plan (2)
- Acute-on-chronic liver failure (2)
- Addiction (2)
- Addison’s disease (2)
- Adipose tissue (2)
- Adipose-derived mesenchymal stem cells (2)
- Adolescence (2)
- Adult neurogenesis (2)
- Adverse drug reaction (2)
- Africa (2)
- Age (2)
- Age estimation (2)
- Aggression (2)
- Akaike information criterion (AIC) (2)
- Akute lymphatische Leukämie (2)
- Akuter Anfallsplan (2)
- Alcohol consumption (2)
- Alcoholic liver disease (2)
- Algorithms (2)
- Alleles (2)
- Allergen avoidance (2)
- Allergic asthma (2)
- Allergy (2)
- Allosteric inhibition (2)
- Alpelisib (2)
- Alpha-synuclein (2)
- Alzheimer-Krankheit (2)
- Anaemia (2)
- Anal cancer (2)
- Analgesia (2)
- Analgesie (2)
- Analyse der Körperzusammensetzung (2)
- Anamneseerhebung (2)
- Anandamide (2)
- Anatomy (2)
- Angiographie (2)
- Animal model (2)
- Anschlussheilbehandlung (2)
- Anti-IgE (2)
- Anti-seizure medication (2)
- Anticoagulant therapy (2)
- Anticonvulsants (2)
- Antigen test (2)
- Antikonvulsiva (2)
- Antikörpertest (2)
- Antimicrobial resistance (2)
- Antimicrobial treatment (2)
- Antiretrovirals (2)
- Aortic dissection (2)
- Apheresis (2)
- Apixaban (2)
- Appendectomy (2)
- Arbeitsgemeinschaft Sammlung Deutscher Drucke (2)
- Arrhythmia (2)
- Arthroplasty (2)
- Arzneimittel (2)
- Arzneimittelmarkt (2)
- Asphyxia (2)
- Assessment (2)
- Associative memory (2)
- Asthma (2)
- Ataxia (2)
- Atezolizumab (2)
- Attention-deficit/hyperactivity disorder (2)
- Audio signal processing (2)
- Auditory rehabilitation (2)
- Auditory system (2)
- Augenheilkunde (2)
- Aurora A (2)
- Aurora kinase (2)
- Austria (2)
- Autoimmunity (2)
- Autologous biomaterial (2)
- Axons (2)
- Ayurveda (2)
- BA.1 (2)
- BCL2 (2)
- BCL6 (2)
- BCOR (2)
- BCX7353 (2)
- BFR training (2)
- BMNC (2)
- BNT162b2 (2)
- BPH (2)
- BRCA1 (2)
- BRCA2 (2)
- Babesia divergens (2)
- Babesia microti (2)
- Back pain (2)
- Bacteria (2)
- Bacterial biofilms (2)
- Bacterial meningitis (2)
- Balance (2)
- Bartonella henselae (2)
- Bauchaortenaneurysma (2)
- Begriff (2)
- Behandlungsposition (2)
- Benefit (2)
- Berufskrankheit (2)
- Betriebliche Gesundheitsförderung (2)
- Bevacizumab (2)
- Bewegung (2)
- Bewegungsmangel (2)
- Biceps brachii (2)
- Big Data (2)
- Big Five (2)
- Bildgebung (2)
- Bile duct stone (2)
- Biodiversity (2)
- Bioenergetics (2)
- Biofilm (2)
- Bioinformatics (2)
- Biological profile (2)
- Biomedical engineering (2)
- Biomedical informatics (2)
- Biophysical chemistry (2)
- Biophysical models (2)
- Biorecognition strategies (2)
- Biosynthetic mesh (2)
- Biotechnology (2)
- Bipolar (2)
- Birth weight (2)
- Bleeding (2)
- Blog (2)
- Blood groups (2)
- Blood loss (2)
- Blood loss estimation (2)
- Blood plasma (2)
- Bloodstream infections (2)
- Blow flies (2)
- Blutübertragbare Virusinfektionen (2)
- Body mass index (2)
- Body modification (2)
- Body posture (2)
- Bone marrow aspiration (2)
- Bone marrow-derived mesenchymal stem cells (2)
- Bone metastases (2)
- Borderline personality disorder (2)
- Bowel obstruction (2)
- Breast neoplasms (2)
- Breast tumors (2)
- Bungarus niger (2)
- Burden of disease (2)
- CAM (2)
- CBA (2)
- CC16 (2)
- CCL2 (2)
- CD14 (2)
- CD16 (2)
- CD44 (2)
- CD62 (2)
- CDK9 (2)
- CDKN1A (2)
- CHIP (2)
- CIOMS (2)
- CIRS (2)
- CLN3 (2)
- CLP (2)
- CMR (2)
- CMV (2)
- CNN (2)
- COVID-19 pandemic (2)
- COVID-19 surveillance (2)
- COVID19-NMR (2)
- CPE (2)
- CRISPR/Cas (2)
- CSM (2)
- CTLA-4 (2)
- CUELA (2)
- CV9202 (2)
- CXCL13 (2)
- Caco-2 cells (2)
- Caenorhabditis elegans (2)
- Callous-unemotional traits (2)
- Calpain (2)
- Calprotectin (2)
- Cancer epidemiology (2)
- Cancer therapy (2)
- Cancer-specific mortality (2)
- Cannabidiol (2)
- Capecitabine (2)
- Carbapenemase (2)
- Carcinoma (2)
- Cardiac arrest (2)
- Cardiac hypertrophy (2)
- Cardiac magnetic resonance (2)
- Cardioprotection (2)
- Cardiovascular biology (2)
- Carotisstenose (2)
- Case management (2)
- Cats (2)
- Causality assessment (2)
- Celiac disease (2)
- Cell binding (2)
- Cell death (2)
- Cell death and immune response (2)
- Cell differentiation (2)
- Cell division (2)
- Cell salvage (2)
- Cellular Immune Response (2)
- Cerebral cortex (2)
- Checkpoint inhibitor (2)
- Chemokines (2)
- Chemoprevention (2)
- Chemotherapie (2)
- Child abuse (2)
- Children and adolescents (2)
- Chinesische Medizin (2)
- Chirurgie (2)
- Chlorides (2)
- Cholangiography (2)
- Cholangiopancreatography (2)
- Chondrocytes (2)
- Chronic depression (2)
- Chronic disease (2)
- Chronic hepatitis (2)
- Chronic inflammation (2)
- Chronic obstructive pulmonary disease (2)
- Chronisch-myeloische Leukämie (2)
- Clinical Global Impression of Change (2)
- Clinical presentation (2)
- Clinical studies (2)
- Clinical study (2)
- Clustering (2)
- Cocaine (2)
- Cochleaimplantation (2)
- Collagens (2)
- Colloids (2)
- Colonoscopy (2)
- Community based intervention (2)
- Community health services (2)
- Complexity (2)
- Complication management (2)
- Computational biology and bioinformatics (2)
- Computational model (2)
- Computational neuroscience (2)
- Computational science (2)
- Computed Tomography (2)
- Computer hardware (2)
- Computer science (2)
- Computertomographie (2)
- Connectivity (2)
- Connectomics (2)
- Coronary artery disease (2)
- Cortex (2)
- Cost-effectiveness (2)
- Cre-recombinase (2)
- Croatia (2)
- Crohn's disease (2)
- CspZ (2)
- Cuela (2)
- Curriculum (2)
- CyberKnife robotic radiosurgery (2)
- CysLTR1 (2)
- Cytogenetics (2)
- Cytologie (2)
- Cytoskeletal proteins (2)
- DEPDC5 (2)
- DMARDs (biologic) (2)
- DNA (2)
- DOMS (2)
- DSM (2)
- Daptomycin (2)
- Database searching (2)
- Datenschutz (2)
- Datenverarbeitung (2)
- Decision trees (2)
- Defibrillation (2)
- Degradation (2)
- Demenz (2)
- Dengue (2)
- Dengue virus (2)
- Density-equalizing mapping (2)
- Dental implants (2)
- Dentist (2)
- Dentists (2)
- Dermatologie (2)
- Diagnostic algorithm (2)
- Diagnostic imaging (2)
- Diagnostic test (2)
- Dialyse (2)
- Dicer (2)
- Differential diagnosis (2)
- Differentiation (2)
- Differenzierung (2)
- Digestive system procedures (2)
- Digitalization (2)
- Direct current electrical stimulation (2)
- Directly acting antiviral agent (2)
- Disc herniation (2)
- Disease Activity (2)
- Disintegration (2)
- Distance to water (2)
- Docetaxel (2)
- Double-balloon enteroscopy (2)
- Drug development (2)
- Drug discovery (2)
- Dynamic MRI (2)
- E. coli (2)
- E3 ligase (2)
- EBM (2)
- EEG-fMRI (2)
- EET (2)
- EMT (2)
- ENCODE-DREAM in vivo Transcription Factor binding site prediction challenge (2)
- EQ-5D (2)
- ERP (2)
- ESBL (2)
- EWSR1 (2)
- Ears (2)
- Ebola virus (2)
- Ecosystem services (2)
- Edinger, Ludwig (2)
- Edoxaban (2)
- Efficacy (2)
- Electrical stimulation (2)
- Electroencephalography – EEG (2)
- Electrophysiology (2)
- Elevation (2)
- Emotion (2)
- Empathy (2)
- EndMT (2)
- Endocannabinoid (2)
- Endocannabinoids (2)
- Endokrinologie (2)
- Endometriosis (2)
- Endoscopic retrograde (2)
- Endoscopic ultrasound (2)
- Endosomes (2)
- Endothel (2)
- Endothelial permeability (2)
- Endotoxin (2)
- Endovaskuläre Behandlung (2)
- Ensemble learning (2)
- Enterobacteriaceae (2)
- Enterscopy (2)
- Environmental support (2)
- Enzyme-linked Immunosorbent Assay (2)
- Enzyme-linked immunoassays (2)
- EphB4 (2)
- Epicutaneous immunotherapy (2)
- Epidemiology and End Results (2)
- Epidermal growth factor receptor (2)
- Epileptic seizures (2)
- Episodic memory (2)
- Epstein-Barr virus (2)
- Equity (2)
- Ergonomics (2)
- Erwachsene (2)
- Erweiterter Suizid (2)
- Etiology (2)
- Euthanasie <Nationalsozialismus> (2)
- Evidence-based (2)
- Evidence-based dentistry (2)
- Evidenz (2)
- Evidenzbasierte Medizin (2)
- Extended donor criteria (2)
- Extended suicide (2)
- Extracellular matrix proteins (2)
- FEV1 (2)
- FFPE (2)
- FHIR (2)
- FLT3-ITD (2)
- Face (2)
- Fachsprache (2)
- Family practice (2)
- Fatty liver (2)
- Fertilität (2)
- Fertilité (2)
- Fettstoffwechsel (2)
- Fibroblasts (2)
- Finanzierung (2)
- Flaps (2)
- Flexibility (2)
- Follow-up treatment (2)
- Forensische Osteologie (2)
- Fortbildung (2)
- Fragebogen (2)
- Frailty (2)
- Frankfurt am Main (2)
- Früherkennung (2)
- Fuchs endothelial dystrophy (2)
- Function (2)
- Functional characterization (2)
- Functional electrical stimulation (2)
- Funding (2)
- Fußkurbelergometerausdauerbelastung (2)
- G2A (2)
- GABA (2)
- GEMs (2)
- GFAP (2)
- GWAS (2)
- Gadobutrol (2)
- Galaktografie (2)
- Galaktomosynthese (2)
- Gaming disorder (2)
- Gastritis (2)
- Gastrointestinal bleeding (2)
- Gastroschisis (2)
- Gehen (2)
- Gelenkersatz (2)
- Gemeinschaftliche Selbsttötung (2)
- Gender reassigning surgery (2)
- Gene (2)
- Gene ontology (2)
- General practitioners (2)
- Genetic engineering (2)
- Genetic testing (2)
- Genetik (2)
- Genexpression (2)
- Genregulation (2)
- Gentherapie (2)
- Geographic variation (2)
- Geographically weighted regression (GWR) (2)
- Geriatric patients (2)
- German people (2)
- Geschichte 1801-1870 (2)
- Gesetz zur Verhütung erbkranken Nachwuchses (2)
- Gesichtsauflösung (2)
- Gesprächsführung (2)
- Gewalt (2)
- Gezielte Therapie (2)
- Ginkgoblatt-Extrakt (2)
- Glaucoma (2)
- Gleason score (2)
- Glucose metabolism (2)
- Glycolysis (2)
- Grafts (2)
- Growth factors (2)
- HBsAg (2)
- HCMV (2)
- HDACi (2)
- HES (2)
- HIV protease inhibitors (2)
- HIV-Infektion (2)
- HL7 FHIR (2)
- HLA class I (2)
- HNO (2)
- HOD (2)
- HRM (2)
- HSV (2)
- HSV-1 (2)
- HUVEC (2)
- Hals-Nasen-Ohren-Heilkunde (2)
- Hashimoto-Thyreoiditis (2)
- Hausarzt (2)
- Hausarztmangel (2)
- Hausarztpraxis (2)
- HeLa cells (2)
- Health care workers (2)
- Health policy (2)
- Health services (2)
- Healthcare personnel (2)
- Healthcare resource utilization (2)
- Heart rate (2)
- Heilkunde (2)
- Hematologic malignancies (2)
- Hemodynamics (2)
- Hepatitis B virus (2)
- Herpes Zoster Infektion (2)
- Herpes-simplex-Virus (2)
- Herzinfarkt (2)
- Herztransplantation (2)
- Heterogeneity (2)
- High oblique sagittal osteotomy (2)
- High-density lipoprotein (2)
- High-density-Lipoproteine HDL (2)
- Hirninfarkt (2)
- Hirnkrankheit (2)
- Hirntumor (2)
- Histologie (2)
- Holmes tremor (2)
- Homicide (2)
- Hospital (2)
- Host-biofilm interactions (2)
- HuR (2)
- Human (2)
- Hypertonie (2)
- Hörrehabilitation (2)
- Hörrinde (2)
- Hüfte (2)
- IAPs (2)
- ICD-11 (2)
- IDH mutation (2)
- IHC (2)
- IKZF1 (2)
- IL-10 (2)
- IL-12 (2)
- IL-33 (2)
- IR-A (2)
- ISR (2)
- Identification (2)
- Ileus (2)
- Image analysis (2)
- Imatinib mesilat (2)
- Imeetto (2)
- Immune Response (2)
- Immune suppression (2)
- Immunenzymtechniken (2)
- Immunity (2)
- Immunität <Medizin> (2)
- Immunmodulation (2)
- Immunoenzyme Techniques (2)
- Immunogenicity (2)
- Immunologic methods (2)
- Immuntherapie (2)
- Immunturbidimetrie (2)
- Impfraten (2)
- Implementation (2)
- In vivo (2)
- Incidence rate (2)
- Incisional hernia (2)
- Indirect-binding (2)
- Indonesia (2)
- Infection control (2)
- Infektiologie (2)
- Infektion (2)
- Information theory (2)
- Injuries (2)
- Innate Immunity (2)
- Innate immune response (2)
- Insulin signalling (2)
- Integration (2)
- Integrin (2)
- Integrins (2)
- Intelligence (2)
- Intensive care treatment (2)
- Interaktion (2)
- Interdisciplinarity (2)
- Interdisziplinarität (2)
- Interferon (2)
- Interleukin-1 (2)
- Intervention (2)
- Interventionsversuch (2)
- Iron (2)
- Iron deficiency (2)
- Iron deficiency anemia (2)
- Ischemia/reperfusion injury (2)
- Joint loading (2)
- Jumping (2)
- KGF (2)
- Katherine (2)
- Ketogenic diet (2)
- Ki-67 (2)
- Kinases (2)
- Kinderkrankheit (2)
- Klassifikation (2)
- Klebsiella pneumoniae (2)
- Klinische Ergebnisse (2)
- Klinische Kompetenz (2)
- Knee joint (2)
- Knochen (2)
- Kolorektales Karzinom (2)
- Kompetenzen (2)
- Komplementsystem (2)
- Komplikation (2)
- Krankenversicherung (2)
- Krebs (2)
- Kunst (2)
- Körpergewicht (2)
- Körperhaltung (2)
- Körpermasseindex BMI (2)
- L-DOPA (2)
- LSCC (2)
- LVAD (2)
- Labordiagnostik (2)
- Laktat (2)
- Lamivudine (2)
- Landarztprogramm (2)
- Laparoskopie (2)
- Lasers (2)
- Laufband (2)
- Left hemisphere (2)
- Leistungsfähigkeit (2)
- Leptin (2)
- Leukemias (2)
- Leukocytes (2)
- Leukotriene (2)
- Lipid signalling (2)
- Lipidomics (2)
- Lipolyse (2)
- Liposomes (2)
- Literatur (2)
- Liver (2)
- Liver cancer (2)
- Liver injury (2)
- Livestock (2)
- Local climate (2)
- Local therapy (2)
- Lokalrezidiv (2)
- Long-COVID (2)
- Long-term potentiation (2)
- Longitudinal (2)
- Low-density-Lipoproteine LDL (2)
- Low-molecular-weight heparin (2)
- Low-virulent infection (2)
- Luciferase (2)
- Lucilia sericata (2)
- Lung cancer (2)
- Lungenfunktion (2)
- Lyme borreliosis (2)
- Lymph nodes (2)
- Lymphectasia (2)
- Lymphocytes (2)
- Lymphom (2)
- Lymphoma (2)
- Lysophosphatidic acids (2)
- Lysosome (2)
- M2-PK (2)
- MALAT1 (2)
- MCI (2)
- MHC (2)
- MICA (2)
- MLH1 (2)
- MLKL (2)
- MLL-r leukemia (2)
- MMP9 (2)
- MR spectroscopy (2)
- MRP4 (2)
- MSC (2)
- MTT assay (2)
- Macroautophagy (2)
- Magnetic resonance (2)
- Makhuwa-Meetto (2)
- Malaria prevalence (2)
- Malnutrition (2)
- Mamma (2)
- Marburg virus (2)
- Markovianity (2)
- Mastectomy (2)
- Maxillary sinus (2)
- Medical consultation (2)
- Medical diagnostics (2)
- Medication Appropriateness Index (2)
- Medicine (2)
- Medizinische Ethik (2)
- Medizinsoziologie (2)
- Meldepflicht (2)
- Membrane potential (2)
- Memory (2)
- Memory consolidation (2)
- Mensch (2)
- Mental imagery (2)
- Mesh (2)
- Metastasis (2)
- Metastatic (2)
- Metastatic breast cancer (2)
- Metastatic castration-resistant prostate cancer (2)
- Mice (2)
- Microarray (2)
- Microglia (2)
- Microstates (2)
- Microsurgery (2)
- Migrants (2)
- Mindfulness (2)
- Minimal residual disease (2)
- Mitochondrial ROS (2)
- Mitochondrial complex I (2)
- Mitosis (2)
- MitraClip (2)
- Mixed methods (2)
- Mobilization (2)
- Model (2)
- Molecular autopsy (2)
- Molecular profiling (2)
- Molecular subtypes (2)
- Monocytes (2)
- Morbus Basedow (2)
- Morphometry (2)
- Mountain (2)
- Multidrug resistance (2)
- Multimorbidität (2)
- Multiple Sklerose (2)
- Multiple chronic conditions (2)
- Multivariable analysis (2)
- Multivariate Analyse (2)
- Music (2)
- Muskuloskeletale Erkrankungen (2)
- Mutation (2)
- Mutations (2)
- Mycobacterium tuberculosis (2)
- Myeloid Neoplasia (2)
- Myocardial perfusion (2)
- Myocarditis (2)
- Myokardinfarkt (2)
- Myokarditis (2)
- NADH:ubiquinone oxidoreductase (2)
- NCCN (2)
- NCoR1 (2)
- NF-κB pathway (2)
- NFκB (2)
- NK cells (2)
- NMR (2)
- NOTCH1 (2)
- NR4A2 (2)
- NS-Medizin (2)
- NS3 (2)
- Nachsorge (2)
- Nachweismethoden (2)
- Nachweisverfahren (2)
- Nadelstichverletzungen (2)
- Necrotizing enterocolitis (2)
- Neoplasms (2)
- Nepal (2)
- Nephrectomy (2)
- Nerve regeneration (2)
- Nervenkrankheit (2)
- Neugeborenes (2)
- Neural circuits (2)
- Neural stem cells (2)
- Neuroimaging (2)
- Neurologie (2)
- Neuron (2)
- Neuronal dendrites (2)
- Neuronal morphology (2)
- Neuronal plasticity (2)
- Neuropathic pain (2)
- Neurophysiologie (2)
- Neurophysiology (2)
- Neuropsychiatrie (2)
- Neurosurgery (2)
- Neurotoxicity (2)
- Nevirapine (2)
- Nicotine (2)
- Non-coding RNA (2)
- Non-interventional study (2)
- Normal distribution (2)
- Notaufnahme (2)
- Notfallmedizin (2)
- Nox1 (2)
- Nucleic acid biomarkers (2)
- Nuklearmedizin (2)
- Numerical simulation (2)
- Nursing (2)
- Nutrition (2)
- OCT (2)
- Object vision (2)
- Observational (2)
- Obstetrics and gynecology (2)
- Occupational disease (2)
- Olfactory system (2)
- Onkologie (2)
- Operation/Chirurgie (2)
- Ophthalmology (2)
- Opioids (2)
- Opportunistic infections (2)
- Optical phenomena (2)
- Oral immunotherapy (2)
- Oral surgery (2)
- Ordinary least squares (OLS) (2)
- Organ dysfunction (2)
- Organ dysfunctions (2)
- Organ preservation (2)
- Organoids (2)
- Oroantral (2)
- Orthognathic surgery (2)
- Osteoarthritis (2)
- Osteocalcin (2)
- Osteogenic differentiation (2)
- Osteoporotic fractures (2)
- Outcome assessment (2)
- Outcomes research (2)
- Outpatients (2)
- Ovarian cancer (2)
- Oxidative stress (2)
- OxyELITE Pro (2)
- P2X7 receptor (2)
- PAC-1 (2)
- PAH (2)
- PARP (2)
- PC12 cells (2)
- PD-1 (2)
- PD1/ PDL1 (2)
- PD‑L1 (2)
- PET (2)
- PGE2 (2)
- PINK1 (2)
- PLGA (2)
- PML (2)
- PPARγ (2)
- PRF (2)
- PRNT (2)
- PROTAC (2)
- PTEN (2)
- Pacemaker (2)
- Pain management (2)
- Pain sensation (2)
- Palliative care (2)
- Palliative care [MeSH] (2)
- Parenteral nutrition (2)
- Parkin (2)
- Parkinson (2)
- Parkinson disease (2)
- Particulate matter (2)
- Pathologic complete response (2)
- Pathology (2)
- Patient (2)
- Patient Blood Management (2)
- Patient information (2)
- Patient manikins (2)
- Patient needs (2)
- Patient preference (2)
- Patient*inneninformation (2)
- Patient-centred care (2)
- Patientenbedürfnisse (2)
- Patientenverfügung (2)
- Patterns of care (2)
- Pediatric infections (2)
- Pelargonium sidoides (2)
- Penile cancer (2)
- Pentaglobin (2)
- Percutaneous coronary intervention (2)
- Perikarditis (2)
- Periodontal therapy (2)
- Periodontal treatment (2)
- Periphere arterielle Verschlusskrankheit (2)
- Peritonitis (2)
- Permutation (2)
- Persistent wound infections (2)
- Person-Umwelt-Passung (2)
- Person-environment fit (2)
- Personal- und Organisationsentwicklung (2)
- Personalisierte translationale Therapie (2)
- Petri net (2)
- Philadelphia chromosome (2)
- Phospholipids (2)
- Phylogenetic analysis (2)
- Physical environment (2)
- Physics (2)
- Physikalische Medizin (2)
- Physikalische Therapie (2)
- Plasma (2)
- Plasmodium (2)
- Plattenepithelcarcinom (2)
- Plerixafor (2)
- Plk1 inhibitors (2)
- Pneumocystis jirovecii (2)
- Pneumoperitoneum (2)
- Podospora anserina (2)
- Point-of-care testing (2)
- Police (2)
- Positron emission tomography (2)
- Post-mortem interval (2)
- Post-translational modifications (2)
- Post-traumatic stress disorder (2)
- Postoperative radiochemotherapy (2)
- Posttraumatische Belastungsstörung (2)
- Posture analysis (2)
- Poverty (2)
- Practical skills (2)
- Predictive coding (2)
- Predominant polarity (2)
- Preeclampsia (2)
- Primary cilium (2)
- Prisoners (2)
- Prisons (2)
- Probability density (2)
- Probability distribution (2)
- Procalcitonin (2)
- Professional dance (2)
- Professionalisierung (2)
- Prognose (2)
- Prognosefaktoren (2)
- Prognostic (2)
- Prognostic tool (2)
- Programm (2)
- Prostatic neoplasms (2)
- Proteasome (2)
- Protein biomarkers (2)
- Protein degradation (2)
- Protein synthesis (2)
- Protein translation (2)
- Proteins (2)
- Prädiktive Validität (2)
- Prädiktivfaktoren (2)
- Präkonditionierung (2)
- Prävalenz (2)
- Pseudomonas aeruginosa (2)
- Psychedelics (2)
- Psychoanalyse (2)
- Psychological stress (2)
- Psychopathology (2)
- Psychopharmaka (2)
- Psychotherapie (2)
- Pulmonary veins (2)
- Qualitative research (2)
- Quality indicators (2)
- Qualitätsmanagement (2)
- Quarantine (2)
- Quinine (2)
- RAS (2)
- RBFOX1 (2)
- RDoC (2)
- RIPK3 (2)
- RMS (2)
- RNA binding proteins (2)
- RNA interference (RNAi) (2)
- RNA isolation (2)
- RNA processing (2)
- RNA therapy (2)
- RNA-binding protein (2)
- RNA-binding proteins (2)
- RNA-sequencing (2)
- RNAseq (2)
- ROS1 (2)
- Rab7 (2)
- Radiation (2)
- Radical prostatectomy (2)
- Radiochemotherapy (2)
- Radiologie (2)
- Rainfall (2)
- Random forest (2)
- Randomized controlled trials (2)
- Reanimation (2)
- Recurrence (2)
- Red blood cell transfusion (2)
- Redoxin (2)
- Refractory ALL (2)
- Refugees (2)
- Rehabilitation outcome (2)
- Rehabilitationsergebnis (2)
- Rejection (2)
- Remission (2)
- Remuneration (2)
- Renal system (2)
- Reproducibility (2)
- Rescue medication (2)
- Research architecture (2)
- Respiratory chain (2)
- Respiratory distress syndrome (2)
- Respiratory infections (2)
- Restenosis (2)
- Resting state (2)
- Resting-state (2)
- Retina (2)
- Return to play (2)
- Reward (2)
- Rheumatoid Arthritis (2)
- Ribavirin (2)
- Richtlinie (2)
- Risikofaktoren (2)
- Risikokommunikation (2)
- Risk communication (2)
- Risk factor (2)
- Risk stratification (2)
- Rivaroxaban (2)
- Roussel Uclaf Causality Assessment Method (RUCAM) (2)
- Rural area (2)
- Rückenschmerzen (2)
- S1P lyase (2)
- S1P receptors (2)
- SAMHD1 (2)
- SARS coronavirus (2)
- SARS-CoV-2 monitoring (2)
- SARS-CoV-2 testing (2)
- SARS-CoV‑2 (2)
- SARS‐CoV‐2 (2)
- SCC (2)
- SCCHN (2)
- SD-OCT (2)
- SENP (2)
- SIRS (2)
- SIRT1 (2)
- SMAD (2)
- SOD (2)
- SPM (2)
- SPTAN1 (2)
- STAT1 (2)
- STING (2)
- SUMOylation (2)
- SV2A (2)
- Sarcoidosis (2)
- Sauerstoff (2)
- Scheimpflug imaging (2)
- Schilddrüsenfunktion (2)
- Schilddrüsenknoten (2)
- Schizophrenie (2)
- Schmerztherapie (2)
- Scientists (2)
- Selbstmanagement (2)
- Self-management (2)
- Self-renewal (2)
- Senescence (2)
- Sensitivität (2)
- Sensory processing (2)
- Serin (2)
- Serodiagnose (2)
- Seroprevalence (2)
- Serum (2)
- Sestrin 2 (2)
- Sholl analysis (2)
- Short bowel syndrome (2)
- Shunt (2)
- Simulation and modeling (2)
- Simulation training (2)
- Skills (2)
- Slack (2)
- Smac mimetic (2)
- Small molecules (2)
- Smoking habits (2)
- Snakebite (2)
- Social Media (2)
- Social epidemiology (2)
- Social health determinants (2)
- Social neuroscience (2)
- Social participation (2)
- Social phobia (2)
- Socio-economic analysis (2)
- Socioeconomic status (2)
- Solution NMR spectroscopy (2)
- Sonication (2)
- Sorafenib (2)
- Soziologie (2)
- Specificity (2)
- Speech discrimination (2)
- Speech signal processing (2)
- Spezifität (2)
- Spinal cord (2)
- Spirochetes (2)
- Spiroergometrie (2)
- Sprache (2)
- Sprachverstehen (2)
- Sprechen (2)
- Sprechstörung (2)
- Staff development (2)
- Standard endoscopy (2)
- Standard value (2)
- Standardization (2)
- Stem-cell therapies (2)
- Sterblichkeit (2)
- Stereotaxie (2)
- Stickstoffmonoxid (2)
- Stress (2)
- Striatum (2)
- Stroke unit (2)
- Structural biology (2)
- Structural plasticity (2)
- Study protocol (2)
- Subarachnoid hemorrhage (2)
- Sudden death (2)
- Suicide pact (2)
- Suizidalität (2)
- Sumatra (2)
- Sunitinib (2)
- Superficial vein thrombosis (2)
- Superoxide (2)
- Supplementation (2)
- Supported decision making (2)
- Supportivtherapie (2)
- Survey (2)
- Survival analysis (2)
- Survivin (2)
- Sweden (2)
- Synaptic transmission (2)
- Synovial sarcoma (2)
- Systemic inflammation (2)
- Systemic therapy (2)
- T-Zellen (2)
- T-cell (2)
- T-cell targeting (2)
- T-cells (2)
- TBSS (2)
- TEP (2)
- TF-complexes (2)
- TGF-β1 (2)
- THR (2)
- TIGAR (2)
- TLR (2)
- TMT (2)
- TRPA1 (2)
- Tailored therapy (2)
- Target validation (2)
- Targeted therapies (2)
- Teeth (2)
- Tenofovir (2)
- Tetrahydrobiopterin (2)
- Thailand (2)
- Theft (2)
- Thromboembolism (2)
- Thrombolysis (2)
- Thrombophilie (2)
- Thrombotic thrombocytopenic purpura (2)
- Tick (2)
- Tick-borne diseases (2)
- Tight junctions (2)
- Toll-like receptor (2)
- Tomography (2)
- Tomography (x-ray computed) (2)
- Tomosynthese (2)
- Tooth loss (2)
- Transcription (2)
- Transcription Factors (2)
- Transfusionsmedizin (2)
- Transgender (2)
- Translation (2)
- Transmission (2)
- Transplantatabstoßung (2)
- Transplantation (2)
- Traumatic brain injury (2)
- Traumatic injury (2)
- Treatment position (2)
- Treg cell (2)
- Triglyzeride (2)
- Troponin (2)
- Tuberculosis (2)
- Tumor (2)
- Tumor marker (2)
- Tumour immunology (2)
- Tyrosinkinasen (2)
- T‑DM1 (2)
- UGCG (2)
- USA (2)
- Ubiquitin (2)
- Ubiquitylation (2)
- Ulcerative colitis (2)
- Ultrasonography (2)
- Universität Frankfurt am Main (2)
- Universitätskliniken (2)
- Unsterblichkeit (2)
- Unterstützung der Umwelt (2)
- Urethral cancer (2)
- Urology (2)
- Usability (2)
- Uteroglobin (2)
- V4 (2)
- VDR (2)
- VEGF receptors (2)
- VIGALL (2)
- VRE (2)
- VT (2)
- Vaccine (2)
- Vaccine uptake rate (2)
- Validierung (2)
- Vascular endothelial growth factor (VEGF) (2)
- Vasculitis (2)
- Veins (2)
- Vemurafenib (2)
- Versorgung (2)
- Versorgungsforschung (2)
- Versorgungsstrukturen (2)
- Viral Load (2)
- Viral infection (2)
- Virologie (2)
- Virulence (2)
- Viruslast (2)
- Virussicherheit (2)
- Visual acuity (2)
- Visual cortex (2)
- Visual estimation (2)
- Visual quality (2)
- Vitamin D deficiency (2)
- Vmem (2)
- Volume therapy (2)
- Voxel-based morphometry (2)
- Vulnerability (2)
- Warburg effect (2)
- Wearable cardioverter-defibrillator (2)
- Web 2.0 (2)
- Weight loss (2)
- Weiterbildung (2)
- Western blot (2)
- White blood cells (2)
- Wissenschaftsgeschichte (2)
- Working memory (2)
- Wortschatz (2)
- Wounds (2)
- Wundversorgung (2)
- Yoga (2)
- Zahnmedizin (2)
- Zebrafish (2)
- Zellkultur (2)
- Zentralnervensystem (2)
- Zigarette (2)
- Zika fever (2)
- Zingiber officinale Roscoe (2)
- Zink (2)
- Zoopotentation (2)
- Zooprophylaxis (2)
- ablation (2)
- abuse (2)
- accelerometry (2)
- acetyl-CoA (2)
- active aging (2)
- acute lung injury (2)
- acute myeloid leukaemia (2)
- acute respiratory distress syndrome (2)
- adalimumab (2)
- adaptations to microgravity (2)
- additive manufacturing (2)
- additives (2)
- adenovirus (2)
- adipocytes (2)
- adipose-derived mesenchymal stem cells (2)
- adipose-derived stromal/stem cells (2)
- admission test (2)
- adolescence (2)
- adolescent (2)
- adoptive cancer immunotherapy (2)
- adoptive immunotherapy (2)
- adult neurogenesis (2)
- advanced (2)
- advanced care planning (2)
- adverse reaction (2)
- age-related macular degeneration (2)
- ageing (2)
- air flow (2)
- alcoholic liver disease (2)
- algorithm (2)
- allogeneic hematopoietic stem cell transplantation (2)
- allostery (2)
- alpelisib (2)
- alpha band (2)
- alpha power (2)
- alpha-synuclein (2)
- alzheimer’s disease (2)
- ambulatory assessment (2)
- amino acids (2)
- amphiregulin (2)
- amyotrophic lateral sclerosis (ALS) (2)
- analgesia (2)
- analgesics (2)
- analysis of body composition (2)
- anaplastic large cell lymphoma (2)
- angiography (2)
- animal experiment (2)
- animal experiments (2)
- ankyrin (2)
- anorexia nervosa (2)
- antibiotic resistance (2)
- antibiotic therapy (2)
- antibody (2)
- antibody test (2)
- anticoagulation (2)
- anticonvulsants (2)
- antiepileptic drug (2)
- antiepileptic drugs (2)
- antifungal therapy (2)
- antigen (2)
- antioxidant (2)
- antiseizure medication (2)
- antisocial behavior (2)
- antiviral drugs (2)
- aortic valve stenosis (2)
- arachidonic acid (2)
- arousal (2)
- arthritis (2)
- assessment (2)
- astrocytoma (2)
- athletes (2)
- attachment loss (2)
- autism (2)
- autoantibodies (2)
- autoimmune diabetes (2)
- autoimmune disease (2)
- autoimmunity (2)
- autopsy (2)
- axon bifurcation (2)
- back pain (2)
- baicalein (2)
- bats (2)
- benchmarking (2)
- betulinic acid (2)
- bibliometric analysis (2)
- bicycle ergometer endurance exercise (2)
- biliary stricture (2)
- bio imaging (2)
- bio-enabling formulations (2)
- bioavailability (2)
- biochemistry (2)
- bioenergetics (2)
- bioequivalence (2)
- biofilm (2)
- biologics (2)
- bioluminescence (2)
- biopsy (2)
- biopsy cores (2)
- blended learning (2)
- blood borne infection (2)
- blood flow restriction (2)
- blood pressure (2)
- blood-brain barrier (2)
- bloodborne viruses (2)
- blood–brain barrier (2)
- blutübertragbare Infektionskrankheiten (2)
- body mass index BMI (2)
- body plethysmography (2)
- body weight (2)
- bone healing (2)
- bone marrow microenvironment (2)
- bone marrow mononuclear cells (2)
- bone metabolism (2)
- bone metastasis (2)
- borrelia (2)
- boswellic acids (2)
- brain (2)
- brain networks (2)
- brain states (2)
- brain tumor (2)
- brain-derived neurotrophic factor (2)
- broadly neutralizing antibodies (2)
- bromodomains (2)
- bulimia nervosa (2)
- c-MYC (2)
- cAMP (2)
- cART (2)
- cGKI (2)
- cabozantinib (2)
- calcitriol (2)
- campesterol (2)
- cancer cell metabolism (2)
- cancer therapy (2)
- cancer treatment (2)
- cancer-associated fibroblasts (2)
- cancer-specific mortality (2)
- cancer-specific survival (2)
- cannabis (2)
- capsaicin (2)
- carbapenem resistance (2)
- carbapenemase (2)
- carcinoma (2)
- cardiovascular (2)
- cardiovascular diseases (2)
- case-referent study (2)
- caspase-1 (2)
- cataract surgery (2)
- cell culture (2)
- cell motility (2)
- cells (2)
- central nervous system (2)
- ceramide (2)
- cerebral hemorrhage (2)
- cerebral ischemia (2)
- cerebral protection (2)
- cerebral venous thrombosis (2)
- cerebrovascular disease (2)
- cesarean section (2)
- chemotaxis (2)
- chemotherapy resistance (2)
- chest trauma (2)
- childhood (2)
- childhood acute myeloid leukemia (2)
- childhood cancer (2)
- children and adolescents (2)
- cholangiocarcinoma (2)
- cholestanol (2)
- cholesterol absorption (2)
- cholesterol synthesis (2)
- chromatin (2)
- chronic granulomatous disease (2)
- chronic hepatitis C (2)
- chronic infection (2)
- chronic inflammation (2)
- chronic thromboembolic pulmonary hypertension (2)
- chronic wounds (2)
- chronische Wunden (2)
- chronobiology (2)
- cigarette (2)
- circadian rhythm (2)
- circadian rhythms (2)
- circular RNA (2)
- cisplatin resistance (2)
- citation (2)
- citrate (2)
- cleaning (2)
- clinical immunology (2)
- clinical isolates (2)
- clinical studies (2)
- clinically important restrictions and symptoms (2)
- clock genes (2)
- clonal dominance (2)
- clonal hematopoiesis (2)
- coagulopathy (2)
- colon carcinoma cells (2)
- colorectal cancer (CRC) (2)
- colorectal carcinoma (2)
- combination therapies (2)
- communication (2)
- complementary and alternative medicine (2)
- complementary medicine (2)
- complex systems (2)
- compliance (2)
- computational modeling (2)
- computer-assisted (2)
- concordance (2)
- congenital diaphragmatic hernia (2)
- consensus (2)
- constipation (2)
- contemporary (2)
- convulsive seizures (2)
- coping (2)
- corneal edema (2)
- corneal transplantation (2)
- corona virus (2)
- coronary artery bypass graft surgery (2)
- coronary artery disease (2)
- corpus callosum (2)
- cost-effective (2)
- counseling (2)
- criticality (2)
- cryoballoon (2)
- cryopreservation (2)
- cyclooxygenase (2)
- cyclosporin A (2)
- cyclosporine (2)
- cytochrome P450 2E1 (2)
- cytokine (2)
- cytotoxic T cells (2)
- dabrafenib (2)
- dance (2)
- data quality (2)
- deafness (2)
- decompensated liver cirrhosis (2)
- dedifferentiation (2)
- delay (2)
- delirium (2)
- dental assistant (2)
- dental assistants (2)
- dentists (2)
- dentoalveolar surgery (2)
- desensitization (2)
- dialysis (2)
- dietary supplements (2)
- dihydroceramide (2)
- disease burden (2)
- disease models (2)
- disease progression (2)
- dislocation (2)
- distress (2)
- docetaxel (2)
- dorsal root ganglia (2)
- doxycycline (2)
- drug-induced liver injury (2)
- drugs (2)
- dual task (2)
- dysphagia (2)
- e-Learning (2)
- eLearning (2)
- eating disorders (2)
- economic burden (2)
- economy (2)
- eicosanoids (2)
- elderly patients (2)
- electrocardiography (2)
- electron transport chain (2)
- emergency care (2)
- endodontic curriculum (2)
- endodontic education (2)
- endoscopic retrograde cholangiopancreatography (2)
- endothelial (2)
- endothelial cell (2)
- endothelium (2)
- endovascular treatment (2)
- entorhinal cortex lesion (2)
- ephrinB2 (2)
- epidemics (2)
- epidermal growth factor (2)
- epidermis (2)
- epileptic encephalopathy (2)
- epileptogenesis (2)
- epithelial cells (2)
- epithelial to mesenchymal transition (2)
- erastin (2)
- erectile dysfunction (2)
- erythrocyte (2)
- erythropoietin (2)
- esophageal cancer (2)
- euthymic (2)
- event-related potentials (2)
- exercise countermeasure (2)
- expertise (2)
- extraversion (2)
- eye movements (2)
- factor H (2)
- fall (2)
- farnesoid X receptor (2)
- fasting (2)
- fat-free-mass (2)
- feasibility (2)
- fecal occult blood test (2)
- female subjects (2)
- femoral artery ligation (2)
- ferric carboxymaltose (2)
- ferroptosis (2)
- fibrinolysis (2)
- focal therapy (2)
- follow‑up (2)
- fortgeschritten (2)
- fracture (2)
- fragment screening (2)
- frankincense (2)
- frontal cortex (2)
- functional genetics (2)
- functional genomics (2)
- fungi (2)
- funktionelle Bildgebung (2)
- furcation involvement class III (2)
- fusion biopsy (2)
- fäkaler okkulter Stuhltest (2)
- gait analysis (2)
- galactography (2)
- galactomosynthesis (2)
- gallbladder cancer (2)
- gallbladder cancer xenografts (2)
- gaming disorder (2)
- gamma oscillations (2)
- gangliosides (2)
- gene signature (2)
- genes (2)
- genetic diversity (2)
- genetic markers (2)
- genetic predisposition (2)
- genetic variants (2)
- genome (2)
- glecaprevir (2)
- glucose metabolism (2)
- growth factor (2)
- guidebook (2)
- guided bone regeneration (2)
- haemophilia (2)
- haemophilia A (2)
- head and neck neoplasms (2)
- head and neck squamous cell carcinoma (2)
- health care (2)
- health information exchange (2)
- health services research (2)
- healthcare personnel (2)
- healthcare workers (2)
- hearing loss (2)
- hedgehog signaling (2)
- hemodynamic (2)
- hemorrhagic transformation (2)
- hepatic encephalopathy (2)
- hepatitis B virus (2)
- hepatotoxicity (2)
- herbal hepatotoxicity (2)
- herpes zoster (2)
- high density lipoproteins HDL (2)
- high-throughput sequencing (2)
- hip (2)
- hippocampal sclerosis (2)
- histamine (2)
- histological validation (2)
- histone deacetylase (2)
- histone deacetylase inhibitor (2)
- homeostatic plasticity (2)
- hormones (2)
- human biology and medicine (2)
- human cytomegalovirus (2)
- human genomics (2)
- human immunodeficiency virus (2)
- human space flight (2)
- humans (2)
- hyperalgesia (2)
- hyperhomocysteinemia (2)
- hypertension (2)
- hypertrophy (2)
- iCBT (2)
- iDILI (2)
- iPS (2)
- idiopathic pulmonary fibrosis (2)
- immune therapy (2)
- immunocytochemistry (2)
- in vitro model (2)
- in-cabin exposure (2)
- induced membrane (2)
- induction chemotherapy (2)
- infants (2)
- infections (2)
- infectious disease (2)
- infectivity (2)
- infiltration (2)
- influenza vaccination (2)
- inhibitor (2)
- inhibitors (2)
- injury (2)
- inner ear (2)
- insulin (2)
- integrate-and-fire (2)
- integrated stress response (2)
- integration (2)
- integrative medicine (2)
- interferon (2)
- interferon gamma (2)
- interleukin-18 (2)
- interleukin-4 (2)
- intermediate risk (2)
- international (2)
- internet (2)
- intervention trial (2)
- intracranial hemorrhage (2)
- irritable bowel syndrome (2)
- isolation (2)
- job-exposure matrix (2)
- joint contact forces (2)
- keratinized mucosa (2)
- kidney cancer (2)
- kidney function (2)
- kinase inhibitor (2)
- kinase regulation (2)
- kinematic analysis (2)
- kinematics (2)
- kinesin (2)
- klinischer Nutzen (2)
- knowledge discovery (2)
- laboratory testing (2)
- language (2)
- lapatinib (2)
- lathosterol (2)
- layer-specificity (2)
- learning (2)
- leisure time activity (2)
- lenalidomide (2)
- leukodystrophy (2)
- leukopenia (2)
- leukotriene (2)
- lifestyle intervention (2)
- lipolysis (2)
- lipoproteins (2)
- liposomes (2)
- liver damage (2)
- liver disease (2)
- liver metastases (2)
- local control (2)
- local fat reduction (2)
- local information dynamics (2)
- localized prostate cancer (2)
- lokale Fettabnahme (2)
- long-term outcome (2)
- long-term potentiation (2)
- long-term success (2)
- long-term survival (2)
- long-term tooth survival (2)
- longevity (2)
- loss (2)
- low density lipoproteins LDL (2)
- low molecular weight heparin (2)
- low-glycaemic meal replacement (2)
- lung development (2)
- lymph node dissection (2)
- lymphocytes (2)
- lysosomes (2)
- mHealth (2)
- mRNA stability (2)
- mTOR inhibitor (2)
- major depression (2)
- malaria (2)
- malignancy (2)
- malignant melanoma (2)
- mammary carcinoma (2)
- mandatory reporting (2)
- marginal bone loss (2)
- mast cells (2)
- mathematical models of viral RNA cycle (2)
- matrix (2)
- medical studies (2)
- medication review (2)
- medulloblastoma (2)
- melatonin (2)
- memantine (2)
- memory consolidation (2)
- mental health (2)
- mesenchymal stromal cell (2)
- metastatic castration-resistant prostate cancer (2)
- methylprednisolone (2)
- miR (2)
- miR-122 (2)
- miR-181 (2)
- miR-21 (2)
- microdosing (2)
- microenvironment (2)
- microscopy (2)
- microsurgery (2)
- microvesicles (2)
- mindfulness (2)
- minimalinvasive Biopsie (2)
- minimally invasive biopsies (2)
- mitophagy (2)
- mobile air quality study (2)
- modularity (2)
- molecular dynamics (2)
- molecular marker (2)
- molecular mimicry (2)
- molecular typing (2)
- monitoring (2)
- morphogenesis (2)
- morphometry (2)
- motor control (2)
- mouse models (2)
- mucormycetes (2)
- multicentre study (2)
- multidetector computed tomography (2)
- multinucleated giant cells (2)
- multiple trauma (2)
- muscle quality (2)
- musculoskeletal modeling (2)
- mutation (2)
- myelin (2)
- myelodysplastic syndrome (2)
- myocardial infarction (2)
- natural scenes (2)
- ncRNA (2)
- needlestick injury (2)
- neoadjuvante Chemotherapie (2)
- neoadjuvante Therapie (2)
- neocortical circuits (2)
- nephropathy (2)
- nerve injury (2)
- network analysis (2)
- network topology (2)
- neurobiology (2)
- neurocognitive (2)
- neurodegenerative diseases (2)
- neuroendocrine (2)
- neurogenesis (2)
- neuroinflammation (2)
- neuroinformatics (2)
- neuron (2)
- neuronal ceroid lipofuscinosis (2)
- neuronal populations (2)
- neurooncology (2)
- neuroprotection (2)
- neurosurgery (2)
- neuroticism (2)
- neutropenia (2)
- neutrophils (2)
- next generation sequencing (2)
- next generation sequencing (NGS) (2)
- niche (2)
- nivolumab (2)
- non-alcoholic fatty liver disease (2)
- non-alcoholic steatohepatitis (2)
- non-small cell lung cancer (2)
- non-small-cell lung cancer (2)
- non-structural proteins (2)
- nuclear receptor (2)
- nursery schools (2)
- nutlin-3 (2)
- occupational exposure (2)
- occupational health (2)
- olfaction (2)
- oligomerisation (2)
- omega-3 fatty acids (2)
- oncogene (2)
- oncogenes (2)
- oncomodulation (2)
- oral and maxillofacial surgery (2)
- osteogenesis (2)
- other-cause mortality (2)
- out-patient paediatrics (2)
- oxygen (2)
- p16 (2)
- pH (2)
- paclitaxel (2)
- pain management (2)
- paired associative stimulation (2)
- palatal tremor (2)
- pancreatic ductal adenocarcinoma (2)
- partial information decomposition (2)
- particle size distribution (2)
- passive smoke (2)
- pathology (2)
- patient (2)
- patient centered care (2)
- patient preferences (2)
- patient triage (2)
- patient-reported outcomes (2)
- pediatric surgery (2)
- pelvic packing (2)
- penile cancer (2)
- peptide aptamer (PA) (2)
- peri-implant diseases (2)
- pericytes (2)
- periodontal diseases (2)
- periodontitis stage III and IV (2)
- peri‐implantitis (2)
- personalized oncology (2)
- pertussis (2)
- phagocytes (2)
- pharmacoresistance (2)
- pharmacovigilance (2)
- phase separation (2)
- phenotype (2)
- phosphate (2)
- photoaging (2)
- photodynamic therapy (2)
- physical training (2)
- pibrentasvir (2)
- polo-like kinase 1 (2)
- poly(lactic-co-glycolic acid) (PLGA) (2)
- polygenic risk score (2)
- polymerase chain reaction (2)
- polymorphism (2)
- polyphenols (2)
- population dynamics (2)
- post-transcriptional regulation (2)
- post-translational modifications (2)
- preclinical (2)
- prediction (2)
- predictive (2)
- predictive factors (2)
- preterm birth (2)
- primary biliary cholangitis (2)
- primary motor cortex (2)
- prior knowledge (2)
- process evaluation (2)
- prognostic (2)
- prognostic value (2)
- progranulin (2)
- prostaglandin E (2)
- prostate carcinoma cells (2)
- proteasome inhibitor (2)
- protein kinase (2)
- protein phosphorylation (2)
- protein turnover (2)
- protein-rich (2)
- proteolysis (2)
- proteolysis systems (2)
- proto-oncogene proteins c-akt (2)
- proximal tubule (2)
- psychiatric comorbidity (2)
- psychiatric disorders (2)
- psychiatry (2)
- psychosis (2)
- pulmonary embolism (2)
- pulmonary vein isolation (2)
- pulse wave velocity (2)
- qRT-PCR (2)
- quality (2)
- quality control (2)
- quality management (2)
- quantum biology (2)
- race (2)
- radical cystectomy (2)
- radioimmunotherapy (2)
- randomised controlled study (2)
- randomisierte kontrollierte Studie (2)
- randomized (2)
- randomized controlled trial (2)
- rare disease (2)
- rare diseases (2)
- rat model (2)
- re-osseointegration (2)
- real-world (2)
- real-world data (2)
- recommendations (2)
- reference values (2)
- refractory (2)
- refugees (2)
- regenerative medicine (2)
- regulatory T cell (2)
- renal failure (2)
- renal tubular epithelial cells (2)
- research (2)
- residual myometrial thickness (2)
- resistance training (2)
- resistant cell lines (2)
- resolution of inflammation (2)
- respiratory chain (2)
- respiratory failure (2)
- respiratory infections (2)
- respiratory tract infection (2)
- response inhibition (2)
- resting-state (2)
- review (2)
- revision surgery (2)
- rhodopsin (2)
- ribavirin (2)
- risk assessment (2)
- risk group (2)
- risk management (2)
- risk prediction (2)
- robotics (2)
- running (2)
- saliva (2)
- salvage radical prostatectomy (2)
- sarcoma (2)
- scaffold (2)
- school-based prevention (2)
- scientometry (2)
- second-hand smoke (2)
- second-line (2)
- secondary data analysis (2)
- secretion (2)
- secukinumab (2)
- selection (2)
- sensory neurons (2)
- sensory neuropathy (2)
- serine protease (NS3-4A) (2)
- serology (2)
- shunt (2)
- siRNA (2)
- signal transducer and activator of transcription 5 (Stat5) (2)
- signature (2)
- single-sided deafness (2)
- sitosterol (2)
- skin (2)
- skin infection model (2)
- sleep quality (2)
- smoking cessation (2)
- smooth muscle cells (2)
- soft tissue (2)
- soluble MICA (2)
- soluble epoxide hydrolase (2)
- somatic mutations (2)
- sound-induced flash illusion (2)
- space adaptations (2)
- spectroscopy (2)
- speech (2)
- speech and language disorder (2)
- speech perception (2)
- sphingosine 1-phosphate receptor (2)
- spiking neural networks (2)
- spinal dural leaks (2)
- spine head (2)
- sports nutrition (2)
- spreadsheet (2)
- stability (2)
- stage (2)
- standard value (2)
- standardization (2)
- starvation (2)
- stationarity (2)
- steatosis (2)
- stem cell therapy (2)
- stem cells (2)
- stereotactic radiosurgery (2)
- stimulus encoding (2)
- stress granules (2)
- structural biology (2)
- studies (2)
- study protocol (2)
- sub-lineage (2)
- subchondral bone (2)
- suicide (2)
- superficial siderosis (2)
- supersaturation (2)
- supplementation (2)
- supportive therapy (2)
- survival rate (2)
- survivin (2)
- sympathetic nervous system (2)
- symptoms (2)
- synapse (2)
- synaptopodin (2)
- synchronization (2)
- synovium (2)
- tDCS (2)
- telemedicine (2)
- temsirolimus (2)
- terminology (2)
- test methods (2)
- testing (2)
- testosterone (2)
- tetracycline (2)
- tetrahydrobiopterin (2)
- tetrahydrocannabinol (2)
- tetrapolar bioimpedance analysis (2)
- tetrapolare Bioimpedanzanalyse (2)
- therapy resistance (2)
- thromboembolism (2)
- thrombophilia (2)
- thromboxane (2)
- time-lapse imaging (2)
- tissue Doppler imaging (2)
- tobacco (2)
- tobacco smoke (2)
- tolerability (2)
- tolerance (2)
- tomosynthesis (2)
- tooth transplantation (2)
- total hip replacement (2)
- tracking (2)
- traffic emissions (2)
- training program (2)
- transcription factors (2)
- transcriptomics (2)
- transforming growth factor-β (2)
- transgenic mice (2)
- translation (2)
- trastuzumab (2)
- treatment outcome (2)
- treatment preference (2)
- treatment/therapy (2)
- triple-negative breast cancer (2)
- trophoblast (2)
- trophoblasts (2)
- tuberous sclerosis complex (2)
- tumor (2)
- tumor infiltrating lymphocytes (2)
- tumor necrosis factor (2)
- tumor stroma (2)
- tumor suppressor (2)
- tumor-infiltrating lymphocytes (2)
- type 2 diabetes (2)
- undergraduate medical education (2)
- unilateral hip osteoarthritis (2)
- unsupervised learning (2)
- upgrading (2)
- urethral stricture (2)
- urethroplasty (2)
- urinary incontinence (2)
- urological cancer (2)
- ursodeoxycholic acid (2)
- ustekinumab (2)
- uteroglobin (2)
- vaccination rates (2)
- vaccine uptake rates (2)
- validation (2)
- vascular biology (2)
- vascular disease (2)
- vasodilation (2)
- venous thrombosis (2)
- ventral striatum (2)
- vergence (2)
- vertebroplasty (2)
- very high risk (2)
- virology (2)
- virulence factor (2)
- viruses (2)
- vision (2)
- visual system (2)
- vitamin B deficiency (2)
- von Willebrand disease (2)
- wIRA (2)
- waiting time (2)
- warts (2)
- weight loss (2)
- white matter hyperintensity (2)
- within-host viral modelling (2)
- women (2)
- workflow (2)
- xenograft (2)
- yeast (2)
- yellow flags (2)
- zebrafish (2)
- Ärztliche Aufklärung (2)
- Ökonomie (2)
- Übergewicht (2)
- 创伤后应激障碍 (2)
- "NS"-Euthanasie (1)
- "alternative" technology (1)
- "conventional" analysis technics (1)
- (cardiac) surgery (1)
- (lyso)phospholipids (1)
- (novel) brominated flame retardants ((N)BFR) (1)
- (sub-) luxation (1)
- 1,2-dichloroethane (1)
- 1,25-Dihydroxyvitamin D (1)
- 1-propanol (1)
- 10-Hydroxyaloins A/B (1)
- 11q23/MLL rearrangements (1)
- 11th September (1)
- 14-3-3 gene family (1)
- 15-PGDH (1)
- 15. Jahrhundert (1)
- 16 segment AHA model (1)
- 16S rRNA sequencing (1)
- 16p11.2 (1)
- 177Lu-PSMA (1)
- 17‐OH itraconazole (1)
- 18-Hydroxycorticosteron (1)
- 18-OH corticosterone (1)
- 19F MR spectroscopy (1)
- 1H MR spectroscopy (1)
- 1α,25(OH)2D3 (1)
- 2'-deoxyguanosine riboswitch (1)
- 2-AG (1)
- 2-Arachidonoyl glycerol (1)
- 2-deoxy-d-glucose (1)
- 2-deoxyglucose (2-DG) (1)
- 2-hydroxyglutarate (1)
- 2019-nCoV (1)
- 223Radium-dichloride (1)
- 26 LncRNA (1)
- 2D NMR spectroscopy (1)
- 2‑methoxyestradiol (1)
- 2′,3′-cGAMP (1)
- 2′-O-methylation (1)
- 3 mm RAS instruments (1)
- 3 mm instruments (1)
- 3,4-DCA; biotransformation (1)
- 3-hydroxyanthranilic acid (1)
- 3-hydroxyisovaleryl carnitine (1)
- 3-year survival (1)
- 32D progenitor cells (1)
- 3C protease(3Cpro) (1)
- 3Cs technology (1)
- 3D cell culture (1)
- 3D culture (1)
- 3D gait analysis (1)
- 3D image analysis (1)
- 3D laparoscopy (1)
- 3D modeling (1)
- 3D printed cell-free scaffold (1)
- 3D printing using composite resin (1)
- 3D printing using zirconia (1)
- 3D spatiotemporal resolved mathematical models (1)
- 3D tissue models (1)
- 3D-Druck (1)
- 3D-models (1)
- 3D-printing (1)
- 3T3-L1 mouse fibroblasts (1)
- 3years (1)
- 4-1BB (1)
- 4-FA (1)
- 4-fluoroamphetamine (1)
- 5 lipoxygenase (1)
- 5' UTR (1)
- 5-Aminolävulinsäure (5-ALA) (1)
- 5-Lipoxygenase (1)
- 5-Lipoxygenase activating protein (FLAP) (1)
- 5-aminolevulinic acid (5-ALA) (1)
- 5_SL4 (1)
- 6-Schritt-Methode (1)
- 8 weeks (1)
- 9-HODE (1)
- 90% or more improvement in baseline Psoriasis Area and Severity Index (1)
- 98/79/EC (1)
- 99mTc-MIBI (1)
- 99mTc-pertechnetate (1)
- A-FFIP (1)
- A-PRF+ (1)
- A2BP1 (1)
- A375 human melanoma cell line (1)
- A375 human melanoma cells (1)
- A498 cells (1)
- A549 (1)
- AA-amylodosis (1)
- AAA (1)
- AAA+ disaggregase (1)
- AABR (1)
- AB-serum (1)
- ABC transporter (1)
- ABC transporters (1)
- ABCB5 (1)
- ABS (1)
- ABT-737 (1)
- ACAD (1)
- ACE inhibitor (1)
- ACE-Bestimmung (1)
- ACE-inhibitor (1)
- ACI-Rat (1)
- ACI-Ratte (1)
- ACKR (1)
- ACT-777991 (1)
- ACTH (1)
- ACURATE neo (1)
- ADAM-17 (1)
- ADAM10 (1)
- ADAMTS-13 (1)
- ADAMTS13 (1)
- ADAR (1)
- ADC (1)
- ADC-Karte (1)
- ADC-Map (1)
- ADCC (1)
- ADGRE1 (1)
- ADHD differential diagnosis (1)
- AEC syndrome (1)
- AF4–MLL (1)
- AFS (1)
- AGC kinase (1)
- AGMO (1)
- AICAR (1)
- AIH immunopathogenesis (1)
- AIS (1)
- AKT signaling (1)
- AKT-mTOR pathway (1)
- ALD (1)
- ALDH2 (1)
- ALF (1)
- ALK gene (1)
- ALK-rearranged NSCLC (1)
- ALLO (1)
- AMD3100 (1)
- AML – acute myeloid leukemia (1)
- AMP-activated kinase (1)
- AMP-activated kinase (AMPK) (1)
- AO-PCCF (1)
- AOSpine (1)
- AOSpine injury score (1)
- API (1)
- APM (1)
- APMPPE - acute posterior multifocal placoid pigment epitheliopathy (1)
- APP (1)
- APRI (1)
- APS (1)
- APT-CEST (1)
- ARA (1)
- ARID5B (1)
- ASA (1)
- ASA-Klassifikation (1)
- ASA404 (1)
- ASAP (1)
- ASC (1)
- ASCT (1)
- ASD-specific (1)
- ASO (1)
- ASPECTS (1)
- AT-101 (1)
- AT1 receptor antagonist (1)
- ATAD2 (1)
- ATG3 (1)
- ATO (1)
- ATP binding (1)
- ATP synthase (1)
- ATPases (1)
- ATXN2 (1)
- AU-rich element (1)
- AVM hemorrhage (1)
- AZD7762 (1)
- Aachen <2012> (1)
- Abatacept (1)
- Abdominal infections (1)
- Abdominal surgery (1)
- Abdominal trauma (1)
- Abductor pollicis longus (1)
- Abiraterone acetate (1)
- Abl kinase inhibitors (1)
- Ablation (1)
- Ablation Techniques (1)
- Abnahme einer Hypersekretion (1)
- Abnahme vermehrter Speichelbildung (1)
- Abnahme von Schleimbildung (1)
- Abrasion (1)
- Abruf (1)
- Absenteeism (1)
- Absolute quantification (1)
- Absorption modeling (1)
- Abstrich <Medizin> (1)
- Abstrichisolate (1)
- Abtötung (1)
- Abtötungskinetik (1)
- Abusive head trauma (AHT) (1)
- Abweichungen (1)
- Academic health centres (1)
- Academics (1)
- Accelerometry (1)
- Accessibility (1)
- Accessory olfactory system (1)
- Access® immunoassay system (1)
- Access®-Immunoassaysystem (1)
- Accident (1)
- Accidents (1)
- Accumulated degree days (1)
- Acellular dermis (1)
- Acenocoumarol (1)
- Acer platanoides (1)
- Acetabulumdefekt (1)
- Acetylsalicylsäure (1)
- Achtundsechzig (1)
- Achtundsechziger (1)
- Acid ceramiase (1)
- Acide gamma-aminobutyrique (1)
- Acidic Dissociation (1)
- Acoustic signals (1)
- Acquired drug resistance (1)
- Acquired resistance (1)
- Acrylamid (1)
- Actaea cimicifuga (1)
- Actin (1)
- Actinomycin D (1)
- Action Plan for Medication Safety (1)
- Action potential (1)
- Activated partial thromboplastin time (1)
- Active middle ear implants (1)
- Activin (1)
- Activity control (1)
- Acupuncture (1)
- Acute (1)
- Acute HIV infection (1)
- Acute Hemiparesis (1)
- Acute Myeloid Leukemia (1)
- Acute Promyelocytic Leukemia (1)
- Acute appendicitis (1)
- Acute bronchitis (1)
- Acute calcolous cholecystitis (1)
- Acute coronary syndrome (1)
- Acute cough (1)
- Acute elbow dislocation (1)
- Acute heart failure (1)
- Acute hospital (1)
- Acute injuries (1)
- Acute kidney failure (1)
- Acute leukemia, chromosomal translocation, MLL, KMT2A, AF4-MLL, reciprocal fusion protein, MLL-r leukemia, (1)
- Acute renal failure (1)
- Acute respiratory distress syndrom (1)
- Acute-on-chronic subdural hematoma (1)
- Adaptationsfähigkeit (1)
- Adaptive immunity (1)
- Adaptive process control (1)
- Adeno associated virus (1)
- Adeno-associated virus vector (1)
- Adenosine (1)
- Adenosine A1 receptor (1)
- Adenylyl cyclase (1)
- Aderlass (1)
- Adhesins (1)
- Adhesion Factor (1)
- Adhärenz (1)
- Adipose tissue-derived mesenchymal stem cells (1)
- Adipositas (1)
- Adipositas Chirurgie (1)
- Adiposity (1)
- Adjustment of dosage at steady state (1)
- Adjuvant procedure (1)
- Adjuvant therapies (1)
- Adjuvante Therapie (1)
- Adjuvantes Verfahren (1)
- Administrative claims data (1)
- Adoptive Immuntherapie (1)
- Adrenal crisis (1)
- Adrenale Krise (1)
- Adrenalektomie (1)
- Adrenocorticotropic hormone (1)
- Adrenokortikotropes Hormon (1)
- Adult (1)
- Adult T-cell acute lymphoblastic leukemia (1)
- Adult-onset ADHD (1)
- Advanced biliary tract cancer (1)
- Advanced breast cancer (1)
- Advanced glycation endproducts (1)
- Advanced stage (1)
- Adverse effects (1)
- Aedes aegypti (1)
- Aedes albopictus (1)
- Aerobic exercise training (1)
- Aeroplysinin-1 (1)
- Aerosolspektrometrie (1)
- Aesthetics (1)
- Affect (1)
- Affective Misattribution Procedure (1)
- Affective disorders (1)
- Afrikanische Schlafkrankheit (1)
- Ag-RDT (1)
- Aganglionosis (1)
- Agardiffusion (1)
- Age determination (1)
- Age determination by skeleton (1)
- Age-structure (1)
- Ageing (1)
- Aggregation (1)
- Aggressive periodontitis (1)
- Agitation (1)
- Agoraphobia (1)
- Agreement (1)
- Aikido (1)
- Air traffic (1)
- Airport-related emissions (1)
- Airways (1)
- Akkreditierung (1)
- Akt-mTOR pathway (1)
- Akt-mTOR signaling (1)
- Aktive Zone (1)
- Aktivierte partielle Thromboplastinzeit (1)
- Aktivität (1)
- Akupressur (1)
- Akupunktur (1)
- Akute (1)
- Akute Leukämie (1)
- Akute Lymphatische Leukämie (1)
- Akute Niereninsuffizienz (1)
- Akute Nierenschädigung (1)
- Akute Verletzungen (1)
- Akute lymphoblastische Leukämie (1)
- Akutes Koronarsyndrom (1)
- Akutmedizin (1)
- Akzelerationszeit (1)
- Albumin (1)
- Albumin ratio (1)
- Alignment <Biochemie> (1)
- Aliphatic halogenated hydrocarbons (1)
- Alisertib (1)
- Alkaline phosphatase (1)
- Alkalische Phosphatase (1)
- Alkaloid (1)
- Alkohol (1)
- Alkoholiker (1)
- Alkoholismus (1)
- Alkoholmissbrauch (1)
- All oral (1)
- All-oral therapy (1)
- All-trans retinoic acid (1)
- Allergen (1)
- Allergen immunotherapy (1)
- Allergen-Testung (1)
- Allergenprovokation (1)
- Allergic rhinitis (1)
- Allergische Rhinitis (1)
- Allergisches Asthma (1)
- Allergoid (1)
- Allgemeinmedizin Forschung (1)
- Allogeneic (1)
- Allogeneic Stem Cell Transplantation (SCT) (1)
- Allogeneic hematopoietic stem (1)
- Allogeneic stem cell transplantation (1)
- Allograft bone block (1)
- Allokation der Ressourcen (1)
- Allopregnanolon (1)
- Alpha oscillations (1)
- Alpha power (1)
- Alpha rhythm (1)
- Alpha-V integrin (1)
- Alpha-fetoprotein (AFP) (1)
- Alpha-synuclein deficiency (1)
- Alphavirus (1)
- Alte Medizin (1)
- Altenheim (1)
- Altern (1)
- Alternative oxidase (1)
- Alternative splicing (1)
- Alterung (1)
- Altitude training (1)
- Alveolar macrophages (1)
- Alveolar ridge augmentation (1)
- Alzheimer’s dementia (1)
- Ambient air (1)
- Ambroxol (1)
- Ambulante Pflege (1)
- Ambulatory Assessment (1)
- Ameloblastoma (1)
- American Football (1)
- Amino acid analysis (1)
- Amino acids (1)
- Aminosäuremetabolismus (1)
- Aminosäuren (1)
- Aminotransferases (1)
- Amiodaron (1)
- Amisulpride (1)
- Amitriptyline (1)
- Amizon (1)
- Amniotic fluid (1)
- Amphetamine (1)
- Amsterdam-Kriterien (1)
- Amygdala (1)
- Amyloid precursor protein (1)
- Amyloid-beta (1)
- Amyloid-beta 42 (1)
- Amyotrophic lateral sclerosis (1)
- Anabolism (1)
- Anaesthesia (1)
- Anahuasca (1)
- Anakinra (1)
- Analkarzinom (1)
- Analschleimhautabstrich (1)
- Analysis tool (1)
- Anaplastic astrocytoma (1)
- Anatomic competence (1)
- Anatomie (1)
- Anatomie und Histologie (1)
- Andersen-Tawil syndrome (1)
- Anderson–Fabry (1)
- Andexanet alpha (1)
- Andropogon virginicus (1)
- Anemia management (1)
- Anerkennung (1)
- Anesthesia, Intravenous (1)
- Aneurysm (1)
- Aneurysmal subarachnoid hemorrhage (1)
- Aneurysms (1)
- Anfall (1)
- Anfallsserie (1)
- Anfallsunterbrechende (1)
- Anfallsunterbrechende Medikamente (1)
- Angeborene Fehlbildungen (1)
- Angiectasia (1)
- Angiodysplasia (1)
- Angioedema (1)
- Angiogenèse (1)
- Angiomyolipoma (1)
- Angioplasty (1)
- Angiotensin Converting Enzyme (1)
- Angiotensin-converting enzyme (1)
- Angststörungen (1)
- Animal disease models (1)
- Animal experiment (1)
- Animal wings (1)
- Aniridia (1)
- Anisakidae, Pseudoterranova decipiens Komplex, Transkriptom, Verbreitung, Zoonose (1)
- Anisotrope Diffusion (1)
- Ankle arthrometer (1)
- Ankylosierende Spondylitis (1)
- Ankylosing spondylitis (1)
- Anomalie <Medizin> (1)
- Anomalous venous atrial connections (1)
- Anopheles (1)
- Anorexia Nervosa (1)
- Anosmia (1)
- Anpassung (1)
- Antagonist (1)
- Antarctic parasites (1)
- Anterior cingulate cortex (1)
- Anterior cruciate ligament (1)
- Anterior cruciate ligament reconstruction (1)
- Anthranoids (1)
- Anthropologie (1)
- Anti platelet therapy (1)
- Anti-CMV IgG (1)
- Anti-Cardiolipin-Antikörper (1)
- Anti-Müller-Hormon (1)
- Anti-Phospholipid-Syndrom (1)
- Anti-TNF (1)
- Anti-inflammatory (1)
- Anti-rheumatic agents (1)
- Anti-tumor immunity (1)
- Anti-viral activity (1)
- Antiangiogenesis (1)
- Antibiotic (1)
- Antibiotic generic drugs (1)
- Antibiotic steward-ship (1)
- Antibiotic stewardship (1)
- Antibiotic therapy (1)
- Antibiotika (1)
- Antibiotikaresistenz (1)
- Antibody avidity (1)
- Antibody detection (1)
- Antibody isotypes (1)
- Antibody therapy (1)
- Antibody-mediated rejection (1)
- Anticancer therapy (1)
- Anticholinergic (1)
- Anticoagulant (1)
- Anticoagulants (1)
- Anticoagulants [MeSH] (1)
- Anticonvulsant (1)
- Anticonvulsant activity (1)
- Antidepressant (1)
- Antidepressiva (1)
- Antiepileptica (1)
- Antifungal agents (1)
- Antigen (1)
- Antigen CD62 (1)
- Antigen processing and presentation (1)
- Antigen- und Nukleinsäurenachweis (1)
- Antigen-presenting cells (1)
- Antigene Virale/Immunologie (1)
- Antigennachweis (1)
- Antigens (1)
- Antigens,Viral/immunology (1)
- Antigens/Peptides/Epitopes (1)
- Antihormone therapy (1)
- Antike (1)
- Antikörpernachweis (1)
- Antineoplastic agents (1)
- Antioxidant (1)
- Antioxidants (1)
- Antiplatelet therapy (1)
- Antiproliferative (1)
- Antireflux surgery (1)
- Antirheumatic agents (1)
- Antiseizure medication (1)
- Antiseizure medication Instructions for action (1)
- Antisense-Oligonucleotide (1)
- Antithrombotic therapy (1)
- Antivenom (1)
- Antiviral agents (1)
- Antiviral immune response (1)
- Antiviral response (1)
- Antiviral treatment (1)
- Antivirale Therapie (1)
- Anwendbarkeit (1)
- Anxiolytic pharmacological therapy (1)
- Anzapfsyndrom (1)
- Aortendissektion (1)
- Aortic Valve Replacement (1)
- Aortic aneurysm (1)
- Aortic arch replacement (1)
- Aortic debranching (1)
- Aortic input function (1)
- Aortic stiffness (1)
- Aortic valve sparing (1)
- Aperiodic (1)
- Apes (1)
- Aphakia (1)
- Aphantasia (1)
- Aphasia (1)
- Aphasie (1)
- Apoptose (1)
- Apoptotic cell death (1)
- Appendicitis (1)
- Appendizitis (1)
- Aquaporins (1)
- Aquilegia (1)
- Ara h2-specific IgE (1)
- Arabin pessary (1)
- Arabin-Pessar (1)
- Arachidonic acid cascade (1)
- Arbeit (1)
- Arbeitsbedingt erworbene Infektion (1)
- Arbeitsbedingungen (1)
- Arbeitsflexibilisierung (1)
- Arbeitsmedizin (1)
- Arbeitsplatzkonflikt (1)
- Arboviruses (1)
- Arc protein (1)
- ArchT (1)
- Archaeology (1)
- Archery (1)
- Architektur (1)
- Arcuate fascicle (1)
- Area deprivation (1)
- Argatroban (1)
- Arms (1)
- Aromatase Inhibitors (1)
- Aromatase inhibitors (1)
- Arrhythmia syndromes (1)
- Arrhythmia/all (1)
- Arrow (1)
- Artemether-lumefantrine (1)
- Artemisinin-combination-therapy (1)
- Arteria ophthalmica (1)
- Arterielle Thrombose (1)
- Arterielle Verschlusskrankheit (1)
- Arteriogenesis (1)
- Arteriosclerosis (1)
- Arteriovenous malformation (1)
- Artesunate (1)
- Arthrodese (1)
- Arthroscopy (1)
- Arthroskopischer Bankart-Repair (1)
- Artificial Intelligence (1)
- Artificial feeding bioassays (1)
- Artificial iris (1)
- Artificial neural networks (1)
- Arznei- und Heilmittelrichtlinie (1)
- Arzneimitteldesign (1)
- Arzneimittelrecht (1)
- Arzt (1)
- Arzt-Patient-Beziehung (1)
- Asparaginase (1)
- Aspergillosis (1)
- Aspergillus species (1)
- Aspirin (1)
- Assay variation (1)
- Assessment of care (1)
- Asthma and allergic disorders (1)
- Asthmadiagnostik (1)
- Astrocytoma (1)
- Astrocytoma grades (1)
- Astrozyt (1)
- Astrozyten (1)
- Ataxia score (1)
- Atazanavir (1)
- Atemtest (1)
- Atención centrada en el paciente (1)
- Athena SWAN (1)
- Atherosklerose (1)
- Athlete (1)
- Athletes (1)
- Atm (1)
- Atomic force microscopy (1)
- Atomoxetine (1)
- Atrial Fibrillation (1)
- Atrial appendage occlusion (1)
- Atrial fibrillation classification (1)
- Atrial function (1)
- Attack (1)
- Attention Deficit Hyperactivity Disorder (1)
- Attention Deficit Hyperactivity Disorder (ADHD) (1)
- Attention deficit (1)
- Attention-Deficit/Hyperactivity Disorder (ADHD) (1)
- Attention-deficit / hyperactivity disorder (1)
- Attentional bias (1)
- Attentional set (1)
- Attrition (1)
- Atxn2 (1)
- Audio equipment (1)
- Audiologie (1)
- Audiology (1)
- Audition (1)
- Auditory (1)
- Auditory cortex (1)
- Auditory midbrain (1)
- Aufmerksamkeit (1)
- Aufmerksamkeits-und-hyperaktivitätsstörung (1)
- Aufmerksamkeitsleistung (1)
- Aufsatzsammlung (1)
- Augenarzt (1)
- Augenchirurgie (1)
- Augenerkrankungen (1)
- Augenverletzungen (1)
- Auric nanoparticles (1)
- Aurora (1)
- Aurora Ax (1)
- Aurora kinase inhibitor (1)
- Ausbildung (1)
- Ausdauertraining (1)
- Australia (1)
- Authoritarianism (1)
- Autism Spectrum disorder (1)
- Autism spectrum disorders (1)
- Autismus-Spektrum-Störungen (1)
- Autistic Behavior (1)
- Autistic disorder (1)
- Auto transfusion (1)
- Autobiografie (1)
- Autobiography (1)
- Autogenous bone block (1)
- Autoimmun (1)
- Autoimmune Disease (1)
- Autoimmune encephalomyelitis (1)
- Autoimmune response (1)
- Autoimmune vasculopathy (1)
- Autoimmunität (1)
- Autologous stem cell transplantation (1)
- Automated Tube Potential Selection (1)
- Automatic Environmental Tobacco Smoke Emitter (1)
- Automatic prediction (1)
- Automation (1)
- Automatisation (1)
- Autonomes Nervensystem (1)
- Autonomic nervous system (1)
- Autophagie (1)
- Autoregulation (1)
- Autosomal recessive cutis laxa type 1C (1)
- Awareness (1)
- Awareness campaign (1)
- Axial spondyloarthritis (1)
- Axiale Spondyloarthritis (1)
- Axiales Längenwachstum (1)
- Axiography (1)
- Axon (1)
- Ayahuasca (1)
- Ayurvedic herbal products (1)
- Azacitidine (1)
- Azan (1)
- Azan trichrome stain (1)
- Azathioprin (1)
- Azathioprine (1)
- Azidothymidine (1)
- B cell cancer (1)
- B cell differentiation (1)
- B cell malignancies (1)
- B cell precursor acute lymphoblastic leukemia (1)
- B cell receptor (1)
- B cell subpopulations (1)
- B-cell (1)
- B-cell antigen receptor (1)
- B-cell immunology (1)
- B-cell non-Hodgkin lymphoma (1)
- B-cell receptor (1)
- B-cell transcription factors (1)
- B.1.1.529 (1)
- B.1.1.7 (1)
- B.1.617.1 (1)
- B.1.617.2 (1)
- B16 cells (1)
- B3GNT2 (1)
- BA.4 (1)
- BA.5 (1)
- BACTEC™ 9000 (1)
- BATF3 (1)
- BBB (1)
- BCG (1)
- BCG-Therapie (1)
- BCL-2 (1)
- BCL11b (1)
- BCORL1 (1)
- BCR signaling (1)
- BCR-ABL (1)
- BEACOPP (1)
- BET inhibitor (1)
- BET inhibitors (1)
- BET proteins (1)
- BEZ235 (1)
- BFIS (1)
- BFR (1)
- BG-index (1)
- BH3 mimetics (1)
- BH4 (1)
- BI1361849 (1)
- BIAM switch assay (1)
- BIAM-switch (1)
- BIRC5 (1)
- BK channel (1)
- BMAC (1)
- BMP4 (1)
- BMSC (1)
- BNC2 (1)
- BNT2b2 (1)
- BOPTA (1)
- BPD (1)
- BPDCN (1)
- BPO (1)
- BPTF (1)
- BRAF V600E (1)
- BRAF inhibitors (1)
- BRAF mutation (1)
- BRD2 (1)
- BRD4-NUT (1)
- BRD7 (1)
- BRG1 (1)
- BROMO-10 (1)
- BRUCE (1)
- BRVO (1)
- BSP (1)
- BTC (1)
- BTK (1)
- BV6 (1)
- Babesia venatorum (1)
- Baby-Bodyplethysmographie (1)
- Bachelorabschluss (1)
- Bachelor’s degree (1)
- Bacillus subtilis (1)
- Back scan (1)
- Backpropagating action potential (1)
- Bacteraemia (1)
- Bacteremia/diagnosis (1)
- Bacteria-host interaction (1)
- Bacterial Chromosome (1)
- Bacterial Protein Kinases (1)
- Bacterial Protein Phosphatases (1)
- Bacterial abundance (1)
- Bacterial adhesion (1)
- Bacterial biofilm (1)
- Bacterial intestinal overgrowth (1)
- Bacterial leakage (1)
- Bacterial pathogenesis (1)
- Bacterial pathogens (1)
- Bacterial structural biology (1)
- Bacteriological techniques (1)
- Bad (1)
- BadA, (1)
- Bag6 (1)
- Bagatelltrauma (1)
- Bakterien (1)
- Bakterientest (1)
- Bakteriologische Techniken (1)
- Bakterizidie Index (1)
- Bakteriämie/Diagnostik (1)
- Ballet (1)
- Ballon (1)
- Ballon-assisted enteroscopy (1)
- Balloon-expandable TAVI (1)
- Balneologie (1)
- Bamlanivimab (1)
- Bandpass filters (1)
- Bankart-Läsion (1)
- Bariatric surgery (1)
- Barlow disease (1)
- Barrier (1)
- Bartonella (1)
- Bartonella adhesin A (1)
- Bartonella grahamii (1)
- Bartonella schoenbuchensis (1)
- Basal Ganglia (1)
- Basal ganglia (1)
- Basalzellkarzinom (1)
- Basedow-Krankheit (1)
- Basel Consensus Statement (1)
- Basler Consensus Statement (1)
- Bassoon (1)
- Bayesian inference (1)
- Bayesian model (1)
- Bcl-2 (1)
- Bcr-Abl (1)
- Beatmung (1)
- Beck Depression Inventory (1)
- Beckenschiefstand (1)
- Beckwith–Wiedemann syndrome (1)
- Becton Dickinson (1)
- Bedburg-Hau, Anstalt (1)
- Bee venom allergy (1)
- Befinden (1)
- Befindlichkeit (1)
- Beginners (1)
- Begriffsbestimmung (1)
- Behandlungskontrolle (1)
- Behandlungspfad (1)
- Behandlungssystematik (1)
- Behandlungsumfang (1)
- Behavioral analysis (1)
- Behavioral experiment (1)
- Behavioral tests (1)
- Behavioural ecology (1)
- Behinderung (1)
- Belastung (1)
- Bence Jones (BJ) proteinuria (1)
- Bence Jones-Proteinurie (1)
- Benchmarks (1)
- Benign disorder (1)
- Benign enlargement of the subarachnoid spaces (BESS) (1)
- Benign prostatic hyperplasia (1)
- Benign pulmonary diseases (1)
- Benigne Lungenerkrankungen (1)
- Bentall operation (1)
- Beratung (1)
- Berci needle (1)
- Bereavement (1)
- Berner, Friedrich (1)
- Bernhard Waldenfels (1)
- Bernštejn, Nikolaj A. (1)
- Berotralstat (1)
- Berufliche Gesundheit (1)
- Berufszufriedenheit (1)
- Beschneidung <Frau> (1)
- Beschreibung (1)
- Beschäftigte (1)
- Besessenheit (1)
- Besiedelungsgrad (1)
- Best practice (1)
- Best-practice model (1)
- Bestimmungsmethoden (1)
- Bestrahlung (1)
- Betazellfunktion (1)
- Betriebliches Wiedereingliederungsmanagement (1)
- Beurteilungen (1)
- Bevölkerungsschutz (1)
- Bewegungsanalyse mit Inertialsensoren (1)
- Bewegungserziehung (1)
- Bewegungsphysiologie (1)
- Bewegungssteuerung (1)
- Bewegungsstörung (1)
- Bewertungen (1)
- Bewältigung (1)
- Bezeichnungen (1)
- Bias (1)
- Bibliometric analysis (1)
- Bidirectional genes (1)
- Big data (1)
- Big five (1)
- Biglycan (1)
- Bilateral cochlear implant (1)
- Bilateral sagittal split osteotomy (1)
- Bildgebendes Verfahren (1)
- Bildnis (1)
- Bildqualität (1)
- Bildung (1)
- Bildverarbeitung (1)
- Biliary physiology (1)
- Biliary tree (1)
- Biliary tree stones (1)
- Bilirubin (1)
- Bilirubinbestimmung (1)
- Billroth II gastroenterostomy (1)
- Billroth papillotome (1)
- Billroth’s operation-II (1)
- Bilobalid (1)
- Bilobalide (1)
- Binding analysis (1)
- Binocular Rivalry (1)
- Bio safety (1)
- BioCreative V.5 (1)
- BioID (1)
- BioNLP (1)
- Bioactivity-guided fractionation (1)
- Bioavailability (1)
- Bioavailability prediction (1)
- Bioelektrische Impedanzanalyse (1)
- Bioequivalence (1)
- Biofluids (1)
- Bioinformatik (1)
- Biological (1)
- Biological heart valves (1)
- Biological markers (1)
- Biological neural networks (1)
- Biological psychiatry (1)
- Biological sciences (1)
- Biological techniques (1)
- Biologisches Profil (1)
- Biomarker Discovery Study (1)
- Biomarker Lipoprotein(a) (1)
- Biomarker TIMP‑2 und IGFBP7 (1)
- Biomarkers & Diagnostic Imaging (1)
- Biomarkers TIMP‑2 and IGFBP7 (1)
- Biomechanical analysis (1)
- Biomedical named entity recognition (1)
- Bioprosthesis (1)
- Biopsychosocial (1)
- Biopsychosocial model (1)
- Biopsychosoziales Krankheitsmodell (1)
- Biopterin (1)
- Biowaiver (1)
- Bipolare Störung (1)
- Biposiekomplikationen (1)
- Birds (1)
- Birkenpollen (1)
- Birth (1)
- Bispecific (1)
- Bisphosphonates (1)
- Black cohosh (1)
- Black cohosh induced liver injury (1)
- Blasenkarzinom (1)
- Bleeding Risk (1)
- Blended learning curriculum · (1)
- Blended-Learning-Curriculum (1)
- Blended-learning (1)
- Bletilla striata (1)
- Blinatumomab (1)
- Blindness (1)
- Blockbuch (1)
- Blocked occlusion (1)
- Blood Banks/standards (1)
- Blood Transfusion, Autologous (1)
- Blood brain barrier (1)
- Blood cells (1)
- Blood coagulation disorder (1)
- Blood flow (1)
- Blood flow restriction (1)
- Blood loss calculator (1)
- Blood loss formula (1)
- Blood management (1)
- Blood parameters (1)
- Blood sample handling (1)
- Blood sampling (1)
- Blood transfusion (1)
- Bloodstream infection (1)
- Blot, Western (1)
- Blot, western (1)
- Blow fly (1)
- Blowflies (1)
- BluePrint (1)
- Blurred vision (1)
- Blut- und Plasmaprodukte (1)
- Blutbanken/Standards (1)
- Blutflussrestriktion (1)
- Blutflußumkehr (1)
- Blutgefäß (1)
- Blutgerinnungshemmung (1)
- Blutkulturdiagnostik (1)
- Blutparameter (1)
- Blutpräparate (1)
- Blutspenderscreening (1)
- Blutstammzelle (1)
- Blutstammzelle ; Nabelschnur ; Antigen CD34 ; Zellkultur (1)
- Bluttransfusion, Autologe (1)
- Blutung (1)
- Blutungskontrolle (1)
- Bochum <2010> (1)
- Body Composition (1)
- Body image (1)
- Body limbs (1)
- Body measurements (1)
- Body sway (1)
- Body temperature (1)
- Body-contouring surgery (1)
- Bodyplethysmographie (1)
- Bold fmri (1)
- Bologna process (1)
- Bologna-Prozess (1)
- Bone (1)
- Bone Gla Protein (1)
- Bone and joint mechanics (1)
- Bone cancer (1)
- Bone cement implantation syndrome (1)
- Bone conduction devices (1)
- Bone disease (1)
- Bone diseases (1)
- Bone diseases, Metabolic (1)
- Bone dust (1)
- Bone fracture (1)
- Bone marrow aspirate concentrate (1)
- Bone marrow cells (1)
- Bone marrow fibrosis (1)
- Bone marrow mononuclear cells (1)
- Bone metastasis (1)
- Bone remodelling (1)
- Bone strength assessment (1)
- Bone substitute (1)
- Bone tumor (1)
- Borrelia Garinii (1)
- Borrelia miyamotoi (1)
- Borrelien (1)
- Bortezomib (1)
- Boswellia serrata (1)
- Boswellic acids (1)
- Bottom-up (1)
- Bovine Spongiforme Enzephalopathie (BSE) (1)
- Bovine spongiform, encephalopathy (BSE) (1)
- Bow (1)
- Brachial artery (1)
- Brachytherapy (1)
- Bradycardia (1)
- Bradykinin (1)
- Brain DNA methylation (1)
- Brain anatomy (1)
- Brain asymmetry (1)
- Brain damage (1)
- Brain development (1)
- Brain imaging (1)
- Brain injuries (1)
- Brain injury (1)
- Brain ischemia (1)
- Brain lesion (1)
- Brain repair (1)
- Brain size I (1)
- Brain structure (1)
- Brain tumor surgery (1)
- Brain tumors (1)
- Brain-stimulus synchrony (1)
- BrainNet Europe consortium (1)
- Brazil (1)
- Breast Cancer (1)
- Breast cancer survivers (1)
- Breast conserving surgery (1)
- Breast neoplasm (1)
- Breast reconstruction (1)
- Breath testing (1)
- Breathing (1)
- Breech delivery (1)
- Bright light therapy (1)
- Brms (1)
- Brodalumab (1)
- Bromodomänen (1)
- Bronchial challenge (1)
- Bronchial inflammation (1)
- Bronchiale Hyperreagibilität (1)
- Bronchialkrebs (1)
- Bronchiolitis (1)
- Bronchiolitis obliterans (1)
- Bronchitis severity scale (1)
- Broncho-alveoläre Lavage (1)
- Bronchodilator agents (1)
- Bronchopulmonary dysplasia (1)
- Brownian dynamics simulation (1)
- Browsertool (1)
- Brust (1)
- Brustkrebs ; Klinische Medizin ; Kontrollierte klinische Studie (1)
- Bundesärztekammer / Ausschuss Arbeitsmedizin (1)
- Bungarus (1)
- Bungarus walli (1)
- Bunyavirus (1)
- Buparlisib (1)
- Bupivacain (1)
- Bupivacaine (1)
- Burden (1)
- Burkholderia arboris (1)
- Burkitt’s lymphoma (1)
- Burnout-Syndrom (1)
- Burns (1)
- Burst (1)
- Business strategy in drug development (1)
- Butterworth filters (1)
- Butyrate (1)
- Bypass liner (1)
- Bühnentanz (1)
- Büroangestellte (1)
- Büroarbeit (1)
- C-clamp (1)
- C-reactive proteins (1)
- C-reaktive protein (1)
- C-reäktives Protein (1)
- C1 esterase inhibitor (human) (1)
- C1-INH (C1 inhibitor, C1-esterase inhibitor) (1)
- C1-esterase inhibitor protein (1)
- C1-inhibitor (1)
- C1-inhibitor concentrate (1)
- C1-inhibitor deficiency (1)
- C2 domain (1)
- C3M (1)
- C4M (1)
- C5 acylcarnitine (1)
- C57BL/6J mice (1)
- C57BL/6N mice (1)
- C6 ceramide (1)
- CA (1)
- CA1 (1)
- CAC-DRS Score (1)
- CAD-CAM (1)
- CAD/ CAM crown (1)
- CAD/CAM crown (1)
- CAKUT (1)
- CAPON (1)
- CAR T cells (1)
- CAR-NK cell (1)
- CAR-T cell (1)
- CAR-immunotherapy (1)
- CAT (1)
- CBC (1)
- CBCT (1)
- CBT (1)
- CCC-2 (1)
- CCN2 (1)
- CCTT (1)
- CD107-Assay (1)
- CD137 (1)
- CD23 (1)
- CD271 (1)
- CD3 (1)
- CD3/19 depletion (1)
- CD3/CD19 depletion (1)
- CD34 (1)
- CD34 selection (1)
- CD34+ cell enumeration (1)
- CD34 + cells (1)
- CD4 binding site (1)
- CD4+ T cells (1)
- CD4+ T lymphocytes (1)
- CD40 (1)
- CD41 (1)
- CD45RA Depletion (1)
- CD45RA naïve lymphocytes (1)
- CD47 (1)
- CD49d (1)
- CD56 (1)
- CD62L (1)
- CD62P (1)
- CD62p+Exosomes (1)
- CD74 (1)
- CD8 (1)
- CD8+ T cell (1)
- CD8+ T cells (1)
- CD8+ T lymphocytes (1)
- CD8+ T-cell mediated tumor suppression (1)
- CD8+ tumor infiltrating lymphocytes (1)
- CD8+ zytotoxische T-Zellen (1)
- CD95/Fas receptor (1)
- CDH13 (1)
- CDI (1)
- CDK inhibitor (1)
- CDK-cyclin axis (1)
- CDK2 (1)
- CDK4/6 inhibitor (1)
- CDK4/6 inhibitors (1)
- CDK4/CDK6 (1)
- CDKN2A (1)
- CE (1)
- CE marking (1)
- CE-Kennzeichnung (1)
- CEBPD (1)
- CEBPE (1)
- CEST (1)
- CEST EPI (1)
- CGD (1)
- CGN codon (1)
- CHA2DS2-VASc-score (1)
- CHAID-Analyse (1)
- CHAID-Analysis (1)
- CHEPs (1)
- CHRDL1 (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- CIE-11 (1)
- CIK cell (1)
- CIM (1)
- CK2α (1)
- CLEC-2 (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- CLOCC (1)
- CLS (1)
- CMS (1)
- CMV isolation (1)
- CMV risk groups are: pregnancy - blood transfusion - organ transplantation - prostitutes (1)
- CMV-Isolierung (1)
- CMVepidemiology (1)
- CNDAC (1)
- CNP (1)
- CNS (1)
- CNS cancer (1)
- CNS infection (1)
- CNS melanoma (1)
- CNS toxicity (1)
- CNS tumor (1)
- CNV (1)
- CNVs (1)
- CO2-induced forced ventilation (1)
- COBAS Taqman (1)
- COBL (1)
- COI (1)
- COII (1)
- COINS (1)
- COMT (1)
- COPD assessment test (1)
- COPD course and therapy (1)
- COVID (1)
- COVID 19 pandemic (1)
- COVID-19 epitope signatures (1)
- COVID-19 regulations (1)
- COVID-19 vaccination (1)
- COVID-19, Primary care (1)
- COVID‐19 (1)
- CPET (1)
- CPT1A (1)
- CPTAC (1)
- CPVT (1)
- CQL (1)
- CRBN (1)
- CRC65 (1)
- CRE-dependent transcription (1)
- CRE-luciferase (1)
- CREB inhibitor (1)
- CRF (1)
- CRISPR screen (1)
- CRISPR-Cas9 gene conversion (1)
- CRISPR/dCas9 (1)
- CRM1 (1)
- CRPC (1)
- CRT (1)
- CRT-D (1)
- CRVO (1)
- CSC marker (1)
- CT dual-energy computed tomography (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CT-guidance (1)
- CT-guided interventions (1)
- CTC (1)
- CTX (1)
- CTX and NTX (1)
- CTX und NTX (1)
- CUELA system (1)
- CUP (1)
- CVD biomarker (1)
- CVID (1)
- CWS Studiengruppe (1)
- CX-2 (1)
- CXCL10 (1)
- CXCL16 (1)
- CXCR3 antagonism (1)
- CXCR5 (1)
- CY-503 (1)
- CYBA/p22phox (1)
- CYP1A1 (1)
- CYP450 (1)
- Ca2+ imaging (1)
- CaMPARI (1)
- Cabozantinib (1)
- Caco 2 cells/metabolism (1)
- Caco‐2 cells (1)
- Caffeine (1)
- Calcium calmodulin kinase (1)
- Calcium gluconate (1)
- Calcium recordings (1)
- Calcium signalling (1)
- Calcium waves (1)
- Calciumphosphatprodukt (1)
- Call for action (1)
- Calliphora (1)
- Calnexin (1)
- Calstabin2/FKBP12.6 (1)
- Campylobacter (1)
- Canada (1)
- Cancer Staging (1)
- Cancer cell migration (1)
- Cancer check up (1)
- Cancer detection (1)
- Cancer development (1)
- Cancer epigenetics (1)
- Cancer of unknown primary (1)
- Cancer progression (1)
- Cancer risk factors (1)
- Cancer staging (1)
- Cancer stem cells (1)
- Cancer survivors (1)
- Cancer therapeutic resistance (1)
- Cancer-specific survival (1)
- Candida spp (1)
- Cannabis-based Medicine (1)
- Capacity deficit (1)
- Capillary-Leak-Syndrom (1)
- Capnography (1)
- Capsaicin (1)
- Capsule endoscopy, video (1)
- Carbapenem-resistente Gram-negative Bakterien (CRGN) (1)
- Carbapenemasen (1)
- Carbohydrates (1)
- Carbon tetrachloride (1)
- Carcinogenese (1)
- Carcinogenität (1)
- Carcinoma penis (1)
- Carcinoma, Ductal, Breast (1)
- Cardiac (1)
- Cardiac Fibrosis (1)
- Cardiac acoustic biomarkers (1)
- Cardiac biomarkers (1)
- Cardiac causes of death (1)
- Cardiac device therapy (1)
- Cardiac fibroblast (1)
- Cardiac function (1)
- Cardiac implantable electronic devices (1)
- Cardiac infarction (1)
- Cardiac masses (1)
- Cardiac monitoring (1)
- Cardiac necroenzymes (1)
- Cardiac output (1)
- Cardiac rehabilitation (1)
- Cardiac remodeling (1)
- Cardiac remodelling (1)
- Cardiac resynchronization therapy (1)
- Cardiac surgery patients (1)
- Cardiac troponin (1)
- Cardiavascular function (1)
- Cardio-oncology (1)
- CardioMEMS™ HF system (1)
- Cardiogenic shock (1)
- Cardiomyocyte signaling pathways (1)
- Cardiomyopathy (1)
- Cardiopulmonary bypass (1)
- Cardiotoxicity (1)
- Cardiovascular Magnetic Resonance (CMR) (1)
- Cardiovascular disease risk (1)
- Cardiovascular epidemiology (1)
- Cardiovascular genetics (1)
- Cardiovascular mortality (1)
- Cardiovaskuläre Erkrankungen (1)
- Care centers (1)
- Care gaps (1)
- Care home (1)
- Career promotion (1)
- Careers (1)
- Caregiver burden (1)
- Caritas (1)
- Carotid injury (1)
- Carotid stenosis (1)
- Carrier-bound fibrin sealant (1)
- Cartilage (1)
- Cartilage Biology (1)
- Cary-Blair medium (1)
- Cary-Blair-Medium (1)
- Cas9 inhibitor (1)
- Case management [MeSH] (1)
- Casirivimab (1)
- Caspase-8 (1)
- Caspasen (1)
- Castleman’s disease (1)
- Castor bean tick (1)
- Catch-up validation study (1)
- Catel, Werner (1)
- Catheters (1)
- Catumaxomab (1)
- Causality (1)
- Causality assessment. (1)
- Cause of death (1)
- Cdk1/cyclin B1 (1)
- Cell Biology (1)
- Cell Death (1)
- Cell Metabolism (1)
- Cell Migration (1)
- Cell Signaling (1)
- Cell Surface Receptor (1)
- Cell adhesion (1)
- Cell cultures (1)
- Cell cycle (1)
- Cell distribution (1)
- Cell membranes (1)
- Cell metabolism (1)
- Cell motility (1)
- Cell plasticity (1)
- Cell processing (1)
- Cell surface proteoglycans (1)
- Cell-assisted lipotransfer (1)
- Cell-based Assays (1)
- Cell-based therapies (1)
- Cell-to-Cell Spread (1)
- Cellular (1)
- Cellular energy metabolism (1)
- Cellular imaging (1)
- Cellular inflammatory response (1)
- Cellular network formation (1)
- Cellular neuroscience (1)
- Cellular stress (1)
- Cellular stress responses (1)
- Cement gap (1)
- Cementation (1)
- Center-specific time in therapeutic range (cTTR) (1)
- Centers for Disease Control and Prevention (1)
- Central Europe (1)
- Central nervous system (1)
- Central nervous system metastases (1)
- Centrifugation (1)
- Cephalometry via electromagnetic induction (1)
- Cephalometry without x-rays (1)
- Ceramic (1)
- Ceramide (1)
- Ceramide Synthase (1)
- Ceramides (1)
- Cerasorb (1)
- Cerclage (1)
- Cerebellar ataxia (1)
- Cerebral Vasospasm (1)
- Cerebral hypoperfusion (1)
- Cerebral ischemia (1)
- Cerebral oxygen saturation (1)
- Cerebral toxoplasmosis HIV (1)
- Cerebral vasospasm (1)
- Cerebrospinal Fluid (1)
- Cerebrospinal fluid diagnostics (1)
- Cerebrovascular (1)
- Cerebrovascular disorders (1)
- Certification (1)
- Cervical (1)
- Cesarean delivery (1)
- Cethromycin (1)
- ChAdOx1-S (1)
- ChIP-Seq (1)
- Chagas (1)
- Change Management (1)
- Chaperones (1)
- Checkliste (1)
- Checkpoint Inhibitor (1)
- Checkpoint kinase (1)
- Checkpoints (1)
- Chemical company (1)
- Chemical ecology (1)
- Chemical labeling (1)
- Chemical modification (1)
- Chemikalie (1)
- Chemiluminescence (1)
- Chemilumineszenz (1)
- Chemische Sonden (1)
- Chemobrain (1)
- Chemoembolization (1)
- Chemoinformatics (1)
- Chemokine CCL2 (1)
- Chemoradiation (1)
- Chemorefractory advanced gastric cancer (1)
- Chemosensitivity (1)
- Chest pain unit (1)
- Chewa (1)
- Chewa-Sprache (1)
- Chichewa (1)
- Chikungunya (1)
- Chikungunya virus (1)
- Child adiposity (1)
- Child and adolescent psychotherapy (1)
- Child health (1)
- Childhood (1)
- Childhood abuse (1)
- Childhood sexual abuse (1)
- Chimeric Antigen Receptor (CAR) (1)
- Chimerism (1)
- Chimiothérapie (1)
- Chinesischer Rhabarber (1)
- Chinoxalinderivate (1)
- Chlamydia-Infections/urine (1)
- Chlamydien (1)
- Chlamydieninfektionen/Urin (1)
- Chloralhydrat (1)
- Chloroform (1)
- Chloroquin (1)
- Cholecystectomy (1)
- Cholesterinveresterung (1)
- Cholesterol (1)
- Cholinergic (1)
- Chondral Lesion (1)
- Chondrocyte (1)
- Chondrocyte signalling (1)
- Chrna7 knockout (1)
- Chrom (1)
- Chromatin and Epigenetics (1)
- Chromatin conformation (1)
- Chromodomains (1)
- Chromoendoscopy (1)
- Chromosom (1)
- Chromosomal deletion (1)
- Chromosomal translocations (1)
- Chromosomale Translokation (1)
- Chronic Hepatitis C (1)
- Chronic ankle instability (1)
- Chronic care model (1)
- Chronic conditions (1)
- Chronic disease [MeSH] (1)
- Chronic health condition (1)
- Chronic heart failure (1)
- Chronic hepatitis C virus (1)
- Chronic illness (1)
- Chronic infection (1)
- Chronic intestinal failure (1)
- Chronic lymphocytic leukemia (1)
- Chronic medical conditions (1)
- Chronic obstructive airway disease (1)
- Chronic pain (1)
- Chronic pancreatitis (1)
- Chronic periodontiti (1)
- Chronification (1)
- Chronisch aktive/Diagnostik (1)
- Chronisch-venöse Insuffizienz (1)
- Chronische Fehl- und Überlastungsschäden (1)
- Chronische Krankheit (1)
- Chronische Niereninsuffizienz (1)
- Chronischer Schmerz (1)
- Chronology of disease (1)
- CiNyungwe (1)
- Cigarette (1)
- Cigarettes (1)
- Cindau (1)
- Cine (1)
- Cinnarizine (1)
- Cinryze® (1)
- Ciprofloxacin (1)
- Circadian (1)
- Circadian rhythms and sleep (1)
- Circulating MiRNA (1)
- Circulating markers (1)
- Circulating miRNA (1)
- Circulation (1)
- Cirugía (1)
- Cisplatinresistenz (1)
- Citation (1)
- Citationrate (1)
- Cities (1)
- Citrat (1)
- Civil liberties (1)
- Civil protection (1)
- Claudin 5 (1)
- Clavien–Dindo classification (1)
- Cleanliness level (1)
- Cleft palate (1)
- Click chemistry (1)
- Climate (1)
- Climate change (1)
- Climate inequity (1)
- Clincial pharmacology (1)
- CliniMACS (1)
- Clinical (1)
- Clinical Decision Support System (1)
- Clinical Skills (1)
- Clinical effectiveness (1)
- Clinical efficacy (1)
- Clinical frailty scale (1)
- Clinical management (1)
- Clinical neuropsychology (1)
- Clinical outcome (1)
- Clinical pathway (1)
- Clinical pathways (1)
- Clinical pharmacology (1)
- Clinical phenotype (1)
- Clinical practice guidelines (1)
- Clinical psychometry (1)
- Clinical skills (1)
- Clinical tasks (1)
- Clinical variation (1)
- Clinician-administered PTSD Scale PTSD (1)
- Clip (1)
- Cln3 (1)
- Clonidin (1)
- Clonidine (1)
- Clopidogrel (1)
- Clostridioides difficile (1)
- Clostridium (1)
- Closure (1)
- ClpB (1)
- Cluster (1)
- Cluster randomization (1)
- Clustering coefficients (1)
- Co-culture (1)
- Co-morbidity (1)
- Coagulation (1)
- Coagulopathy management (1)
- Cocain (1)
- Cochlear Implant (1)
- Codierung (1)
- Coexistence (1)
- Cofilin (1)
- Cognitive (1)
- Cognitive behavioural therapy (1)
- Cognitive control (1)
- Cognitive dysfunction (1)
- Cognitive enhancers of exposure therapy (1)
- Cognitive neurology (1)
- Cognitive psychology (1)
- Cognitive training (1)
- Cognitive-motor interference (1)
- Coherent infomax (1)
- Cohort Analysis (1)
- Cohort study (1)
- Colchicum (1)
- Cold hardiness (1)
- Cold pain (1)
- Cold tolerance (1)
- Colitis Ulcerosa (1)
- Colitis assoziate colorectal cancer (1)
- Collagen Maps (1)
- Collagen antibody-induced arthritis (1)
- Collagen hemostat (1)
- Collagen type I (1)
- Collagen type III (1)
- Collagen-based biomaterial (1)
- Collective cell migration (1)
- Colon cancer (1)
- Colon capsule endoscopy (1)
- Colonic neoplasms (1)
- Colonisation (1)
- Colonkrebs (1)
- Colony stimulating factor 1 receptor (1)
- Colorectal Cancer (1)
- Colorimetric blood loss estimation (1)
- Combined immune checkpoint blockade (1)
- Combined surgical therapy (1)
- Combo® DTS (1)
- Combustion (1)
- Commercial Immunoglobulins (1)
- Communicable diseases (1)
- Communication-through-coherence (CTC) (1)
- Comparative analysis (1)
- Comparative effectiveness research (1)
- Comparative study (1)
- Comparators (1)
- Compartmental modeling (1)
- Competencies (1)
- Complement Regulator (1)
- Complement cascade (1)
- Complement system (1)
- Complementary medicine (1)
- Complementation rate (1)
- Complete heart block (1)
- Complete response (1)
- Completed suicide (1)
- Complex Systems (1)
- Complex decongestive therapy (1)
- Complex elbow fractures (1)
- Complex hernia (1)
- Complex networks (1)
- Complexin 1 (1)
- Complexin-1 (1)
- Compliance-Beobachtung (1)
- Complicated appendicitis (1)
- Complicated stage (1)
- Complication (1)
- Comprehensive cancer centers (1)
- Comprehensive complication index (1)
- Compression stocking (1)
- Computational chemistry (1)
- Computed axial tomography (1)
- Computed tomography imaging (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computed tomography, X-ray (1)
- Computer simulation (1)
- Computer-Assisted (1)
- Computer-Tomographie (CT) gesteuerte Verfahren (1)
- Computer-aided drug design (1)
- Computer-unterstützte (1)
- Computers (1)
- Computerspielstörung (1)
- Concept paper (1)
- Conception (1)
- Concurrent CNS diseases (1)
- Concurrent chemoradiotherapy (1)
- Conditional gene trap (1)
- Conduct problems (1)
- Conduit function (1)
- Cone-beam computed tomography (1)
- Confinement (1)
- Confocal endomicroscopy (1)
- Conformational change (1)
- Congenital (1)
- Congenital CMVinfection (1)
- Congenital anomalies (1)
- Congenital diaphragmatic hernia (1)
- Congenital duodenal obstruction (1)
- Congenital ocular motor apraxia (1)
- Coniosporium corticale (1)
- Conometric connection (1)
- Conscious perception (1)
- Consciousness (1)
- Consensus document (1)
- Consensus methods (1)
- Consensus statement (1)
- Conservation (1)
- Conservative (1)
- Conservative treatment (1)
- Consolidation (1)
- Consortia (1)
- Constipation (1)
- Constitution (1)
- Constrained posture (1)
- Contact network (1)
- Contact precautions (1)
- Contamination (1)
- Contingent Negative Variation, CNV (1)
- Continuous Performance Test, CPT (1)
- Continuous Process Verification (1)
- Continuous renal replacement therapy (1)
- Contraceptifs hormonaux (1)
- Contractile function (1)
- Contrast agent (1)
- Contrast-Enhancing Lesions (1)
- Contrast-enhanced (1)
- Contrast-medium, injection rate, iodine concentration, hepatic malignancy, multiphasic CT (1)
- Contrastive analysis (1)
- Control (1)
- Controlled freezing/thawing (1)
- Conventional Chemotherapeutic (1)
- Conventional and unconventional ubiquitination (1)
- Conventional dendritic cells (1)
- Conventional synthetic disease-modifying antirheumatic drug (1)
- Convolutional Neural Networks (1)
- Cooperation (1)
- Coordination Of Control Modes (1)
- Copy number (1)
- Copy number variation (1)
- Cord blood transplantation (1)
- Cordichin (1)
- Core needle biopsy (1)
- Cornea (1)
- Corneal tomography (1)
- Corneometrie (1)
- Corona pandemic (1)
- Corona virus (1)
- Coronary CT (1)
- Coronary Heart Disease (1)
- Coronary Plaque Burden (1)
- Coronary artery disease (CAD) (1)
- Coronary calcification (1)
- Coronary intervention (1)
- Coronaviren (1)
- Coronaviruses (1)
- Cortical column (1)
- Cortical degeneration (1)
- Cortical thickness (1)
- Corticotropic axis (1)
- Cortisol (1)
- Cost And Quality Management (1)
- Cost-effectiveness analysis (1)
- Couch tracking (1)
- Council for International Organizations of Medical Sciences (1)
- Course (1)
- Course evaluation (1)
- Covid19-nmr (1)
- Cox-2-Inhibitoren (1)
- Cox-Regression (1)
- Coxibs (1)
- Coxsackieviren (1)
- Cp (1)
- Cpk (1)
- Craniomandibular disorders (1)
- Craniomaxillofacial injuries (1)
- Creatinine (1)
- Credentialing (1)
- Creeping Disease (1)
- Crisis (1)
- Crispr/Cas (1)
- Critical Online Reasoning Assessment (1)
- Critical bleeding (1)
- Critical care and emergency medicine (1)
- Critical haematocrit (1)
- Critical pathway (1)
- Critical size (1)
- Cross- sectional study (1)
- Cross-border mobility (1)
- Cross-contamination (1)
- Cross-frequency coupling (1)
- Cross-sectional (1)
- Cross-sectional study (1)
- Crosscorrelation (1)
- Crossmodal (1)
- Cryo-concentration (1)
- Cryo-electron microscopy (1)
- Cryoablation (1)
- Cryoballoon (1)
- Cryptococcus (1)
- Cryptostroma corticale (1)
- CspA (1)
- Cue-P3 (1)
- Culex pipiens (1)
- Culex pipiens biotypes pipiens/molestus (1)
- Culture (1)
- Culture positive (1)
- Cumulative dose (1)
- Curcumin (1)
- Curcumin micelles (1)
- Curcuminoid concentrations (1)
- Curcumis sativus (1)
- Cure (1)
- Curvilinear dose response (1)
- Cushing-Syndrom (1)
- Cushing’s syndrome (1)
- Custom-made mouthguard (1)
- Cuticular hydrocarbons (1)
- Cy5.5 (1)
- Cyanoacrylate (1)
- CyberKnife (1)
- Cyborg (1)
- Cyclic GMP (1)
- Cyclin T1 (1)
- Cyclocymopol-Derivat (1)
- Cyclooxygenase (1)
- Cyclosporin A (1)
- Cyp46a1 (1)
- Cystatin C (1)
- Cysteine‐Rich Domain (CRD) (1)
- Cytochrome P450 (1)
- Cytochrome P450 enzymes (1)
- Cytokines Induction (1)
- Cytology (1)
- Cytomegalie (1)
- Cytomegalie-Virus (1)
- Cytomegalievirus (1)
- Cytomegalovirus (1)
- Cytomegalovirus (CMV) (1)
- Cytomegalovirus Infection (1)
- Cytoplasm (1)
- Cytoplasmic staining (1)
- Cytoreductive nephrectomy (1)
- Cytotoxic CD8+ T cell (1)
- Cytotoxicity (1)
- C‐reactive protein (1)
- D-amino acid oxidase (1)
- D-dimer (1)
- D2-autoreceptor (1)
- DAMP (1)
- DAMPs (1)
- DAN-G (1)
- DBH genotype (1)
- DBS (1)
- DC-NK cell interaction (1)
- DCK (1)
- DCM (1)
- DDA (1)
- DDDPlus (1)
- DDIT4 (1)
- DDX6 (1)
- DECT (1)
- DEE (1)
- DFNB9 (1)
- DHA (1)
- DILI database case quality (1)
- DIN EN ISO 15189 (1)
- DIRAS2 (1)
- DJ-Katheter (1)
- DKK1 (1)
- DKTK-ROG (1)
- DLBCL (1)
- DLI (1)
- DLPFC (1)
- DMARDs (synthetic) (1)
- DME (1)
- DMXAA (1)
- DNA Adducts (1)
- DNA Damage (1)
- DNA double-strand break repair (1)
- DNA integrity (1)
- DNA repair (1)
- DNA replication (1)
- DNA sequence analysis (1)
- DNA sequencing (1)
- DNA, Virale/Blut (1)
- DNA-Methylierung (1)
- DNA-PAINT (1)
- DNA-PK (1)
- DNA-based identification (1)
- DNA-binding proteins (1)
- DNA-protein crosslinks (1)
- DOK1 (1)
- DOT1L (1)
- DPPIV (1)
- DR5 (1)
- DRG (1)
- DRIL-Procedur (1)
- DRIL-procedure (1)
- DSAEK (1)
- DSS /AOM (1)
- DST (1)
- DTHR (1)
- DUBs (1)
- DVI (1)
- DVT (1)
- DWI (1)
- DYRK1A (1)
- DYT1 (1)
- Dabigatran (1)
- Daboia russelii (1)
- Daclatasvir (1)
- Daily diary (1)
- Dance (1)
- Dancer (1)
- Dark triad (1)
- Darmerkrankung (1)
- Darreichungsform (1)
- Darunavir (1)
- Data Analysis (1)
- Data acquisition (1)
- Data exploration (1)
- Data mining (1)
- Data monitoring (1)
- Data preprocessing (1)
- Data protection (1)
- Data reduction (1)
- Data structure detection (1)
- Data validation (1)
- Data visualization (1)
- Databases (1)
- Dataset bias (1)
- Datenanalyse (1)
- Datenqualität (1)
- Daubert criteria (1)
- Dauerversorgung (1)
- David technique (1)
- De-isolation (1)
- Dead space (1)
- Death certificate (1)
- Decay (1)
- Decision Confidence (1)
- Decision impact (1)
- Decision support (1)
- Decision-making (1)
- Declaration of Cologne (1)
- Decolonization (1)
- Decontamination (1)
- Deep learning (1)
- Deep neural network (1)
- Deep vein thrombosis (1)
- Default-mode network (1)
- Defekt (1)
- Deficient Inhibition (1)
- Definition Gesundheit (1)
- Deformation (1)
- Degrader design (1)
- Dehnen (1)
- Dehnen verkürzter Muskulatur (1)
- Dehntraining (1)
- Delay of gratification (1)
- Delayed Cerebral Ischemia (1)
- Delayed Infectivity Panning (1)
- Delayed union (1)
- Deletion mutation (1)
- Delivery mode (1)
- Delivery quality assurance (1)
- Delphi Survey (1)
- Delphi consensus (1)
- Delphie-Befragung (1)
- Demenzerkrankung (1)
- Demersal fish (1)
- Democracy (1)
- Dendritic Cells (1)
- Dendritic cell (1)
- Dendritic cell population (1)
- Dendritic cells (1)
- Dendritic spines (1)
- Dendritic structure (1)
- Dendritische Zelle (1)
- Denervation (1)
- Dengue fever (1)
- Dengue fever virus (1)
- Denguefieber (1)
- Density equalizing (1)
- Dental air (1)
- Dental assistants (1)
- Dental casts (1)
- Dental education (1)
- Dental phobia (1)
- Dental practice (1)
- Dental training (1)
- Dentale Implantate (1)
- Dentalkeramik; Grünling <Technik>; CAM; Hartmetallwerkzeug; Werkzeugverschleiß; Dimensionsstabilität; Schleifwerkzeug; Diamantwerkzeug (1)
- Dentin adhesives (1)
- Dentition (1)
- Depolarization (1)
- Depression stigma (1)
- Dermatitis (1)
- Dermatomyositis (1)
- Dermatopharmakokinetik (1)
- Designed ankyrin repeat protein (1)
- Desinfektion von Flugzeugen (1)
- Desmin (1)
- Detection (1)
- Detection workflow (1)
- Determination method (1)
- Detraining (1)
- Deubiquitination (1)
- Deutsch als Zweitsprache (1)
- Deutsch-Ostafrika (1)
- Deutsche Gesellschaft für Arbeitsmedizin (1)
- Deutsche Gesellschaft für Chirurgie (1)
- Deutscher Gewerkschaftsbund (1)
- Deutsches Rotes Kreuz (1)
- Deutschland / Bundesministerium für Gesundheit (1)
- Deutschland / Fallpauschalengesetz (1)
- Developmental Biology (1)
- Developmental and epileptic encephalopathy (1)
- Developmental disorders (1)
- Developmental programming (1)
- Developmental trajectory (1)
- Developmentally adapted cognitive processing therapy (1)
- Devic disease (1)
- Devic syndrome (1)
- Device (1)
- Dexamethasone (1)
- Dexterity (1)
- DiI (1)
- Diabetes mellitus Typ 1 und Typ 2 (1)
- Diabetes mellitus Typ 2 (1)
- Diabetic nephropathy (1)
- Diadenosinpolyphosphate (1)
- Diagnosen ICD-10 Ziffern G41.0, G41.1, G41.2, G41.8, G41.9 (1)
- Diagnosenschlüssel (1)
- Diagnoses ICD-10 codes G41.0, G41.1, G41.2, G41.8, G41.9 (1)
- Diagnosezeitpunkt (1)
- Diagnosis related groups (1)
- Diagnostic accuracy (1)
- Diagnostic differentiation (1)
- Diagnostic dye (1)
- Diagnostic error (1)
- Diagnostic techniques and procedures (1)
- Diagnostic tests (1)
- Diagnostik von MLL Translokationen (1)
- Dialectical behavioral therapy (1)
- Dialyse-assoziiertes Steal-Syndrom (1)
- Dialysis-associated Steal Syndrome (1)
- Diary Data (1)
- Diastolische Dysfunktion (1)
- Dichloromethane (1)
- Dichtebestimmung (1)
- Dickdarmkrebs (1)
- Dictyostelium discoideum ; Retrotransposon ; t-DNS ; Nachweis ; In vivo (1)
- Didaktik (1)
- Diesel (1)
- Diet (1)
- Dietary HDAC inhibitor (1)
- Dietary intake (1)
- Dietary supplements (1)
- Dieulafoy’s lesion (1)
- Differential Scanning Calorimetry (DSF) (1)
- Differential equations (1)
- Differential expression (1)
- Difficult Airway Management (1)
- Diffuse astrocytoma (1)
- Diffuse large B cell lymphoma (1)
- Diffuse large B-cell lymphoma (1)
- Diffusion (1)
- Diffusion MRI (1)
- Diffusion Tensor Imaging (1)
- Diffusion magnetic resonance imaging (1)
- Diffusion of Innovations (1)
- Diffusion-Weighted Imaging (1)
- Diffusions-Tensor-Bildgebung (1)
- Diffusionsbildgebung (1)
- Diflapolin (1)
- Digenic model (1)
- Digestive system (1)
- Digital (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital ethics (1)
- Digital hybrid visualization (1)
- Digital mammography (1)
- Digital pathology (1)
- Digital rectal examination (1)
- Digital subtraction angiography (1)
- Digital transformation (1)
- Digital workshops (1)
- Digitale Ethik (1)
- Digitale Pathologie (1)
- Digitale Transformation (1)
- Digitale Volumen Tomographie (1)
- Digitization (1)
- Dilated cardiomyopathy (1)
- Dimer (1)
- Dimers (Chemical physics) (1)
- Dimethyltryptamine (1)
- Dioecy (1)
- Dioscorea (1)
- Dipeptide (1)
- Diphosphonates (1)
- Diphtheria (1)
- Direct Acting Antivirals (DAA) (1)
- Direct acting antiviral therapies (1)
- Direct costs (1)
- Direct measurement (1)
- Direct oral anticoagulation (1)
- Direct-acting antiviral agents (DAAs) (1)
- Direct-acting antivirals (1)
- Directional freezing (1)
- Disabilities (1)
- Disability (1)
- Disabling back pain (1)
- Disaster victim identification (1)
- Discitis (1)
- Disconnection (1)
- Discovery (1)
- Discs large (1)
- Disease burden (1)
- Disease management (1)
- Disease progression (1)
- Disinfection of aircraft (1)
- Diskonnektion (1)
- Diskursanalyse (1)
- Dislocations of the knee (1)
- Displacement (1)
- Dissemination (1)
- Dissociative seizures (1)
- Dissolution nanoparticles (1)
- Distale Revascularisation- Intervall Ligatur (1)
- Distance learning (1)
- Distanzunterricht (1)
- Distress (1)
- Distress screening (1)
- Distribution (1)
- Distribution limits (1)
- Disturbancies and mistakes (1)
- Dizygotic ectopic (1)
- Doctors In Management (1)
- Dog (1)
- Dogs (1)
- Domestic (1)
- Donau (1)
- Donor Selection (1)
- Donor T cells (1)
- Donor screening (1)
- Doppler-Sonographie (1)
- Dorsal root ganglia (1)
- Dorsolateral prefrontal cortex (1)
- Dose optimization (1)
- Dosiskonzepte (1)
- Dot-probe task (1)
- Double balloon enteroscopy (1)
- Double suicide (1)
- Double-blind placebo-controlled trial (1)
- Doubling time (1)
- Douleur (1)
- Down's syndrome (1)
- Downgrading (1)
- Downy mildew (1)
- Doxorubicin (1)
- Doxycyclin (1)
- Doxycycline (1)
- Dravet (1)
- Drogenabhängigkeit (1)
- Drogenhilfe (1)
- Drogenkonsum (1)
- Drogentherapie (1)
- Drogentote (1)
- Droplets (1)
- Drosophila (1)
- Drosophila melanogaster (1)
- Drospirenon (1)
- Drought (1)
- Drug (1)
- Drug Delivery (1)
- Drug Resistance (1)
- Drug Therapy (1)
- Drug addiction (1)
- Drug delivery systems (1)
- Drug discovery and development (1)
- Drug interactions (1)
- Drug permeability (1)
- Drug resistance/synergy (1)
- Drug safety (1)
- Drug screens (1)
- Drug substance bottles (1)
- Drug susceptibility testing (1)
- Drug targeting (1)
- Drug targets (1)
- Drug-Drug Interactions (1)
- Dual energy CT (1)
- Dual task walking (1)
- Dual therapy (1)
- Dual-Source CT (1)
- Dual-energy computed tomography (1)
- Duchenne’s muscular dystrophy (1)
- Dumon stents (1)
- Duodenal atresia (1)
- Duodenal stenosis (1)
- Duodenum (1)
- Dural onlays (1)
- Durchblutungsstörung (1)
- Durchseuchung (1)
- Dvc1 (1)
- Dynamical systems (1)
- Dysfibrinogenämia (1)
- Dysfunctional social assumptions (1)
- Dyslexia (1)
- Dysphagia (1)
- Désir d’enfant (1)
- D’Amico classification (1)
- E protein structure (1)
- E-NTPDase (1)
- E-cadherin (1)
- E-cadhérine (1)
- E-health (1)
- E-learning (1)
- E/I-Balance (1)
- E2F-1 (1)
- EAA (1)
- EASI (1)
- EBRA-FCA (1)
- EBRT (1)
- ECLS (1)
- ECM (1)
- EDB (1)
- EDOF (1)
- EDTA-plasma (1)
- EEC syndrome (1)
- EEG reference choices (1)
- EEG-TMS (1)
- EFP1 (1)
- EFRS (1)
- EGF (1)
- EGF-Rezeptor (1)
- EGFL7 (1)
- EGFP (1)
- EGFR inhibitor (1)
- EGFR pathway (1)
- EGFRvIII mutation (1)
- EGR1-dependent transcription (1)
- EGR1/2/3 (1)
- EHL concentrates (1)
- EIIIB (1)
- EKoti (1)
- ELISPOT (1)
- ELSID-Diabetes (1)
- EMD 55900 (1)
- EMD 72000 (1)
- EMR1 (1)
- EN ISO 15189 (1)
- ENIGMA (1)
- EOB (1)
- EP300 (1)
- EPA (1)
- EQ (1)
- EQ5D5L (1)
- EQA scheme (1)
- EQIP (1)
- ER-phagy (1)
- ERAL1 (1)
- ERBB2 (1)
- ERBB2 (HER2/neu) (1)
- ERCP (1)
- ERK inhibitor (1)
- ERK1/2 signaling (1)
- ERK3 (1)
- ERK3/MAPK6 (1)
- ERM (1)
- ERMS (1)
- ES (1)
- ES cells (1)
- ESMO-MCBS (1)
- ESR Spectroscopy (1)
- ESR and Infrared Studies (1)
- ESWT (1)
- ET (1)
- ET-MP (1)
- ETP-ALL (1)
- ETS (1)
- EVAR (1)
- EWS/Fli1 (1)
- EZ-IO® needle driver (1)
- Early (prenatal and postnatal) life experiences (1)
- Early Rheumatoid Arthritis (1)
- Early diagnosis (1)
- Early goal-directed therapy (1)
- Early intervention (1)
- Early recurrence (1)
- Early setting (1)
- Ebola (1)
- Echocardiography (1)
- Echovirus-30 (1)
- Eclampsia (1)
- Ecological Momentary Assessment (EMA) (1)
- Ecological momentary assessment (1)
- Ecological niche modelling (1)
- Economic analysis (1)
- Economic benchmarks (1)
- Economic botany (1)
- Economic evaluation (1)
- Economic impact (1)
- Economics (1)
- Ecosystem health (1)
- Ecto-5'-nucleotidase (1)
- Ectopic bone formation (1)
- Ectopic pregnancy (1)
- Ectopic varices (1)
- Edentulous jaw (1)
- Edinger, Ludwig (Arzt) (1)
- Educación médica (1)
- Efavirenz (1)
- Effective connectivity (1)
- Effective half-life (1)
- Effectivity (1)
- Ego dissolution (1)
- Eicosanoide (1)
- Eicosanoids (1)
- Eignungsprüfung (1)
- Einfachauswahlverfahren (1)
- Einflussnahme (1)
- Eingangstest (1)
- Eingeborene (1)
- Einmaleinnahme (1)
- Einreibetechnik (1)
- Einstellung (1)
- Einstellungen (1)
- Einstellungen zu Impfungen (1)
- Einwilligungsfähigkeit (1)
- Einzelzahnimplantate (1)
- Eisenbestimmung (1)
- Eisenmangel (1)
- Eisenstoffwechsel (1)
- Ektachem® (1)
- Elastogenesis (1)
- Elastographie (1)
- Elbow (1)
- Elderly patients (1)
- Elderly trauma patient (1)
- Elective caesarean section (1)
- Electric stimulation (1)
- Electrical accident (1)
- Electrical and electronic engineering (1)
- Electrical instability (1)
- Electroconvulsive Therapy (1)
- Electrode potentials (1)
- Electrolytes (1)
- Electromyography (1)
- Electron microscopy (1)
- Electron transport chain (1)
- Electronic cigarettes (1)
- Electrospinning (1)
- Electrotonic analysis (1)
- Elektrischer Sturm (1)
- Elektroencephalographie (1)
- Elektroenzephalographie (1)
- Elektromyographie (1)
- Elektrophysilogie (1)
- Elimination (1)
- Elite football (1)
- Ellipsoids (1)
- Ellipticine (1)
- Elomwe (1)
- Elternurteil (1)
- Emanzipation (1)
- Embden, Gustav (1)
- Embolie (1)
- Embolization (1)
- Embryos (1)
- Emergency (1)
- Emergency card (1)
- Emergency care (1)
- Emergency medicine (1)
- Emergency treatment (1)
- Emotion processing (1)
- Emotional intelligence (1)
- Emotional recognition (1)
- Empfehlungen (1)
- Empfindlichkeitstestung (1)
- Emphysema (1)
- Employment (1)
- Employment effect (1)
- Empty puparia (1)
- Emx2 (1)
- Ena/VASP proteins (1)
- Encephalitis Viruses (1)
- End-of-life decisions (1)
- Endocrine cancer (1)
- Endocrine system and metabolic diseases (1)
- Endocrine therapy (1)
- Endodontie (1)
- Endogene Retroviren (1)
- Endogene Retroviren ; Schwein ; Heterotransplantation ; Wirt (1)
- Endogene Retroviren; Mensch; Schwein; Genregulation; Wirtsspezifität; Heterotransplantation (1)
- Endogenous RNA-Polymerase (1)
- Endogenous retroviruses (ERV) (1)
- Endoluminal (1)
- Endometrial cancer (1)
- Endometrial carcinoma (1)
- Endometriome (1)
- Endometriose (1)
- Endomicroscopy (1)
- Endométriomes (1)
- Endoplasmic reticulum (1)
- Endoprothese (1)
- Endorectal (1)
- Endoscopic coronary revascularisation (1)
- Endoscopic papillotomy (1)
- Endoscopic retrograde Cholangiopancreatography (ERCP) (1)
- Endoscopic retrograde cholangiography (1)
- Endoscopic sphincterotomy (1)
- Endoscopic treatment (1)
- Endoskopie (1)
- Endoskopik koroner revaskülarizasyon (1)
- Endothelial (1)
- Endothelial cell (1)
- Endothelial cell (EC) (1)
- Endothelial nitric oxide synthase (1)
- Endothelial progenitor cells (1)
- Endothelial protein C receptor (1)
- Endothelial-to-mesenchymal transition (1)
- Endotheliale Stickstoffmonoxidsynthase (1)
- Endothelzelle (1)
- Endotoxikose (1)
- Endotoxinaktivität (1)
- Endotoxins (1)
- Endourologie (1)
- Endovascular aortic repair (1)
- Endovaskuläre Versorgung (1)
- Endpoint Urea determination (1)
- Endpoints (1)
- Endpunkt-Harnstoffbestimmung (1)
- Endurance training (1)
- Energiebedarf (1)
- Energiedefizit (1)
- Energy (1)
- Energy deficit (1)
- Energy-efficiency (1)
- Enfermedades crónicas (1)
- England (1)
- Engraftment (1)
- Enteral nutrition (1)
- Enteric nervous system (1)
- Enterobacterales (1)
- Enterostomy (1)
- Enterostomy closure (1)
- Enterostomy formation (1)
- Enterovirus 71 (1)
- Entfernung (1)
- Entorhinal cortex lesion (1)
- Entrenamiento práctico (1)
- Entscheidungsfindung (1)
- Entsäuerung (1)
- Entwicklungsbiologie (1)
- Env (1)
- EnvZ signalling (1)
- Envenomation (1)
- Environmental biotechnology (1)
- Environmental chemistry (1)
- Environmental enrichment (1)
- Environmental health (1)
- Environmental impacts (1)
- Environmental sciences (1)
- Enzephalopathie (1)
- Enzym (1)
- Enzymaktivität (1)
- Enzymatic activity (1)
- Enzyme Linked Immunosorbent Assay (ELISA) (1)
- Enzyme kinetics (1)
- Enzyme mechanisms (1)
- Enzyme regulation (1)
- Enzyme-linked immunosorbent assay (1)
- Enzymkinetik (1)
- Enzymtherapie (1)
- Eosinophilie (1)
- Eosinophils (1)
- EpCAM positive tumor (1)
- Eph receptors (1)
- Ephrin ligand (1)
- Ephrin-B2–EphB4 (1)
- Epidemic (1)
- Epidemie (1)
- Epidemiological data (1)
- Epidemiological statistics (1)
- Epidemiologische Surveillance (1)
- Epidermaler Wachstumsfaktor Rezeptor (1)
- Epidermolysis bullosa simplex with muscular dystrophy (1)
- Epidural abscess (1)
- Epidural block (1)
- Epilepsiechirurgie (1)
- Epilepsiezentren (1)
- Epilepsy Acute seizure plan Antiseizure medication Instructions for action Self-management (1)
- Epilepsy center (1)
- Epilepsy centers (1)
- Epilepsy surgery (1)
- Epileptic seizure (1)
- Epithel (1)
- Epithelial cells (1)
- Epithelialization (1)
- Epithelioma Cells (1)
- Epsilon (1)
- Epstein–Barr virus (1)
- Equality (1)
- Equipment (1)
- Eradication (1)
- ErbB-signaling (1)
- ErbB2; Single-chain Fv Antikörper (1)
- Erblichkeit (1)
- Erdnussallergie (1)
- Ereignis (1)
- Ereigniskorrelierte Felder (1)
- Erfolgsfaktoren (1)
- Ergebnisquantifizierung (1)
- Ergometrie (1)
- Ergometry (1)
- Ergonomic analysis (1)
- Ergonomie am Arbeitsplatz (1)
- Ergonomische Analyse (1)
- Ernährung (1)
- Erprobung (1)
- Erregernachweis (1)
- Erregerspektrum der Tonsillitis (1)
- Erschöpfung (1)
- Erste Hilfe (1)
- Erste-Hilfe-Kurs (1)
- Erwachsener, 50-65 Jahre (1)
- Erythema migrans (1)
- Erythematodes (1)
- Erythrocytes (1)
- Erythrophagocytosis (1)
- Erythropoetin (1)
- Erythropoiesis (1)
- Erythropoietin (1)
- Erythrozytenkonzentrat (1)
- Erythrozytentransfusion (1)
- Erzähltheorie (1)
- Erzählung (1)
- Escala de TEPT administrada por un médico (1)
- Esophageal adenocarcinoma (1)
- Esophageal adenocarcinoma (EAC) (1)
- Esophagectomy (1)
- Esophagogastric (1)
- Estimated glomerular filtration rate (1)
- Estimation of height and sex determination (1)
- Estradiol (1)
- Estrogen Receptor Modulators (1)
- Etanercept (1)
- Ether (1)
- Ethics Committees/Consultation (1)
- Ethik (1)
- Ethnicity (1)
- Ethnische Gruppe (1)
- Ethno-ophiology (1)
- Ethnobotany (1)
- Ethnologische Studie (1)
- Eugenik (1)
- European Comparison (1)
- European Society for Immunodeficiencies (ESID) (1)
- European babesiosis (1)
- European registry for idiopathic pulmonary fibrosis (eurIPFreg) (1)
- Europäische Integration (1)
- Europäische Union (1)
- Euthanasie (1)
- Euthymic phase (1)
- Evaluation in microsurgery (1)
- Evaluationspraxis (1)
- Event related potentials (1)
- Event-related potential (1)
- Event-related potentials (1)
- Everolimus resistance (1)
- Evidence-based drug discovery (1)
- Evidence-based guidelines (1)
- Evidenzbasiert (1)
- Evidenzbasierung (1)
- Evolutionary biology (1)
- Ewing-like (1)
- Exacerbations (1)
- Examination questions (1)
- Exchange PAINT (1)
- Excitability (1)
- Executive function (1)
- Exemestane (1)
- Exercise Metabolism (1)
- Exercise challenge (1)
- Exercise challenge at an ambient temperature (1)
- Exercise challenge in a cold chamber (1)
- Exercise testing (1)
- Exercise therapy (1)
- Exercise training (1)
- Exercise-induced asthma (1)
- Exercise-induced bronchoconstriction (1)
- Exertional angina and myocardial perfusion (1)
- Exhaled nitric oxide (1)
- Exitrons (1)
- Exoscope (1)
- Exosomal cytokines (1)
- Expansion (1)
- Expectation violation (1)
- Expedition (1)
- Experimental autoimmune encephalomyelitis (1)
- Expert Systems (1)
- Expertensysteme (1)
- Explicit (1)
- Explorative Data Analysis (1)
- Explorative Datenanalyse (1)
- Exposure (1)
- Expression (1)
- Extended Glasgow outcome scale (eGOS) (1)
- Extension study (1)
- External beam radiotherapy (1)
- External load (1)
- External-/self-assessment (1)
- Extinction (1)
- Extracellular RNA (1)
- Extracellular RNA (eRNA) (1)
- Extracellular signal-regulated kinase 1/2 (1)
- Extracorporeal circulation (1)
- Extracorporeal devices (1)
- Extracorporeal life support (1)
- Extracorporeal membrane oxygenation (1)
- Extracorporeal purification (1)
- Extrakorporale Dialyse (1)
- Extrakorporaler Kreislauf (1)
- Extraprostatic (1)
- Extreme hypo-fractionation (1)
- Exudates and transudates (1)
- Eye diseases (1)
- Eye tracking (1)
- EyesiNet (1)
- Ezrin (1)
- F 63.8 (1)
- F4/80 (1)
- F508del homozygous (1)
- FAAM (1)
- FABP (1)
- FAIRE-Seq (1)
- FAK (1)
- FAM134 (1)
- FAM134B (1)
- FAP (1)
- FAPI PET (1)
- FAV00A (1)
- FBK-R23 (1)
- FDG-PET/CT (1)
- FDM (1)
- FECD (1)
- FET (1)
- FF-ATP synthase dimer (1)
- FFF (1)
- FFP3 respirator (1)
- FHIR Search (1)
- FIB-4 (1)
- FIV (1)
- FK506 binding protein (1)
- FLT3 (1)
- FOLFIRI (1)
- FOXO1 (1)
- FOXO3 (1)
- FOXO3a (1)
- FPR (1)
- FREEDOM (1)
- FRET imaging (1)
- FSME-Virus (1)
- FSS (1)
- FTMT (1)
- FX06 (1)
- FXR (1)
- Face masks (1)
- Facet joint osteoarthritis (1)
- Facial nerve (1)
- Factor H (1)
- Factor analysis (1)
- FactorXIII Val34Leu polymorphism (1)
- Faculty Development (1)
- Faktor V Leiden Mutation (1)
- Faktor XIII Val34Leu Polymorphismus (1)
- Faktorstruktur (1)
- Falciparum (1)
- Fall (1)
- Fall Leipzig (Kind Knauer) (1)
- Fall risk (1)
- Fallbeispiele (1)
- Falls (1)
- Familiarity (1)
- Familienanamnese (1)
- Family Physician (1)
- Famines (1)
- Farbmuster (1)
- Farbstoff (1)
- Farbwirkung (1)
- Fascia (1)
- Fasciculus arcuatus (1)
- Fast Healthcare Interoperability Resources (1)
- Fast-track (1)
- Fatigue (1)
- Fatiguesyndrom (1)
- Fatty acids (1)
- Fbw7 (1)
- Fc receptor (1)
- Fear conditioning (1)
- Fear of falling (1)
- Fear of infection (1)
- Fear-invoking (1)
- Fearminimising (1)
- Feasibility studies (1)
- Feature tracking (1)
- Fechner, Gustav Theodor (1)
- Fehler (1)
- Fehlerberichtssystem (1)
- Fehlerberichtssysteme (1)
- Fehlerverhütung (1)
- Fehlstatik (1)
- Feinstaub (1)
- Feline bartonellosis (1)
- FemNAT-CD (1)
- Female (1)
- Female adolescents (1)
- Female subjects (1)
- Females (1)
- Feminismus (1)
- Femoral neck (1)
- Fendrr (1)
- Fenofibrate (1)
- Ferritinophagy (1)
- Ferroptose (1)
- Ferroptosis (1)
- Fertigkeit (1)
- Fertigkeiten (1)
- Fertility counseling (1)
- Fetal bovine serum (1)
- Fetal heart (1)
- Fettleber (1)
- Fever (1)
- Fevers (1)
- Fibertracking (1)
- Fibrinolytic (1)
- FibroMax (1)
- FibroScan (1)
- Fibroblast (1)
- Fibroblast growth factor (1)
- Fibromyalgia (1)
- Fibrose (1)
- Fibrotest (1)
- Fibrous dysplasia (1)
- Fibulin-4 (1)
- Fibulin-5 (1)
- Ficus carica (1)
- Fieberhafter Harnwegsinfekt (1)
- Field of View (1)
- Field study (1)
- Filariasis (1)
- Filariosis (1)
- Filgrastim (1)
- Filler (1)
- Filovirus cell entry; attachment factors redundancy; SH-SY5Y cell line; host–pathogen interactions (1)
- Filtermembranmethode (1)
- Finevo (1)
- Finite Element Method (1)
- First experience with patients (1)
- First site of metastatic disease (1)
- First-line combination antiretroviral therapy (1)
- First-line regimen (1)
- Fitness (1)
- Fitnesscenter (1)
- Five-Konzept (1)
- Flaubert, Bouvard und Pécuchet (1)
- Flavin mononucleotide (1)
- Flavivirus (1)
- Flavonoide (1)
- Fleas (1)
- FlexTouch (1)
- Flexible Endoscopic Evaluation of Swallowing (1)
- Flexur (1)
- Flowzytometrie (1)
- Flugzeitmassenspektrometer (1)
- Flugzeitmassenspektrometrie (1)
- Flugzeitspektrometrie (1)
- Fluid overload (1)
- Fluid therapy (1)
- Fluorescence (1)
- Fluorescence imaging (1)
- Fluorescence-in-situ-hybridization (FISH) (1)
- Fluoreszein (1)
- Flüchtlinge (1)
- Flüssigkeitsbeatmung (1)
- Foam rolling (1)
- Focal Adhesion Kinase (1)
- Focal onset seizure (1)
- Folgeerkrankungen (1)
- Folic acid (1)
- Follicular lymphoma (1)
- Follow-up (1)
- Follow-ups (1)
- Fondaparinux (1)
- Food and Drug Administration (1)
- Food and beverage precautions (1)
- Food effects (1)
- Foramen ovale (1)
- Forced expiratory volume in 1 s (1)
- Forensic anthropology (1)
- Forensic examination (1)
- Forensic experts (1)
- Forensic osteology (1)
- Forensic pathology (1)
- Forensics (1)
- Forensische Anthropologie (1)
- Forkhead box (1)
- Formation dance (1)
- Forschung (1)
- Forschungspraxisnetz (1)
- Fortpflanzung (1)
- Foxp1 (1)
- Fracture (1)
- Fracture models (1)
- Fracture risk (1)
- Fracture type (1)
- Fragebogenentwicklung (1)
- Frameshift (1)
- Francisella tularensis (1)
- Francisella tularensis subspecies holarctica (1)
- Frankfurt / Zentrum der Rechtsmedizin (1)
- Frankfurt <Main, 1998> (1)
- Frankfurt <Main, Region> (1)
- Frankfurt <Main> / Carolinum, Zentrum der Zahn-, Mund- und Kieferheilkunde (1)
- Frankfurt <Main> / Geographische Gesellschaft (1)
- Frankfurt <Main> / Klinikum (1)
- Frankfurt <Main> / Neurologisches Institut Frankfurt <Main> (1)
- Frankfurt am Main, Universität (1)
- Frankfurt am Main, Universitätsmedizin (1)
- Frankfurt microsurgery course (1)
- Frankfurt, Anatomie (1)
- Frankfurt, Universität (1)
- Frankfurt, Universität, Seminar für Geschichte der Medizin (1)
- Frankfurt, Universitätsmedizin 1933-1945 (1)
- Frankincense (1)
- Frauen (1)
- Frauenkrankheit (1)
- Free energy (1)
- Freezing and thawing (1)
- Freibad (1)
- Freiburg im Breisgau <2009> (1)
- Freie Atmung (1)
- Freies Malen mit Alzheimer Kranken (1)
- Fresh frozen plasma (1)
- Freud und die Psychoanalyse (1)
- Frontobasal (1)
- Frontotemporal dementia (1)
- Fruit fly (1)
- Frühgeborenes (1)
- Frühsommermeningoenzephalitis (1)
- Fuctional connectivity (1)
- Fukushima (1)
- Functional ankle instability (1)
- Functional aspects of cell biology (1)
- Functional capacity (1)
- Functional genomics (1)
- Functional mitral regurgitation (1)
- Functional outcome (1)
- Functional outcomes (1)
- Functionally-impaired elderly (1)
- Fungemia/diagnosis (1)
- FungiScope® registry (1)
- Fungämie/Diagnostik (1)
- Funktionelle Bildgebung (1)
- Funktionelle Magnetresonanztomographie (1)
- Funktionelle NMR-Tomographie (1)
- Funktionsdefizite (1)
- Funktionsmorphologie (1)
- Further education (1)
- Fusarium (1)
- Fusion Proteins, BCR-ABL (1)
- Fusion proteins (1)
- Fédération Internationale de Médicine du Sport (FIMS) (1)
- Füllungswerkstoff (1)
- G alpha q (1)
- G protein-coupled receptors (1)
- G-protein (1)
- G-protein coupled receptor (1)
- G-protein-coupled receptors (1)
- G-quadruplex binders (1)
- G/P (1)
- G207 (1)
- G2A receptor (1)
- G3BP (1)
- G3BP1 (1)
- G9a/EHMT2/KMT1C (1)
- GABAergic interneurons (1)
- GABAergic synapse (1)
- GCH1 (1)
- GCN (1)
- GC–MS (1)
- GD2 (1)
- GDF11 (1)
- GFR (1)
- GHQ-28 (1)
- GI pH (1)
- GI solubility (1)
- GIIb/IIIa-receptor (1)
- GILZ (1)
- GIRD (1)
- GLA deficiency (1)
- GLI inhibitors (1)
- GLUT1 (1)
- GLUT2 (1)
- GLUT3 (1)
- GM-CSF (1)
- GMP (1)
- GPR4 (1)
- GPRO (1)
- GPVI (1)
- GRADE (1)
- GRAND-SLAM (1)
- GRK2 (1)
- GRX1-roGFP2 (1)
- GSH (1)
- GSK2334470 (1)
- GSK3α (1)
- GSK3β (1)
- GTP cyclohydrolase (1)
- GTPCH1 (1)
- GVHD (1)
- GVL (1)
- Gaba (1)
- Gadopentate dimeglumine (1)
- Gads (1)
- Galenus (1)
- Gallbladder percutaneous drainage (1)
- Gallengangsstenose (1)
- Gallensäurederivate (1)
- Galleria mellonella (1)
- Galvano (1)
- Games (1)
- Gaming Disorder (1)
- Gamma-Band Activity (1)
- Gamma-aminobutyric acid (1)
- Ganganalyse (1)
- Ganglionic (1)
- Gangstörung (1)
- Ganzheitsbezogenheit (1)
- Ganzheitsmedizin (1)
- Gan–Dou–Fu–Mu decoction (GDFMD) (1)
- Gap junctions (1)
- Gas gangrene (1)
- Gastric adenoma (1)
- Gastric motility (1)
- Gastrocnemius muscles (1)
- Gastroenterology (1)
- Gastroesophageal reflux disease (1)
- Gastroesophageal reflux disease symptoms (1)
- Gastrointestinal (1)
- Gastrointestinal cancer (1)
- Gastrointestinal neoplasm (1)
- Gastrointestinal tract (1)
- Gastrointestinaltrakt (1)
- Gaucher disease type III (1)
- Gaucher’s disease (1)
- Gaussian graphical models (1)
- Gebärmutterhalskrebs (1)
- Gedächtnisbelastung (1)
- Gedächtnistraining (1)
- Gefäßinflammation (1)
- Gefäßtonus (1)
- Gegenübertragung (1)
- Gehirn (1)
- Gehörlosigkeit (1)
- Gelastic seizures (1)
- Gelastische Anfälle (1)
- Gemcitabine (1)
- Gemifloxacin (1)
- Genamplifikation (1)
- Genanalyse (1)
- Genauigkeit (1)
- Gender Gap (1)
- Gender analysis (1)
- Gender equality (1)
- Gender gap (1)
- Gene Polymorphism (1)
- Gene Transfer (1)
- Gene engineering (1)
- Gene expression prediction (1)
- Gene microarray analysis (1)
- Gene polymorphism (1)
- Gene prediction (1)
- Gene regulatory networks (1)
- Gene sequencing (1)
- Gene set analysis (1)
- Gene-Amplification (1)
- Gene-protein assay (1)
- Gene/Regulation (1)
- GeneMANIA (1)
- General Practitioner (1)
- General clinical cardiology (1)
- General cognitive ability (1)
- General dental practice (1)
- General practice/family medicine (1)
- General practitioner (1)
- Generalized procrustes analysis (1)
- Generation Y (1)
- Generation of reports on special findings in laboratory medicine (1)
- Generic drugs (1)
- Genetic causes of cancer (1)
- Genetic heart disease (1)
- Genetic loci (1)
- Genetic networks (1)
- Genetic syndromes (1)
- Genetic techniques (1)
- Genetic transduction (1)
- Genfamilie (1)
- Genitalverstümmelung (1)
- Genklonierung (1)
- Genome annotation (1)
- Genome editing (1)
- Genome-wide association study (1)
- Genomic instability (1)
- Genomic medicine (1)
- Gentransfer (1)
- Genu valgum (1)
- Geoffrey Burnstock (1)
- Geographical disparities (1)
- Geriatrics (1)
- Geriatrie (1)
- Gerinnungsfaktor IX (1)
- Gerinnungsfaktor VIII (1)
- Gerinnungsfaktor XIII (1)
- Germ aversion (1)
- German PID-NET registry (1)
- German Society of Surgery (1)
- Gerontologic legal medicine (1)
- Gerontologie (1)
- Gerontologische Rechtsmedizin (1)
- Gerontology (1)
- Gesamteiweißbestimmung im Harn (1)
- Gesang (1)
- Geschichte 1663-1748 (1)
- Geschichte 1700-1800 (1)
- Geschichte 1847-1970 (1)
- Geschichte 1867 (1)
- Geschichte 1878 (1)
- Geschichte 1906-1907 (1)
- Geschichte 1914-2014 (1)
- Geschichte 1930-1940 (1)
- Geschichte 1933-1945 (1)
- Geschichte 1938 (1)
- Geschichte 1939-1940 (1)
- Geschichte 1960-1986 (1)
- Geschichte 1972-2002 (1)
- Geschichte 1973-1998 (1)
- Geschichte der Medizin Frankfurt (1)
- Geschichte der Pharmazie (1)
- Geschlechterdisparitäten (1)
- Geschlechterforschung (1)
- Geschlechtsdysphorie bei Kindern und Jugendlichen (1)
- Geschlechtsidentitätsstörungen im Kindes- und Jugendalter (1)
- Geschwindigkeitsvariation (1)
- Gesellschaftsbild (1)
- Gesetzentwurf (1)
- Gesicht (1)
- Gesicht <Motiv> (1)
- Gestagen-Monopräparate (1)
- Gestaltwahrnehmung (1)
- Gestational age (1)
- Gestational diabetes (1)
- Gestationshyperthyreose (1)
- Gesundheitliche Ungleichheit (1)
- Gesundheitsamt (1)
- Gesundheitsberichterstattung (1)
- Gesundheitsbildung (1)
- Gesundheitskommunikation (1)
- Gesundheitspersonal (1)
- Gesundheitspolitische Zuständigkeit (1)
- Gesundheitsverhalten (1)
- Gesundheitsversorgungseinrichtungen (1)
- Gesundheitswirtschaft (1)
- Gesundheitswissenschaften (1)
- Get Pathway (1)
- Gewebe-Sauerstoffpartialdruck (1)
- Gewebesauerstoffpartialdruck (1)
- Giant lymph node hyperplasia (1)
- Giftgas (Lost) (1)
- Gimbaled tracking (1)
- Ginkgo biloba (1)
- Ginkgobaum (1)
- Girdlestone (1)
- Glabella (1)
- Gleason Grade Group (1)
- Gleason Grade group (1)
- Gleason Score (1)
- Gleason grade group (1)
- Gleason upgrading (1)
- Glia Maturation Factor (1)
- Glioblastoma survival (1)
- Gliom (1)
- Glivec® (1)
- Global Alignment (1)
- Global Health (1)
- Global Health Ethics (1)
- Global Justice (1)
- Global networking (1)
- Global protein synthesis rates (1)
- Global warming (1)
- Glomerular Filtration Rate (1)
- Glomerular diseases (1)
- Glomerulonephritis (1)
- Glomerulosclerosis (1)
- Glomerulus (1)
- Glucocorticoids (1)
- Glucose Transporter Type 1 (1)
- Glucose tolerance test (1)
- Glucosetoleranztest (1)
- Glukose (1)
- Glutamatrezeptor (1)
- Glycinrezeptor (1)
- Glycogen synthase kinase 3 beta (1)
- Glycosphingolipids (1)
- Glyoxalase I (1)
- Glücksspielstörung (1)
- Goal-oriented care (1)
- Gold (1)
- Gonarthrose (1)
- Goserelin (1)
- Gradient boosting (1)
- Grading (1)
- Grado en medicina (1)
- Graft (1)
- Graft function (1)
- Graft quality (1)
- Graft survival (1)
- Gram negative bacteria (1)
- Gram-negative bacteria (1)
- Gram-positive Bakterien ; Linezolid ; Arzneimittelresistenz (1)
- Gram-positive Bakterien ; Moxifloxacin ; Arzneimittelresistenz (1)
- Gram-positive infection (1)
- Grammatical Aspect (1)
- Grammatik (1)
- Granger causality (1)
- Granule cell (1)
- Granulocytes (1)
- Graph database (1)
- Graph theory (1)
- Graphentheorie (1)
- Graphical LASSO (1)
- Grass pollen (1)
- Graves' (1)
- Graves’ disease (1)
- Gravimetric method (1)
- Gray matter (1)
- Gray matter volume (1)
- Graz <2013> (1)
- Greater tuberosity fractures (1)
- Green Tobacco Sickness (GTS) (1)
- Green infrastructure (1)
- Greenhouse effect (1)
- Grenzwert (1)
- Grenzüberschreitung (1)
- Griechenland <Altertum> (1)
- Grip force (1)
- Groddeck, Georg (1)
- Groin pain (1)
- Gross tumor volume optimization (1)
- Grossesse (1)
- Growth cone (1)
- Growth factor (1)
- Growth factor signalling (1)
- Großhirnrinde (1)
- Grundschule (1)
- Grüne Meerkatze ; Immundefekt ; Virusinfektion ; Resistenz (1)
- Guanylatzyklasen (1)
- Guanylyl cyclases (1)
- Guidance (1)
- Guide profession (1)
- Guided bone regeneration (GBR) (1)
- Guided surgery (1)
- Guided tissue regeneration (1)
- Guided tissue regeneration (GTR) (1)
- Guideline adherence (1)
- Guideline-based treatment (1)
- Guiding growth (1)
- Guinea-Bissau (1)
- Gut (1)
- Gut bacteria (1)
- Gut-liver-axis (1)
- GvHD (1)
- GvL (1)
- Gynäkologie (1)
- Gyrasehemmer (1)
- Görden, Anstalt (1)
- Götter (1)
- Güntz, Eduard (1)
- Gütt, Arthur (1)
- H-Index (1)
- H/M ratio (1)
- H3 receptor (1)
- H5N1 (1)
- HACA (1)
- HADS (1)
- HAEGARDA (1)
- HAI‐1 (1)
- HARS2 (1)
- HBV filaments (1)
- HBV genotypes (1)
- HBV reactivation (1)
- HBV surface protein (1)
- HCC marker (1)
- HCC recurrence (1)
- HCMV-Retinitis (1)
- HCV treatment (1)
- HCV-Core-Antigen (1)
- HDAC and BET inhibitor (1)
- HDAC inhibition (1)
- HDAC inhibitor (1)
- HDAC-inhibition (1)
- HDAC4 (1)
- HDR-Brachytherapie (1)
- HDR-brachytherapy (1)
- HEOR (1)
- HER2 c-erbB2 (1)
- HER2-positive (1)
- HER2/neu (ERBB2) (1)
- HERV (1)
- HEUS (1)
- HEV (1)
- HFrEF (1)
- HGF (1)
- HH (1)
- HHUSD (1)
- HHV-8 (1)
- HIBCPP cells (1)
- HIF-1 (1)
- HIF-1α (1)
- HIF-2 (1)
- HIF-2α (1)
- HIF-2α, erythropoietin (1)
- HIF1α (1)
- HIFT (1)
- HIFU (1)
- HILI (1)
- HIPPO signalling (1)
- HIT (1)
- HIV ; Genetische Variabilität ; Immunoassay (1)
- HIV Humanized Mice (1)
- HIV pre-exposure prophylaxis (1)
- HIV prevention technologies (1)
- HIV serodiagnosis (1)
- HIV therapy (1)
- HIV-1 Genotypisierung (1)
- HIV-1 escape restriction (1)
- HIV-1 genotyping (1)
- HIV-Antigen-Test (1)
- HIV-Infektionen (1)
- HIV-Infizierter (1)
- HIV-RNA (1)
- HIV-infected patient (1)
- HIV-infection (1)
- HLA DQ haplotypes (1)
- HLA DQB1 (1)
- HLA antibodies (1)
- HLA class I loss (1)
- HLA class II (1)
- HLA peptidome (1)
- HLHS (1)
- HMA (1)
- HMGB1 (1)
- HNPCC (1)
- HODE (1)
- HOLEP (1)
- HOSO (1)
- HOTAIR (1)
- HOXA profile (1)
- HOXB4 (1)
- HPO (1)
- HPV infection (1)
- HPV-positive OPSCC (1)
- HRAS 28 Gefitinib (1)
- HRCT (1)
- HRV (1)
- HRas (1)
- HSC (1)
- HSP (hereditary spastic paraplegia) (1)
- HSP90 inhibitors (1)
- HSPC (1)
- HSV type specific antibodies (1)
- HSV-2 (1)
- HSV-typenspezifische Antikörper (1)
- HT22 neurons (1)
- HVPG (1)
- Haaranalyse (1)
- Habits (1)
- Hadamar (1)
- Haematocrit (1)
- Haematologic diseases (1)
- Haematoma expansion (1)
- Haematopoietic stem cells (1)
- Haemodialysis (1)
- Haemodynamic monitoring (1)
- Haemophilia (1)
- Haemophilie A (1)
- Haemostatics (1)
- Hals (1)
- Hamburg <2014> (1)
- Hand-foot syndrome (1)
- Handlungsanweisungen (1)
- Hantavirus (1)
- Haploidentical stem cell transplantation (1)
- Haplotypes (1)
- Hard-tissue trauma (1)
- Hard-to-reach population (1)
- Hardware erosion (1)
- Harnsteinanalyse (1)
- Harnsteinkomponenten (1)
- Hashimoto (1)
- Hashimoto Thyreoiditis (1)
- Hashimoto’s thyroiditis (1)
- Hautbarriere (1)
- Hautlokalisation (1)
- Hautoberflächentemperatur (1)
- Hawaii Department of Health (1)
- Hazard assessment (1)
- HbA1c (1)
- Head and neck Cancer (1)
- Head bandage (1)
- Head injury (1)
- Head neck cancer (1)
- Health Communication (1)
- Health Policy (1)
- Health Systems (1)
- Health care access (1)
- Health care resource utilization (1)
- Health care sector (1)
- Health care structures (1)
- Health education and awareness (1)
- Health facilities (1)
- Health information (1)
- Health literacy (1)
- Health personnel (1)
- Health research (1)
- Health risk analysis (1)
- Health sciences (1)
- Health services research [MeSH] (1)
- Health surveys (1)
- Health technology assessment (1)
- Health workforce governance (1)
- Health-related quality of life (1)
- Health-seeking behaviour (1)
- Healthcare (1)
- Healthcare resource utilisation (1)
- Healthcare structure (1)
- Healthy Living Index (HLI) (1)
- Healthy men (1)
- Healthy stem cell donors (1)
- Health‐related quality of life (1)
- Health‑related quality of life (1)
- Heart defects (1)
- Heart regeneration (1)
- Heartrate (1)
- Heat Shock Protein (HSP) (1)
- Heat pain (1)
- Heat shock protein 27 (1)
- Hebbian plasticity (1)
- Heben (1)
- Hedgehog (1)
- Hedgehog pathway (1)
- Heiler (1)
- Heilung (1)
- Heimtraining (1)
- Heinz-Jürgen Voss (1)
- Helpline (1)
- Hemagglutination inhibition assay (1)
- Hematocrit value (1)
- Hematologic adverse events (1)
- Hematoma (1)
- Hematopoietic stem and progenitor cells (HSPCs) (1)
- Hematopoietic stem cell (1)
- Hematopoietic stem cell transplant (1)
- Hematopoietic stem cell transplantation (1)
- Hematopoietic stem cells (1)
- Hematotoxicity (1)
- Hematoxylin staining (1)
- Heme-Oxygenase 1 (1)
- Hemikraniektomie (1)
- Hemispheric specialization (1)
- Hemobilia (1)
- Hemodialyse (1)
- Hemodilution (1)
- Hemodynamic management (1)
- Hemoglobin (1)
- Hemophilia A (1)
- Hemorrhagic shock (1)
- Hemosiderin (1)
- Hemostasis (1)
- Hemostatics (1)
- HepG2 Zellen (1)
- Heparan Sulfate (1)
- Heparin (1)
- Heparinsensitivität (1)
- Hepatectomy (1)
- Hepatic encephalopathy (1)
- Hepatic stellate cell (1)
- Hepatitis B Antibodies/serum (1)
- Hepatitis B Core-Antigene/Immunologie (1)
- Hepatitis B infection (1)
- Hepatitis B vaccination (1)
- Hepatitis B-Antikörper/Serum (1)
- Hepatitis B-Core-Antigens-immunology (1)
- Hepatitis C antibodies (1)
- Hepatitis C antigens (1)
- Hepatitis C, Chronic (1)
- Hepatitis C-Virus (HCV) (1)
- Hepatitis C; DNA (1)
- Hepatitis G virus (1)
- Hepatitis G-Virus (1)
- Hepatitis c (1)
- Hepatitis, Chronic Active/diagnosis (1)
- Hepatoblastom (1)
- Hepatocellular Carcinoma (1)
- Hepatocellular carcinoma (HCC) (1)
- Hepatocytes (1)
- Heptazelluläres Karzinom (1)
- Her2-neu (1)
- Herafill (1)
- Herbal medicine (1)
- Herbalife (1)
- Herbalife products (1)
- Herbs (1)
- Herbs induced liver injury (1)
- Herd immunity (1)
- Hereditary breast and ovarian cancer (1)
- Hereditary breast cancer (1)
- Hereditary ovarian cancer (1)
- Hereditäre Thrombophilie (1)
- Heregulin (1)
- Hernia recurrence (1)
- Hernia surgery (1)
- Herniated disk (1)
- Herpe-Viren (1)
- Herpes Simplex Virus Type 1 (HSV-1) (1)
- Herpes Simplex Virus/isolation and purification . (1)
- Herpes genitalis (1)
- Herpes simplex (1)
- Herpes simplex Virus Typ 1 (1)
- Herpes simplex Virus Typ 2 (1)
- Herpes simplex Virus/Isolierung und Anreicherung (1)
- Herpes simplex virus type 1 (1)
- Herpes simplex virus type 2 (1)
- Herpes virus (1)
- Herpesvirus 1, Humanes (1)
- Herpesvirus 2, Human (1)
- Herpesvirus 2, Humanes (1)
- Herpesvirus1, Human (1)
- Herz-Kreislauffunktion (1)
- Herzchirurgie (1)
- Herzindex (1)
- Herzkatheteruntersuchung (1)
- Heterologous prime-boost (1)
- Heterotopic pregnancy (1)
- Heterozyklen (1)
- Heuristik (1)
- Hexavalent vaccine (1)
- HhAntag (1)
- HiC (1)
- HiChIP (1)
- Hidradenitis suppurativa (1)
- Hierarchical drift-diffusion modeling (1)
- Hif-1 alpha (1)
- Hif1α (1)
- Hig1 (1)
- High altitude (1)
- High performance liquid chromatography (1)
- High radon areas (1)
- High-dose chemotherapy (1)
- High-income countries (1)
- High-intensity interval endurance training (1)
- High-resolution (1)
- High-risk cardiac surgery (1)
- High-risk patient (1)
- High-risk prostate cancer (1)
- High-throughput screening (1)
- Highly infectious diseases (1)
- Highwire (1)
- Himalayas (1)
- Hindu Kush Himalayas (1)
- Hip (1)
- Hip hemiarthroplasty (1)
- Hip revision (1)
- Hippo signaling (1)
- Hippocampal excitability (1)
- Hippocampal subfields (1)
- Hippocampal volume (1)
- Hippokrates, Asteroid (1)
- Hirnmetastasen (1)
- Hirnverletzung (1)
- Hirschsprung disease (1)
- Hirt, August (1)
- Hispanic people (1)
- Hispanic–Latino race/ethnicity (1)
- Histological analysis (1)
- Histone post-translational modifications (1)
- Histonmethylierung (1)
- Histoplasma qPCR (1)
- History (1)
- History of medicine (1)
- Hitachi 705 (1)
- HlV-Infections (1)
- Hmox1 (1)
- Hochansteckende Krankheiten (1)
- Hochdurchsatz (1)
- Hochfrequenz-Katheterablation (1)
- Hochschuldidaktik (1)
- Hodgkin-Lymphom (1)
- Hodgkin’s lymphoma (1)
- Holmium laser enucleation (1)
- Holzhausen (1)
- Home Care Services [MeSH] (1)
- Homeostatic plasticity (1)
- Hometraining (1)
- Homicide-suicide (1)
- Homizid-Suizid (1)
- Homocysteine (1)
- Homogener Enzym Immunoassay (1)
- Homogenous enzymatic immunoassay (1)
- Homonationalismus (1)
- Honolulu Queen’s Medical Center (1)
- Hormonal (1)
- Hormone (1)
- Hormone de régression müllérienne (1)
- Hormone receptor positive breast cancer (1)
- Hormonelle Kontrazeptiva (1)
- Hormones thyroïdiennes (1)
- Horner's syndrome (1)
- Horner-Emmons-Reaktion (1)
- Hornhauttransplantation (1)
- Horses (1)
- Hospital Governance (1)
- Hospital case volume (1)
- Hospitalization (1)
- Hospitalizations (1)
- Host-directed therapies (1)
- Host-targeting agents (HTAs) (1)
- Hounsfield units (1)
- Hounsfieldeinheit (1)
- House dust mite allergy (1)
- Household contacts (1)
- Hrvaška (1)
- Hsp70 (1)
- Hsp90 inhibitor (1)
- Huh7 (1)
- Human Immunodeficiency Virus (1)
- Human chorionic villi mesenchymal stromal cells (1)
- Human experimental pain models (1)
- Human health (1)
- Human immunodeficiency virus (HIV) (1)
- Human olfaction (1)
- Human pancreas (1)
- Human physiology (1)
- Human primary proximal tubular cells (1)
- Human prostate (1)
- Human retroelements (1)
- Human visual cortex (1)
- Human well-being (1)
- Humangenetik (1)
- Humankapital (1)
- Humans (1)
- Humanwissenschaften (1)
- Humeral fractures (1)
- Humerus (1)
- Humerus fracture (1)
- Humerusfraktur (1)
- Hungary (1)
- Huntington (1)
- Hyaluronan (1)
- Hydratation der Epidermis (1)
- Hydrocephalus (1)
- Hydrocortison (1)
- Hydrocortisone (1)
- Hydrodynamik (1)
- Hydrofluoric acid (1)
- Hydrogen bonding (1)
- Hydrolyse (1)
- Hydromineral (1)
- Hydroxyapatite (1)
- Hydroxychloroquine (1)
- Hydroxycut (1)
- Hydroxyethyl starch (1)
- Hydroxyurea (1)
- Hygienestandards (1)
- Hymenoptera venom allergy (1)
- Hymenoptera venom immunotherapy (1)
- Hyperactivity (1)
- Hyperammonemic encephalopathy (1)
- Hyperbare Oxygenation (HBO) (1)
- Hypercholesterinämie (1)
- Hypercolumn (1)
- Hyperhidrosis axillaris (1)
- Hyperlipidemia (1)
- Hyperlipidämie (1)
- Hyperscanning (1)
- Hypertensive disorders in pregnancy (1)
- Hypertext (1)
- Hyperthyroïdie gestationnelle (1)
- Hypofractionated radiotherapy (1)
- Hypokalzämie (1)
- Hyponatremia (1)
- Hypoparathyreoidismus (1)
- Hyposensibilisierung (1)
- Hypothyreose (1)
- Hypothyroïdie (1)
- Hypoxia inducible factor (1)
- Hypoxia inducible factor 1 alphal (1)
- Hypoxia-inducible factor-1α (HIF-1α) (1)
- Hypoxic responses (1)
- Hypoxie (1)
- Hysterektomie-Prävalenz (1)
- Häm-Oxygenase 1 (1)
- Hämatotoxizität (1)
- Hämodynamik Shunt (1)
- Hämophile Arthropathie (1)
- Hämophilie (1)
- Händehygiene (1)
- Hôpital de la Salpêtrière (1)
- Höchstrichterliche Rechtsprechung (1)
- Höhren (1)
- Hörscreening (1)
- Hüftgelenkprothese (1)
- I-FABP (1)
- I-PRF (1)
- IAP (1)
- IAP Proteins (1)
- IAP-IAP (1)
- ICAM-1 (1)
- ICG (1)
- ICH M13A draft guideline (1)
- ICL (1)
- ICL V4c (1)
- ICSD (1)
- ICSI (1)
- IDH1 inhibitor (1)
- IDO1 (1)
- IDT (1)
- IFA (1)
- IFN (1)
- IFN-y (1)
- IFN-β (1)
- IFN-γ expression (1)
- IFN-γ neutralization (1)
- IGF (1)
- IGF-1 (1)
- IGF1 (1)
- IGRA (1)
- IKKε (1)
- IL -17 (1)
- IL -23 (1)
- IL 23p19 knockout mouse (1)
- IL-11 (1)
- IL-13 (1)
- IL-15 (1)
- IL-17 (1)
- IL-17A (1)
- IL-18 (1)
- IL-18 binding protein (1)
- IL-18BP (1)
- IL-18BPa (1)
- IL-1b (1)
- IL-21 (1)
- IL-22 (1)
- IL-23 (1)
- IL-27 cytokine (1)
- IL-38 (1)
- IL-6 neutralization (1)
- IL10R (1)
- ILUVIEN (1)
- IMiD® (1)
- ING (1)
- INR (1)
- IOL scleral Fixation (1)
- IPEX (1)
- IPP (1)
- IPS (1)
- IPS e.max system (1)
- IPSS (1)
- IR (1)
- IRES translation (1)
- IRF-3 (1)
- IRIS (1)
- IRX1 (1)
- ISO (1)
- ISRS (1)
- ISS (1)
- ITGA7 (1)
- IUIS classification 2017 (1)
- IV iron (1)
- IVA interference tandem mass spectrometry (1)
- IVD (1)
- IVD degeneration (IVDD) (1)
- IVD directive (1)
- IVD-Richtlinie (1)
- IVDU (1)
- IVF (1)
- IVIV_E (1)
- IVUS (1)
- Iatrochemie (1)
- Iatrochemistry (1)
- Iatrogen (1)
- Iatrogenic (1)
- Iceland (1)
- Idarucizumab (1)
- Idelalisib (1)
- Identifier (1)
- Identifikation (1)
- Identifizierung von Katastrophenopfern (1)
- Identity (1)
- Identität (1)
- Idiopathic pain (1)
- Idiopathic pulmonary fibrosis (IPF) (1)
- Idiopathische Dystonie (1)
- Ig (sub)class-specific antibody determination (1)
- Ig- (sub)klassen-spezifische Antikörperbestimmung (1)
- IgA deficiency (1)
- IgE (1)
- IgG (1)
- IgG substitution therapy (1)
- IgG4-related disease (1)
- IgGAM (1)
- IgM/Immunologie (1)
- IgM/immunology (1)
- Ileostomy (1)
- Illumina (1)
- Illustration (1)
- Image processing (computer-assisted) (1)
- Imagery (1)
- Imaging (1)
- Imaging genetics (1)
- Imaging in LGG (1)
- Imaging, three-dimensional (1)
- Imatinib (1)
- Imdevimab (1)
- Immediate loading (1)
- Immediate placement (1)
- Immobilization (1)
- Immunbiology (1)
- Immune Complexes (1)
- Immune checkpoint inhibitors (1)
- Immune complex vasculitis (1)
- Immune evasion (1)
- Immune paralysis (1)
- Immune receptor signaling (1)
- Immune response (1)
- Immune status (1)
- Immunfixations-Elektrophorese (1)
- Immunglobulinklassen und -subklassen (1)
- Immunhyperthyreose (1)
- Immunität (Medizin) (1)
- Immunitätsbeurteilung (1)
- Immunkompetenz (1)
- Immunkomplexe (1)
- Immunnephelometrie (1)
- Immunoassay (1)
- Immunoassays (1)
- Immunochemistry (1)
- Immunocompromised (1)
- Immunodeficiency (1)
- Immunofluoreszenz (1)
- Immunogenetics (1)
- Immunoglobulin Therapy (1)
- Immunoglobulin classes and -subclasses (1)
- Immunoglobulins (1)
- Immunohistochemistry techniques (1)
- Immunological techniques (1)
- Immunologie Methods (1)
- Immunologische Diagnostik (1)
- Immunology and Microbiology Section (1)
- Immunomagnetische Antikörper (1)
- Immunomodulation (1)
- Immunomodulatory agents (1)
- Immunomonitoring (1)
- Immunonephelometry (1)
- Immunophenotyping (1)
- Immunosenescence (1)
- Immunoseneszenz (1)
- Immunostaining (1)
- Immunosuppressive Agents (1)
- Immunosuppressive agents (1)
- Immunosuppressive therapy (1)
- Immunoturbidimetry (1)
- Immuno‑histochemistry (1)
- Immunreaktion (1)
- Immunrekonstitution (1)
- Impedanzaggregometrie (1)
- Impella (1)
- Impfkurs (1)
- Impfquoten (1)
- Implant osseointegration (1)
- Implant-supported bars (1)
- Implantable cardioverter-defibrillator (1)
- Implantat (1)
- Implantatverfahren (1)
- Implementación (1)
- Implicit (1)
- Implicit Processing (1)
- Implicit Association Test (1)
- Implicit motives (1)
- Impoverishment (1)
- Impräzision (1)
- Impulse control (1)
- Impulse generator (1)
- Imrt (1)
- In situ (1)
- In situ hybridization (1)
- In vitro wound models (1)
- In vivo electrophysiology (1)
- In-ASK Studie (1)
- In-Hospital Emergencies (1)
- In-TIPS thrombosis (1)
- In-hospital cardiac arrest (1)
- In-line filtration (1)
- In-vitro-Kultur (1)
- In-vivo (1)
- Inactivation (1)
- IncL (1)
- IncX (1)
- Incident reporting system (1)
- Incidental prostate cancer (1)
- Incomplete colonoscopy (1)
- Incontinence (1)
- Independent component analysis (1)
- Independent laboratories (1)
- Indeterminate biliary stricture (1)
- Index (1)
- India (1)
- Indication (1)
- Indication for fertility preservation (1)
- Indirect costs (1)
- Indirect treatment comparison (ITC) (1)
- Individual differences (1)
- Individualisierung des Studiums (1)
- Individualized intervention (1)
- Individualized therapy (1)
- Individuelle Studienbegleitung (1)
- Indocyanine green (1)
- Indoles (1)
- Indoor air pollution (1)
- Induced membrane technique (1)
- Induced pluripotent stem cells (1)
- Induced sputum (1)
- Inducible nitric oxide synthase (iNOS) (1)
- Induction therapy (1)
- Induratio penis plastica (1)
- Inequality (1)
- Inertial motion capture (1)
- Infant (1)
- Infant leukemia (1)
- Infants (1)
- Infarction (1)
- Infectious disease (1)
- Infectious disease epidemiology (1)
- Infektionen (1)
- Infektionskrankheit (1)
- Infektionskrankheiten (1)
- Infektionsprophylaxe (1)
- Infektionsserologie (1)
- Inferior colliculus (1)
- Inferior vena cava thrombus (1)
- Infertilität (1)
- Inflammasome (1)
- Inflammatory Bowel Disease (1)
- Inflammatory fibroid polyp (1)
- Inflammatory pain (1)
- Inflammatory pattern (1)
- Infliximab (1)
- Inflow obstruction (1)
- Influenza Virus (1)
- Influenza vaccination (1)
- Influenza virus (1)
- Information transfer (1)
- Informationstheorie (1)
- Informiertheit (1)
- Infrared Raman (1)
- Infrarot-A-Strahlung (IRA) (1)
- Infrarot-Ganzkörperhyperthermie (1)
- Infrarotspektroskopie (1)
- Infusion management (1)
- Inguinal hernia (1)
- Inguinal pain (1)
- Inherited arrhythmic syndrome (1)
- Injection therapy (1)
- Injektionstherapie (1)
- Injury Severity Score (ISS) (1)
- Innate immune system (1)
- Inner ear therapy (1)
- Inpatient hospital cases (1)
- Inpatients (1)
- Insekten (1)
- Instructions for action (1)
- Insula (1)
- Insulin resistance (1)
- Insulin secretion (1)
- Insulin therapy (1)
- Insulintherapie (1)
- Integrated Pulmonary Index (1)
- Integrated multimodal training (1)
- Integrationsversorgung/integrierte ambulante Versorgung (1)
- Integrative Network Analysis (1)
- Intelligence tests (1)
- Intensive care outcome (1)
- Intensive care unit (1)
- Intensivmedizin (1)
- Intensivpatient (1)
- Intention attribution (1)
- Inter-areal coherence (1)
- Inter-study reproducibility (1)
- Interaction (1)
- Interaktionsdatenbanken (1)
- Interferon alpha (1)
- Interferon response (1)
- Interferon-free (1)
- Interferon-free HCV treatment (1)
- Interferon-frei (1)
- Interferon-α (1)
- Interferon-λ, (1)
- Interferonfrei (1)
- Interferons (1)
- Interleukin-10 (1)
- Interleukin-17A (1)
- Interleukin-18 (1)
- Interleukin-18 binding protein (1)
- Interleukin-22 binding protein (1)
- Interleukin-36 (1)
- Interleukine (1)
- Intermediate filaments (1)
- Intermediate-risk (1)
- Internal load (1)
- International body passport (1)
- International normalized ratio (1)
- Internationale Wettbewerbsfähigkeit (1)
- Internationaler Vergleich (1)
- Internationaler Wettbewerb (1)
- Internet (1)
- Internet Gaming Disorder (1)
- Internet gaming disorder (1)
- Internet technology (1)
- Internet use disorders (1)
- Internet-based therapy (1)
- Internetabhängigkeit (1)
- Internetbezogene Störungen (1)
- Internettechnologie (1)
- Interoperability (1)
- Interposition (1)
- Interpretation Bias (1)
- Interrater Reliability (1)
- Interraterreliabilität (1)
- Intersectoral care (1)
- Interspecific competition (1)
- Interstitial lung diseases (ILD) (1)
- Interstitial pneumonia (1)
- Intervention development (1)
- Interventional Trials (1)
- Interventional cardiology (1)
- Interventional oncological treatment (1)
- Intervertebral disc degeneration (1)
- Intervertebral disc displacement (1)
- Interview (1)
- Interviews (1)
- Intestinal failure-associated liver disease (1)
- Intestinal fistula (1)
- Intestinal metaplasia (1)
- Intestinal neoplasms (1)
- Intestinale bakterielle Fehlbesiedelung (1)
- Intimal-medial thickness (1)
- Intimchirurgie (1)
- Intolerance (1)
- Intoxication (1)
- Intoxikation (1)
- Intra-abdominal infection (1)
- Intrabody (1)
- Intracellular Trafficking (1)
- Intracellular pathogens (1)
- Intracellular pathways (1)
- Intracerebral haemorrhage (1)
- Intracerebroventricular (1)
- Intracranial embolism (1)
- Intracranial haemorrhage (1)
- Intracranial hemorrhage (1)
- Intragastric balloon (1)
- Intraoperative blood salvage (1)
- Intraoperative procedure (1)
- Intraoperative test (1)
- Intraoral scanners (1)
- Intraosseous access (1)
- Intratumoral (1)
- Intratympanic drug delivery (1)
- Intravenous Drug User (1)
- Intravenous antibiotic therapy (1)
- Intravenous antiepileptics (1)
- Intravenous injections (1)
- Intravenous iron (1)
- Intravenöse Antiepileptika (1)
- Intrinsic Disorder (1)
- Intrinsic resistance (1)
- Intubation (1)
- Intubation anesthesia (1)
- Intubationsnarkose (1)
- Invasive candidiasis (1)
- Invasive fungal infection (1)
- Invasive fungal infections (1)
- Invasive mosquitoes (1)
- Invasive species (1)
- Inventory of Callous–Unemotional Traits (1)
- Invisible boundary paradigm (1)
- Inzidenzkorrektur (1)
- Iod (1)
- Iodmangel (1)
- Ion channels in the nervous system (1)
- Ionenkanal (1)
- Ionentransport ; Anion ; Sarkoplasmatisches Retikulum (1)
- Ipilimumab (1)
- Ireb2 (1)
- Ireland (1)
- Iridium-192 (1)
- Iron Overload (1)
- Iron chelation (1)
- Iron estimation (1)
- Iron oxides (1)
- Irregular vaccination (1)
- Ischemia-reperfusion injury (1)
- Ischemia–reperfusion injury (1)
- Ischemic stroke (1)
- Ischämie (1)
- Islam (1)
- Islamethik (1)
- Isocitrate dehydrogenase (1)
- Isoflurane (1)
- Isoforms (1)
- Isolation, separation and purification (1)
- Isoliert-perfundierte Rattenherzen (1)
- Isolierung (1)
- Isolierung <Medizin> (1)
- Isothermal Titration Calorimetry (ITC) (1)
- Isothermal amplification (1)
- Isotope labeling (1)
- Issue 96 (1)
- Italy (1)
- Itpr1 (1)
- Ivor Lewis esophagectomy (1)
- Ixodes (1)
- JAK inhibition (1)
- JAK2V617F (1)
- JAWSTAT pathway (1)
- JNK (1)
- JNK3 (1)
- Jak2(V617F) (1)
- Java <Programmiersprache> (1)
- Jaw surgery (1)
- JawsII (1)
- Job satisfaction (1)
- Jodausscheidung im Urin (1)
- John Taylor (1)
- Joint actions (1)
- Joint destruction (1)
- Joubert syndrome (1)
- Jugend (1)
- Jugendliche (1)
- Jugendlicher (1)
- Julia (1)
- Jurkat (1)
- Juvenile myoclonic epilepsy (1)
- Jüdische Dozenten Frankfurt (1)
- K-homology RNA-binding domain (1)
- K3EDTA plasma sampling (1)
- KAP (1)
- KATP-Kanal Blocker (1)
- KCCQ (1)
- KCGS (1)
- KCNH2 (1)
- KCNJ2 mutation (1)
- KCNQ1 (1)
- KCNQ4 (1)
- KCNT1 (1)
- KDIGO (1)
- KIF (1)
- KIF11 (1)
- KIR (1)
- KLHL11 (1)
- KLK5 (1)
- KMT2A (1)
- KOOS IV (1)
- KPS (1)
- KRAS (1)
- KSHV epidemiology (1)
- KSHV, Epidemiologie (1)
- Kachexie (1)
- Kaiserschnitt (1)
- Kaisidis plate (1)
- Kaliumkanal ; Inhibition ; Herzmuskelzelle (1)
- Kaliumkanal-Aktivatoren (1)
- Kallestad QM 300 (1)
- Kallestad QM 30 (1)
- Kallikrein inhibitor (1)
- Kalorienverbrauch (1)
- Kandidatengen (1)
- Kanzlei des Führers (1)
- Kapazitätsdefizit (1)
- Kapitalismus (1)
- Kaplan-Meier-Schätzung (1)
- Kapnographie (1)
- Kappa (1)
- Kardiomyopathie (1)
- Kardiovaskuläres Risiko (1)
- Karies (1)
- Karotte (1)
- Karyotypes (1)
- Karzinom (1)
- Karzinomzellen (1)
- Katamnese Transidentität im Kindes- und Jugendalter (1)
- Kataraktchirugie (1)
- Katheterablation (1)
- Kava (1)
- Kava hepatotoxicity (1)
- Kavitätenpräparation (1)
- Keap1-Nrf2 (1)
- Kephalometrie mit Magnetinduktion (1)
- Kephalometrie ohne Röntgenstrahlen (1)
- Keratinocytes (1)
- Keratoplastik (1)
- Ketogenic Diet (1)
- Ketolide (1)
- Key stone species (1)
- Ki-67/MIB1 (1)
- Ki67 transgenic c‐myc/TGFα mice (1)
- Kidney (1)
- Kidney Transplantation (1)
- Kidney disease (1)
- Kidney diseases (1)
- Kidney neoplasm (1)
- Kidney transplant recipients (1)
- Kidneys (1)
- Kiefer (1)
- Kieferhöhlenentzündung (1)
- Kif15 mRNA (1)
- Kim-1 (1)
- Kinase inhibitors (1)
- Kinder und Jugendliche (1)
- Kinderchirurgie (1)
- Kindergarten (1)
- Kindersterblichkeit (1)
- Kindertagesstätten (1)
- Kindes- und Jugendalter (1)
- Kindesalter (1)
- Kindestötung (1)
- Kindheit (1)
- Kinds of diseases (1)
- Kindspech (1)
- Kinematic posture analysis (1)
- Kinematics (1)
- Kinematik (1)
- Klavierspiel (1)
- Kleinkind (1)
- Klinische Aufgabengebiete (1)
- Klinische Fertigkeiten (1)
- Knee joint sound (1)
- Knee osteoarthritis (1)
- Knee surgery (1)
- Kniegelenkarthrose (1)
- Kniegelenkinfekt (1)
- Knieinfekt (1)
- Knochenabbau (1)
- Knochendefektheilung (1)
- Knochenevaluation (1)
- Knochenmarksmikromilieu (1)
- Knochenmetastasen (1)
- Knochenstoffwechselerkrankungen (1)
- Knockout (1)
- Koch (1)
- Koch, Richard (1)
- Kodieralgorithmus (1)
- Kognitiv (1)
- Kognitive Beeinträchtigungen (1)
- Kognitiver Prozess (1)
- Kombinationstherapie (1)
- Kombinationstherapien (1)
- Kommerzialisierung (1)
- Kommerzielle Immunglobuline (1)
- Komorbidität (1)
- Komorbiditäten (1)
- Komplementbindungsreaktion (KBR) (1)
- Komplikation allogene Stammzelltransplantation (1)
- Komplikationsrate (1)
- Komposit (1)
- Komprimierte Abtastung (1)
- Konformitätsbewertung (1)
- Kongo <Demokratische Republik> (1)
- Kongress <Wandlitz, 1997> (1)
- Konsens (1)
- Konsensus Methode (1)
- Kontaktallergie (1)
- Kontrastmittel (1)
- Kontrazeption (1)
- Kontroll- und Regressmechanismen (1)
- Kontrollierte klinische Studie (1)
- Konusprothese (1)
- Konversion (1)
- Konzeption (1)
- Konzeptpapier (1)
- Koordination (1)
- Kopf (1)
- Kopfhaar (1)
- Kopfstimme (1)
- Koronare Herzkrankheit (1)
- Koronarfluss (1)
- Korporatismus (1)
- Korporativer Staat (1)
- Korrektheit (1)
- Kortikale Dicke (1)
- Kortikotrope Achse (1)
- Kosmetische Chirurgie (1)
- Kosten-Nutzen-Analyse (1)
- Koti (1)
- Krait (1)
- Kraniomandibuläre Dysfunktion (1)
- Krankengymnastik (1)
- Krankenhaus (1)
- Krankenhausfallaufkommen (1)
- Krankenhausfinanzierung (1)
- Krankenhausinformationssystem (1)
- Krankheitsbegriff (1)
- Krankheitskosten (1)
- Krankheitsverlauf (1)
- Kreatinin (1)
- Krebs (Medizin) (1)
- Krebs <Medizin> (1)
- Krebsfamiliensyndrom (1)
- Krebsforschung (1)
- Krebststammzelle (1)
- Krieg (1)
- Kriminalität (1)
- Kryokonservierung (1)
- Kultur (1)
- Kunsttherapie für Menschen mit vaskulärer Demenz (1)
- Kupfer (1)
- Kupferstich (1)
- Kupffer cells (1)
- Kurzzeitgedächtnis (1)
- Kutner, Luis (1)
- Kynurenine (1)
- Kölner Deklaration (1)
- Körperbild (1)
- Körpergrößenschätzung, Geschlechtsdiskrimination (1)
- Körperliche Belastung (1)
- Körpermaße (1)
- Körpermodifizierung (1)
- Körpersoziologie (1)
- Künste (1)
- L1 cell-adhesion molecule (L1-CAM) (1)
- L1-norm SVM (1)
- LABAs (1)
- LAMP3 (1)
- LAMTOR1 (1)
- LAMTOR2 (1)
- LARS2 (1)
- LASP1 (1)
- LASS (1)
- LAT (1)
- LBP (1)
- LC-MS (1)
- LC-MS-Based Clinical Research (1)
- LC-MS-based lipid mediator analysis (1)
- LC-NE system (1)
- LC3 I/II (1)
- LC3B (1)
- LCD-Array (1)
- LCH (1)
- LC–MS/MS (1)
- LD 2 Ringe (1)
- LD 2 rings (1)
- LDHB (1)
- LDL (1)
- LDL-cholesterol (1)
- LEOSS (1)
- LFP (1)
- LHRH receptor (1)
- LINC00607 (1)
- LIR interaction, (1)
- LIVIN (1)
- LM11A 31 (1)
- LN229 (1)
- LNS (1)
- LOS (1)
- LPP (1)
- LQTS (1)
- LRBA (1)
- LSD1 (1)
- LSEC (1)
- LTB4 (1)
- LTBI (1)
- LTR (1)
- LU-102 (1)
- LUBAC (1)
- LUT (1)
- Label-free (1)
- Laboratory techniques and procedures (1)
- Labordiagnose (1)
- Labormedizin (1)
- Labormedizinische Spezialbefundung (1)
- Labororganisation (1)
- Laborpersonal (1)
- Lack of immunity (1)
- Lactic acidosis (1)
- Lactobacillus (1)
- Lacunar (1)
- Lafora disease (1)
- Lagerungsbedingungen (1)
- Lakunär (1)
- Laminin (1)
- LanCL2 (1)
- Land cover (1)
- Landmark (1)
- Langendorff-Herz (1)
- Langstreckige Knochendefekte (1)
- Language delay (1)
- Language disorders (1)
- Langzeitarbeitsloser (1)
- Langzeiteffekt (1)
- Langzeitergebnis (1)
- Langzeitpflege (1)
- Laparoscopic appendectomy (1)
- Laparoscopic fundoplication (1)
- Laparostomy (1)
- Laparotomy. Joel-Cohen (1)
- Laparscopic Bariatric Surgery (1)
- Large vessel occlusion (1)
- Laryngeal Tube (1)
- Laser interstitial thermal therapy (1)
- Laser navigation system (1)
- Laser-Doppler-Signal (1)
- Laser-Scan-Mikroskopie (1)
- Lasertherapie (1)
- Late Gadolinium Enhancement (LGE) (1)
- Late gadolinium enhancement (1)
- Late presentation (1)
- Latent transforming growth factor β-binding protein 4 (1)
- Lateral flow antigen testing (1)
- Lateral flow immunoassay (1)
- Lateral recess stenosis (1)
- Laterality (1)
- Laufökonomie (1)
- Le carcinome épidermoïde oral (1)
- Lead field (1)
- Leadership (1)
- Learning (1)
- Learning algorithms (1)
- Learning and memory (1)
- Learning outcomes (1)
- Lebensbewältigung (1)
- Lebensgefühl (1)
- Lebenskunst (1)
- Lebenslimitierende Erkrankungen (1)
- Lebensstiländerung (1)
- Leber (1)
- Leber congenital amaurosis (1)
- Leberkrebs (1)
- Lebermetastase (1)
- Lebertransplantation (1)
- Lecithin (1)
- Lectin affinity plasmapheresis (1)
- Lecture (1)
- Lee type, functional outcome (1)
- Lee-type (1)
- Leflunomide (1)
- Left Ventricular Mass (1)
- Left atrial appendage closure (1)
- Left ventricular assist device (1)
- Left ventricular function (1)
- Left ventricular mass (1)
- Left ventricular non-compaction, (1)
- Leg alignment (1)
- Leg axis (1)
- Legal considerations (1)
- Legal medicine (1)
- Legasthenie (1)
- Legionella pneumophila (1)
- Lehre im klinischen Alltag (1)
- Lehrerausbildung (1)
- Lehrforschung (1)
- Lehrveranstaltungsevaluation (1)
- Lehrvideos (1)
- Leib (1)
- Leibesübungen (1)
- Leiblichkeit (1)
- Leibphänomenologie (1)
- Leichenschauschein (1)
- Leigh syndrome (1)
- Leipzig (1)
- Leipzig <2015> (1)
- Leipzig, Universitätskinderklinik (1)
- Leishmania infantum (1)
- Leishmaniasis (1)
- Leistung (1)
- Leistungsmessung (1)
- Leistungsorientierte Mittelvergabe (1)
- Leitbegriff (1)
- Leitlinie (1)
- Leitliniengerechte Behandlung (1)
- Leksell (1)
- Lemperle (1)
- Lenalidomide (1)
- Length of stay (1)
- Lennox-Gastaut syndrome (1)
- Lennox–Gastaut syndrome (1)
- Lentiviral vectors (1)
- Lentiviren (1)
- Lernen (1)
- Lernerfolgsmessung (1)
- Lernziele (1)
- Lernzuwachs (1)
- Les macrophages associés aux tumeurs (1)
- Lesestörung (1)
- Leseverstehen (1)
- Leseverständnis (1)
- Lesion (1)
- Leukaemia (1)
- Leukaemic Cells (1)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)
- Leukocyte depletion filter (1)
- Leukocyte elastase (1)
- Leukodystrophy (1)
- Leukozytenfiltration (1)
- Levobupivacain (1)
- Levobupivacaine (1)
- Lhx2 (1)
- Liberalismus (1)
- Lice (1)
- Lichtalterung (1)
- Lichttherapie (1)
- Life-limiting conditions (1)
- Lifestyle (1)
- Ligand post-insertion (1)
- Ligatur (1)
- Light sheet fluorescence microscopy (1)
- Light-sheet fluorescence microscopy (1)
- Limitation of therapy (1)
- Line Notation (1)
- Lineage (1)
- Lineage tracing (1)
- Linearisierung (1)
- Linkage (1)
- Lipedema (1)
- Lipemia (1)
- Lipid Transition Temperature (1)
- Lipid metabolism (1)
- Lipid peroxidation (1)
- Lipid signaling (1)
- Lipid solution (1)
- Lipid trafficking (1)
- Lipid-based formulation (1)
- Lipidinteraktion (1)
- Lipidol (1)
- Lipidstoffwechsel (1)
- Lipiodol (1)
- Lipocalin-2 (1)
- Lipodystrophy (1)
- Lipopolysaccharide-binding protein (1)
- Lipoprotein(a)/Analytik (1)
- Lipoprotein(a)/analysis (1)
- Lipoproteine (1)
- Liposuction (1)
- Lippen-Kiefer-Gaumenspalte (1)
- Lipämie (1)
- Liquid filled MicroLion ion chamber array (1)
- Liquor cerebrospinalis (1)
- Liquordiagnostik (1)
- Lithium (1)
- Liver Fibrosis (1)
- Liver biopsy (1)
- Liver disease (1)
- Liver enzymes (1)
- Liver histology (1)
- Liver metastases (1)
- Liver resection (1)
- Liver transplant (1)
- Liver-Related Complications (1)
- Liver-related complications (1)
- LiverTox (1)
- LncRNA - long noncoding RNA (1)
- Loa loa (1)
- Local IgE (1)
- Local allergic rhinitis (1)
- Local control (1)
- Local field potential (1)
- Localized prostate cancer (1)
- Locally advanced (1)
- Lockdown (1)
- Loco-regional control (1)
- Locomotor circuit (1)
- Lokales IgE (1)
- Lokalisation (1)
- Lomentospora prolificans (1)
- Lomwe (1)
- Lomwe-Sprache (1)
- Long QT syndrome (1)
- Long interspersed nuclear elements (LINE) (1)
- Long non-coding RNA (1)
- Long noncoding RNA (1)
- Long term output (1)
- Long term result (1)
- Long-read sequencing (1)
- Long-term (1)
- Long-term continence (1)
- Long-term effect (1)
- Long-term follow up (1)
- Long-term follow-up (1)
- Long-term results (1)
- Long-term-measurements (1)
- Longchain polyunsaturated fatty acids (1)
- Longitudinal Study (1)
- Longitudinal analysis (1)
- Longitudinalstudie (1)
- Loving kindness meditation (1)
- Low Molecular Weight PTP (1)
- Low birth weight infant (1)
- Low grade glioma (1)
- Low volume prep (1)
- Low-dose X-irradiation (1)
- Low-dose ionizing radiation (1)
- Low-dose radiation therapy (1)
- Low-grade glioma (1)
- Lower back pain (1)
- Lower limb deformities (1)
- Lp(a)-Lipoproteinbestimmungen (1)
- Lp(a)-lipoprotein determinations (1)
- Lpar2 (1)
- Ltbp-4 (1)
- Ltbp-4L (1)
- Ltbp-4S (1)
- Ltbp4 (1)
- Lucigenin (1)
- Luftverkehr (1)
- Lumbar Disk Degeneration (1)
- Lumbar spinal canal stenosis (1)
- Lumbar stenosis (1)
- Luminex (1)
- Lung (1)
- Lung Cancer (1)
- Lung Neoplasms/serum (1)
- Lung adenocarcinoma (1)
- Lung development (1)
- Lung function (1)
- Lung neoplasms (1)
- Lung ultrasound (1)
- Lungenbiopsie (1)
- Lungenerkrankungen (1)
- Lungenherde (1)
- Lungenkontusion (1)
- Lungenneoplasma/Serum (1)
- Lungentumor (1)
- Lungenversagen (1)
- Lyme Borreliosis (1)
- Lyme Disease (1)
- Lyme disease - Borreliosis (1)
- Lyme-Borreliose (1)
- Lymph node (1)
- Lymphadenopathy (1)
- Lymphangiectasia (1)
- Lymphangiogenesis (1)
- Lymphangioleiomyomatosis (1)
- Lymphedema (1)
- Lymphocyte subpopulations (1)
- Lymphoepithelioma (1)
- Lymphoid Neoplasia (1)
- Lymphoid tissues (1)
- Lymphoma Cells (1)
- Lymphomas (1)
- Lymphopenia Mortality (1)
- Lymphozytenantigen (1)
- Lynch-Syndrom (1)
- Lysosomal storage disease (1)
- Ländlicher Raum (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- MACE (1)
- MAGGIC score (1)
- MAIT cell (1)
- MALDI MS (1)
- MAML2 (1)
- MAP Kinases (MAPKs) (1)
- MAP kinase (1)
- MAPK6 (1)
- MBC (1)
- MC-Fragen (1)
- MCH (1)
- MCP (1)
- MCP-1 (1)
- MDD (1)
- MDM2 (1)
- MDR1 (1)
- MEDIC (1)
- MEIS (1)
- MEIS homeodomain protein (1)
- MEIS2 (1)
- MEK inhibition (1)
- MEK inhibitor (1)
- MELD (1)
- MEN1 (1)
- MET (1)
- MFA (1)
- MGMT (1)
- MGMT promoter (1)
- MIC (1)
- MID task (1)
- MK-0457 (1)
- MKP1 (1)
- ML-IAP (1)
- MLC tracking (1)
- MLL fusion proteins (1)
- MLL-Baby (1)
- MLL-r acute leukemia (1)
- MLL-rearranged leukemia (1)
- MLN8237 (1)
- MLV (1)
- MLV/HIV-1 (1)
- MM-121 (1)
- MMF (1)
- MMP14 (1)
- MMP2 (1)
- MMPs (1)
- MN1 (1)
- MODY (1)
- MOLLI (1)
- MPA (1)
- MPM (1)
- MPN (1)
- MPN-U (1)
- MR-based histology (1)
- MR-guided (1)
- MR-proADM (1)
- MR-spectroscopy (1)
- MRA (1)
- MRI patterns of gliomas (1)
- MRI-negative epilepsy (1)
- MS (1)
- MSC-subsets (1)
- MSM (1)
- MT: Non-coding RNAs (1)
- MTCL (1)
- MTHFR-Mutation (1)
- MTHFR-mutation (1)
- MTL30 (1)
- MTOR inhibitor (1)
- MTRNR1 (1)
- MTRasym (1)
- MTT (1)
- MUTARS® RS Cup (1)
- MUTARS® RS Cup System (1)
- MUTARS® RS cup system (1)
- MVPA (1)
- MYCBP2 (1)
- MYCN amplification (1)
- Machine Learning (1)
- Machine learning algorithms (1)
- Macrophage (1)
- Macrophage Transdifferentiation (1)
- Macular neovascularization (1)
- Madagascar (1)
- Magnet dislocation (1)
- Magnetencephalography (1)
- Magnetfeldresonanztherapie (1)
- Magnetic resonance Imaging (1)
- Magnetic resonance imaging (MRI) (1)
- Magnetic resonance spectroscopic imaging (1)
- Magnetite (1)
- Magnetoencephalographie (1)
- Magnetoencephalography (1)
- Magnetresonanztomografie (1)
- Magnetresonanztomographie (1)
- Main olfactory epithelium (1)
- Maintenance therapy (1)
- Maintenance treatment (1)
- Major Depressive Disorder (1)
- Major Histocompatibility Complex (MHC) (1)
- Major bleeding (1)
- Major infection after cardiac surgery (1)
- Makonde (1)
- Makonde-Sprache (1)
- Makrophage (1)
- Malaria prophylaxis (1)
- Malariae (1)
- Malariaprophylaxe (1)
- Male (1)
- Male Population (1)
- Malignancy (1)
- Malignant meningioma (1)
- MammaPrint (1)
- Mammalian target of rapamycin (1)
- Mammaplasty (1)
- Management (1)
- Manatee invariant (1)
- Manchester scar scale (1)
- Mandatory Vaccinations (1)
- Mandible (1)
- Mandibula (1)
- Mangel (1)
- Mania (1)
- Manuelle Lymphdrainage (1)
- Manufacturing (1)
- Maple bark disease (1)
- Maple bark strippers’ lung (1)
- Mapping (1)
- Marey, Étienne-Jules (1)
- Marginal grafts (1)
- Marginal integrity (1)
- Marine food webs (1)
- Marker genes (1)
- Market Access (1)
- Marknagelung (1)
- Markov model (1)
- Masking effect (1)
- Masquelet (1)
- Mass disaster (1)
- Massage (1)
- Massage (chinesische / japanische / ayurvedische / indische / indonesische / javanesische / balinesische Massage) (1)
- Massenkatastrophe (1)
- Massenspektrometrie (1)
- Massive Online Open Course (1)
- Master Plan 2020 (1)
- Masterabschluss (1)
- Masterplan 2020 (1)
- Master’s degree (1)
- Mastoiditis (1)
- Matching-adjusted indirect comparison (MAIC) (1)
- Material (1)
- Materials science (1)
- Maternal Immune Activation (1)
- Maternal morbidity (1)
- Maternal separation (1)
- Mathematical Modeling (1)
- Mathematical biosciences (1)
- Mathematical functions (1)
- Mathematical methods (1)
- Mathematical model (1)
- Mathematical models (1)
- Mathematics and computing (1)
- Mathematische Biologie (1)
- Matrix metalloproteinase 1 (MMP-1) (1)
- Matrix-Metalloproteinase 1 (MMP-1) (1)
- Matrix-Rhythmus-Therapie (1)
- Maus (1)
- Maxillofacial reconstruction (1)
- Maxillofacial surgery (1)
- Maxillofacial trauma (1)
- Mcl-1 (1)
- MdM2 (1)
- Mean erythrocyte volume (1)
- Measles (1)
- Measurement equipment (1)
- Mechanical ankle instability (1)
- Mechanical ventilation (1)
- Mechanism of action (1)
- Meckel’s diverticulum (1)
- Median nerve (1)
- Mediation (1)
- Medical (1)
- Medical Education (1)
- Medical Humanities (1)
- Medical Oncology (1)
- Medical Physics: Diagnostic (1)
- Medical communication (1)
- Medical database (1)
- Medical errors (1)
- Medical ethics (1)
- Medical examiner (1)
- Medical history (1)
- Medical hypoxia (1)
- Medical imaging (1)
- Medical implants (1)
- Medical law (1)
- Medical management (1)
- Medical school (1)
- Medical staff (1)
- Medical student (1)
- Medical studies (1)
- Medical study (1)
- Medical traineeship (1)
- Medication Appropriatness Index (1)
- Medication changes (1)
- Medicinal chemistry (1)
- Medicinal plants (1)
- Medicine and health sciences (1)
- Medikalisierung sozialer Probleme (1)
- Medikamente (1)
- Medikamente Handlungsanweisungen (1)
- Meditation (1)
- Medizinalrhabarber (1)
- Medizinanthropologie (1)
- Medizinethik (1)
- Medizingeschichte, Lehrbuch (1)
- Medizinische Abbildung (1)
- Medizinische Chemie (1)
- Medizinische Fachangestellte (1)
- Medizinische Fehler (1)
- Medizinische Lehre (1)
- Medizinische Versorgung (1)
- Medizinisches Gutachten (1)
- Medizinisches Personal (1)
- Medizinkritik in der Literatur (1)
- Medizinrecht (1)
- Medizinstudenten 1968 (1)
- Meersseman test (1)
- Mefloquine (1)
- Mehrfachbefunde (1)
- Mehrsprachigkeit (1)
- Meis1 (1)
- Meis2 (1)
- Mekoniumaspiration (1)
- Melanocortin (1)
- Melody (1)
- Membrane Attack Complex (1)
- Membrane Protein (1)
- Membrane Trafficking (1)
- Membrane assays (1)
- Membrane lipids (1)
- Membrane staining (1)
- Membrane-Phloretin Interaction (1)
- Membranproteine (1)
- Memory quality (1)
- Memory training (1)
- Men who have sex with men (1)
- Mena/VASP (1)
- Mengele, Josef (1)
- Meningeom (1)
- Meningioma (1)
- Menschenversuche, verbrecherische (1)
- Mental disorder (1)
- Mental health disorders (1)
- Mental health problems (1)
- Mental health therapies (1)
- Mentale Vorstellung (1)
- Menthol (1)
- Mentor (1)
- Merleau-Ponty, Maurice (1)
- Mesangial cells (1)
- Mesenchym (1)
- Mesenchymal stem cell (1)
- Mesenchymal stem/stromal cells (1)
- Mesenchymal stromal cells (1)
- Mesenchymal stromal cells (MSC) (1)
- Mesh repair (1)
- Messung (1)
- Metabolic (1)
- Metabolic dysfunction (1)
- Metabolic labeling (1)
- Metabolic models (1)
- Metabolic vulnerabilities (1)
- Metabolism, Inborn Errors (1)
- Metabolomic profile (1)
- Metacognition (1)
- Metagenomics (1)
- Metal clip (1)
- Metalloproteases (1)
- Metalloproteinases (1)
- Metapher (1)
- Metastase (1)
- Metastasis-directed therapy (1)
- Metastatic renal cell carcinoma (1)
- Metastatic tumors (1)
- Metformin (1)
- Methacholine challenge test (1)
- Methacholinprovokation (1)
- Methadon (1)
- Methanol (1)
- Methanosarcina mazei (1)
- Methicillin resistance (1)
- Methicillin-resistenter Staphylococcus aureus (1)
- Methionine (1)
- Method validation (1)
- Methoden (1)
- Methodenvalidierung (1)
- Methodenvergleich (1)
- Methods (1)
- Methotrexate (1)
- Methylation (1)
- Methylphenidate (1)
- Metta (1)
- MiR-29 (1)
- MiSpEx Network (1)
- MiSpEx-network (1)
- Michael acceptor (1)
- Michael acceptors (1)
- Micro RNAs (1)
- Micro computed tomography (1)
- Micro-CT (1)
- MicroRNA-181a (1)
- MicroRNAs (miRNAs) (1)
- Microalgae (1)
- Microbial mutation (1)
- Microbiology and Infectious Disease (1)
- Microbiology, Virology & Host Pathogen Interaction (1)
- Microbubbles (1)
- Microdialysis (1)
- Microenvironment (1)
- Microfilaremia (1)
- Microfluidics (1)
- Microgap (1)
- Microglial cells (1)
- Micrognathia (1)
- Microparticles (1)
- Microphones (1)
- Microphysiological models (1)
- Microplastic (1)
- Microsatellite instability (1)
- Microstructural impairment (1)
- Mid-intestinal bleeding (1)
- Midbrain/brainstem expression changes (1)
- Middle East respiratory syndrome coronavirus (1)
- Midkine (1)
- Midline laparotomy (1)
- Midwifery (1)
- Migrant health (1)
- Mikroangiopathie (1)
- Mikrobiom (1)
- Mikroneutralisationstest (1)
- Mikropartikel (1)
- Mikrostromtherapie (1)
- Mikrovesikel (1)
- Mikrowellenablation (1)
- Milch (1)
- Mild chronic inflammation (1)
- Mild cognitive impairment (1)
- Mild hypoxia (1)
- Mind wandering (1)
- Mindestmengen (1)
- Mineralocorticoids (1)
- Mineralokortikoide (1)
- Mini-monovision (1)
- Minimal Residual Disease (MRD) (1)
- Minimal core of imaging (1)
- Minimal detectable change (1)
- Minimal invasive (1)
- Minimal invasive dentistry (1)
- Minimal-invasiv (1)
- Minimale Hemmkonzentration (1)
- Minimale bakterizide Konzentration (1)
- Minimally invasive (1)
- Minimally invasive surgical procedures (1)
- Minimally invasive transforaminal interbody fusion (1)
- Minor injury (1)
- Mislocalised proteins (1)
- Missbildung (1)
- Mitochondrial Apoptosis (1)
- Mitochondrial Metabolism (1)
- Mitochondrial Permeability Transition (1)
- Mitochondrial Transport (1)
- Mitochondrial amino acid tRNA synthetases (1)
- Mitochondrial disease (1)
- Mitochondrial disorder (1)
- Mitochondrial function (1)
- Mitochondrial proteins (1)
- Mitochondrial respiration (1)
- Mitochondrial shuttles (1)
- Mitochondrien (1)
- Mitomycin C (1)
- Mitoxantrone (1)
- Mitral regurgitation (1)
- Mitral valve (1)
- Mitralklappenrekonstruktion (1)
- Mittelalter (1)
- MixCon (1)
- MixCon-LA (1)
- Mixed hearing loss (1)
- Mmp12 (1)
- Mnemonic discrimination (1)
- Mnemotechnik (1)
- Model Organism (1)
- Model organisms (1)
- Modell-Curriculum (1)
- Modelling (1)
- Modellprojekt, (1)
- Moderating factors (1)
- Moderne Medizin (1)
- Modified FDI criteria (1)
- Molar tooth sign (1)
- Molecular Biology (1)
- Molecular Chaperone (1)
- Molecular association (1)
- Molecular biophysics (1)
- Molecular diagnosis (1)
- Molecular diagnostic testing (1)
- Molecular diagnostics (1)
- Molecular docking (1)
- Molecular dynamics simulation (1)
- Molecular genetics (1)
- Molecular glue (1)
- Molecular imaging (1)
- Molecular marker (1)
- Molecular matched therapy (1)
- Molecular mechanisms of cancer (1)
- Molecular mimicry (1)
- Molecular signatures (1)
- Molecular subtype (1)
- Molecular therapy (1)
- Molecularly targeted therapy (1)
- Molekulare Therapie (1)
- Moll, Albert (1)
- Molmassenverteilung (1)
- Monacolin K (1)
- Monetary incentive delay (1)
- Mongolian spot (1)
- Monoacylglycerol lipase (1)
- Monoclonal antibodies (1)
- Monoclonal antibody (mAb) (1)
- Monocyte gene expression (1)
- Monocytes and macrophages (1)
- Monolithic crown (1)
- Monosaccharide Transport Proteins (1)
- Monotherapie (1)
- Monozyt (1)
- Monozyten (1)
- Monte Carlo method (1)
- Monte Carlo simulation (1)
- Mood (1)
- Moraceae (1)
- Morbidität (1)
- Morbus Crohn (1)
- Morbus Cushing Syndrom (1)
- Morbus Parkinson (1)
- Morphin (1)
- Morphological modeling (1)
- Morphologie (1)
- Morris Hepatoma (1)
- Mortalitätskorrektur (1)
- Mortaliät (1)
- Mosquito (1)
- Mosquito crop (1)
- Mosquito-plant interaction (1)
- Mosquitoes (1)
- Motility (1)
- Motility disorder (1)
- Motivating factor (1)
- Motivation (1)
- Motivational situation (1)
- Motivational strategies (1)
- Motivationslage (1)
- Motor cortex (1)
- Motor dysfunction (1)
- Motor neuron disease (1)
- Motor neurons (1)
- Motor skills (1)
- Motor-cognitive (1)
- Mouse model (1)
- Movement behaviour (1)
- Movement patterns (1)
- Moviprep (1)
- MptpA (1)
- Mu-opioid receptor (1)
- Mucomaix® matrix (1)
- Mucopolysaccharidoses (1)
- Mukoviszidose (1)
- Multi-Omics (1)
- Multi-center (1)
- Multi-modal feedback (1)
- Multi-motive grid (1)
- Multi-nucleated cardiomyocytes (1)
- Multi-parameter mapping (1)
- Multi-resistant pathogens (1)
- Multi-stakeholder approach (1)
- Multi-syndrome classification (1)
- Multidetector Computed Tomography (1)
- Multidisciplinary management (1)
- Multidrug-resistance (1)
- Multidrug-resistant bacteria (1)
- Multidrug-resistant organisms (1)
- Multidrug-resistant tuberculosis (1)
- Multilevel two-part modelling (1)
- Multiligament instability (1)
- Multimedia (1)
- Multimedication (1)
- Multimedikation / Polypharmazie (1)
- Multimodal Modeling (1)
- Multimodal imaging (1)
- Multimodal treatment (1)
- Multimorbid patients (1)
- Multimorbilidad (1)
- Multinomial logistic regression (1)
- Multinucleated giant cells (1)
- Multiomics (1)
- Multiparametric MRI (1)
- Multiphoton microscopy (1)
- Multiple Sclerosis (1)
- Multiple myeloma (1)
- Multiple trauma (1)
- Multiple-indication review (1)
- Multiplex immunoassay (1)
- Multiresistente Erreger (1)
- Multisensorische Integrationsleistung (1)
- Multisensory (1)
- Multiset independent component analysis (1)
- Multivariate Modellierung (1)
- Mund-Kiefer-Gesichts-Chirurgie (1)
- Mundhöhlenkarzinome (1)
- Muscarinic acetylcholine receptor (1)
- Muscle (1)
- Muscle analysis (1)
- Muscle atrophy (1)
- Muscle contractile properties (1)
- Muscle damage (1)
- Muscle differentiation (1)
- Muscle functions (1)
- Muscle pain (1)
- Muscle tissue (1)
- Muscle weakness (1)
- Muscular diseases (1)
- Musculoskeletal (1)
- Musculoskeletal abnormalities (1)
- Musculoskeletal mechanics (1)
- Musculoskeletal problems (1)
- Musculoskeletal ultrasound (1)
- Music chair concepts (1)
- Music perception (1)
- Musician (1)
- Musician-specific seating position (1)
- Musiktherapie (1)
- Muskeltonus (1)
- Muskuloskeletales System (1)
- Muskuloskelettale Erkrankungen (1)
- Muslimische Patienten (1)
- Mutant p53 (1)
- Mutation databases (1)
- Mutter (1)
- Muttermilch (1)
- Mutual information (1)
- Mycobacteria (1)
- Mycobacterium avium complex (1)
- Mycophenolat Mofetil (1)
- Mycophenolate mofetil (1)
- Mycophenolatmofetil (1)
- Mycoses (1)
- Mycosis (1)
- Myelin or myeloarchitecture (1)
- Myelodysplastic syndrome (1)
- Myelofibrosis (1)
- Myeloperoxidase (1)
- Myelopoiesis (1)
- Myeloproliferative disease (1)
- Myiasis (1)
- Mykose (1)
- Myocardial infarction (MI) (1)
- Myocardial injury (1)
- Myocardial remodeling (1)
- Myocardial revascularization (1)
- Myocardial segmentation (1)
- Myonecrosis (1)
- Myopia (1)
- Myotonic dystrophy (1)
- Mysterienspiel (1)
- Mythologie (1)
- Männerstimme (1)
- Müdigkeit (1)
- München <2011> (1)
- Mφs (1)
- N-Acetylaspartate (1)
- N-acetyl-L-cysteine (1)
- N-acetylcysteine (1)
- N-cadherin (1)
- N-cadhérine (1)
- N-glycoproteome (1)
- N-glycosylation (1)
- N-hydroxysuccinimide (1)
- N-methyl-D-aspartate receptor (1)
- N-myc (1)
- N2 (1)
- N471D strumpellin knock-in mice (1)
- N501Y (1)
- NADPH oxidase 4 (1)
- NAFL (1)
- NAPS (1)
- NAT (1)
- NCAM (1)
- NCH93 (1)
- NCOA4 (1)
- NDBI (1)
- NDM (1)
- NDNF interneurons (1)
- NDR1 (1)
- NDUFA6 (1)
- NDUFAF8 (1)
- NEAT1 (1)
- NEAT2 (1)
- NEBL (1)
- NET (1)
- NETs (1)
- NF-kB (1)
- NF-ĸB (1)
- NF-кB (1)
- NFAT (1)
- NFkB (1)
- NGS (1)
- NGS sequencing (1)
- NHE (1)
- NHEJ (1)
- NIS (1)
- NK Receptor (1)
- NK cell subset (1)
- NK cell subsets (1)
- NK receptors (1)
- NK-ZELL-BASIERTER IMMUNTHERAPIE (1)
- NK-ZELLEN (1)
- NK-Zellen (1)
- NK-cells (1)
- NKG2A blocking (1)
- NKT cell (1)
- NLPHL (1)
- NLRP3 inflammasomes (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NMDAR subunit GluN2B (1)
- NMES (1)
- NMO-IgG (1)
- NMOSD (1)
- NMR Spectroscopy (1)
- NMRI (1)
- NO-GC stimulators (1)
- NOD (1)
- NOD2 (1)
- NOESY (1)
- NOS (1)
- NOS-I (1)
- NOS1AP (1)
- NOTCH (1)
- NOXA (1)
- NPC disease (1)
- NPH insulin (1)
- NPR2 (1)
- NPSR1 (1)
- NR4A3 (1)
- NRAS (1)
- NREM sleep (1)
- NS-Kindereuthanasie (1)
- NS1608 (1)
- NS3 protease inhibitor (1)
- NS3-4A protease inhibitor (1)
- NS3/4A protease inhibitors (PI) (1)
- NS3/4A-Protease (1)
- NS5A inhibitors (1)
- NS5B polymerase inhibitor (1)
- NSAIDs (1)
- NSBB (1)
- NSC350625 (1)
- NSE (1)
- NSF (1)
- NSG mice (1)
- NSTEMI (1)
- NTDs (1)
- NTM (1)
- NURF (1)
- NVBP (1)
- NXF1 (1)
- Nachteile (1)
- Nachtschattengewächs (1)
- Nachwuchsmangel (1)
- Nackenmuskulatur (1)
- Nackenschmerzen (1)
- Nahrungsmittelallergie (1)
- Nahrungsmittelhygiene (1)
- Naja (1)
- Named entity recognition (1)
- Nano-ESI MS (1)
- NanoBone (1)
- Nanocarriers (1)
- Nanocrystalline (1)
- Nanomedicine (1)
- Nanoparticles (1)
- Nanopartikel (1)
- Nanoplastic (1)
- Nanopore (1)
- Narkose (1)
- Narrativ <Sozialwissenschaften> (1)
- Nasenpolyp (1)
- Nasenschleimhaut (1)
- Nateglinide (1)
- National catalogue of competence-based learning objectives in dentistry (1)
- Native T1 (1)
- Native T1 mapping (1)
- Natriuretic peptide (1)
- Natriuretic peptides (1)
- Natural Killer (NK) Cell (1)
- Natural killer cells (1)
- Natural product (1)
- Natural products (1)
- Natural sounds (1)
- Nature (1)
- Nature contributions to people (1)
- Naturwissenschaften (1)
- Nav channel activity (1)
- Nav1.7 (1)
- Nd:YAG laser capsulotomy (1)
- Ndau (1)
- Nebennierenrinden-Adenom (1)
- Nebennierenrinden-Hyperplasie (1)
- Neck muscles (1)
- Neck pain (1)
- Necroptosis (1)
- Necrosis (1)
- Necrosis (Necrotic Death) (1)
- Necrotic area (1)
- Necrotizing fasciitis (1)
- Needs Assessment [MeSH] (1)
- Needs assessment [MeSH] (1)
- Negative appendectomy rate (1)
- Negative mental images (1)
- Negative staining (1)
- Negative-pressure wound therapy (1)
- Neglected tropical diseases (1)
- Negligence (1)
- Nek1 (1)
- Nekrose (1)
- Neoadjuvant radiochemotherapy (1)
- Neoadjuvant systemic therapy (1)
- Neoadjuvant therapy (1)
- Neoadjuvant treatment (1)
- Neocortex (1)
- Neonatal (1)
- Neonatal abstinence syndrome (1)
- Neonatal brain damage (1)
- Neonatal intensive care unit (1)
- Neonatal morbidity (1)
- Neonatal outcome (1)
- Neonatal surgery outcome (1)
- Neonatal urea cycle disorders (1)
- Neonatales Entzugssyndrom (1)
- Neonatologie (1)
- Neoplasm staging (1)
- Nephelometrie und Turbidimetrie (1)
- Nephelometry and Turbidimetry (1)
- Nephrogenese (1)
- Nephrons (1)
- Nephropathie (1)
- Nerven <Begriff> (1)
- Nerves (1)
- Nervous system diseases (1)
- Nesplora Aquarium (1)
- Network analysis (1)
- Network model (1)
- Network models (1)
- Network motifs (1)
- Netzhaut (1)
- Netzhaut ; Nervenzelle ; Inhibition (1)
- Neuer Mensch (1)
- Neugeborene (1)
- Neugeborenen-Hörscreeningverfahren ; DPOAE- und AABR-Messungen ; Gerätevergleich ABaer und Ero-Scan (1)
- Neural Network (1)
- Neural coding (1)
- Neural correlates of consciousness (1)
- Neural encoding models (1)
- Neural function (1)
- Neural goal function (1)
- Neural map (1)
- Neural signature (1)
- Neurasthenie (1)
- Neuro-ophthalmology (1)
- NeuroSAFE (1)
- Neurobiology of disease and regeneration (1)
- Neuroblastom, SAMHD1, Chemoresistenz (1)
- Neuroblastoma (1)
- Neuroblasts (1)
- Neurochemistry (1)
- Neurocognition (1)
- Neurodegenerative diseases (1)
- Neurodegenerative syndromes (1)
- Neurodevelopment (1)
- Neurodevelopmental Psychiatric Disorders (1)
- Neurodevelopmental disorder (1)
- Neurodevelopmental disorders (1)
- Neuroendocrine cancer (1)
- Neuroendocrine tumor (1)
- Neuroepithelial (1)
- Neuroepithelial tumor (1)
- Neurofeedback (1)
- Neurofilament light chain (1)
- Neurofilament light chains (1)
- Neurofilament-Leichtketten (1)
- Neurofuzzy medical systems (1)
- Neurogenese (1)
- Neurogenesis (1)
- Neurohypophyse (1)
- Neuroligins (1)
- Neurologe (1)
- Neurologiegeschichte (1)
- Neurologisches Institut <Frankfurt am Main> (1)
- Neuromodulatorisches Netzwerk (1)
- Neuromodulatory network (1)
- Neuromuscular exercise (1)
- Neuromyelitis optica (1)
- Neuron-Specific Enolase/serum (1)
- Neuron-spezifische Enolase/Serum (1)
- Neuronal homeostasis (1)
- Neuronal migration (1)
- Neuronal network models (1)
- Neuronal networks (1)
- Neuronal nitric oxide synthase (1)
- Neuronal oscillations (1)
- Neuronales Netzwerk (1)
- Neuronavigation (1)
- Neuronspecific Enolase (1)
- Neuronspezifische-Enolase (1)
- Neurooncology (1)
- Neuropathie (1)
- Neuropathologie (1)
- Neuropilin (1)
- Neuroprotection (1)
- Neuroprotektion (1)
- Neuropsychiatric disorders (1)
- Neuropsychological testing (1)
- Neuropsychologie (1)
- Neuropsychology (1)
- Neuroscience, neural computation & artificial intelligence (1)
- Neurosciences (1)
- Neurostimulation (1)
- Neurotransmission (1)
- Neurotrophe Faktoren (1)
- Neurovascular damage (1)
- Neurovascular lesion (1)
- Neurowissenschaften (1)
- Neutrophils (1)
- Nevus of Ito (1)
- Nevus of Ota (1)
- New Developments (1)
- New E3-ligase ligands (1)
- Newbornhearingscreening (1)
- Next generation sequencing (1)
- NfL (1)
- Nfe2l2 (1)
- Niche (1)
- Niche differentiation (1)
- Nicht-Ereignis (1)
- Nicht-allergische Rhinitis (1)
- Nichtversicherung (1)
- Nicolaides-Baraitser syndrome (1)
- Nicotine (Nicotiana tabacum/ Nicotiana rustica) (1)
- Nicotinic acetylcholine receptors (1)
- Niere (1)
- Nierendosimetrie (1)
- Nierentubulusepithelzellen (1)
- Nikotin (Nicotiana tabacum/ Nicotiana rustica) (1)
- Nikotinerge Acetylcholinrezeptoren (1)
- Nimotuzumab (1)
- Nitric Oxide Synthase (1)
- Nkx2-5 (1)
- Nociception (1)
- Nociceptors (1)
- Nodular lymphocyte predominant Hodgkin lymphoma (1)
- Non-Hodgkin Lymphoma (1)
- Non-Hodgkin lymphoma (1)
- Non-Hodgkin-Lymphom (1)
- Non-RCT (1)
- Non-abusive head trauma (NAHT) (1)
- Non-alcoholic fatty liver disease (1)
- Non-allergic-rhinitis (1)
- Non-aneurysmal (1)
- Non-apoptotic functions (1)
- Non-clear cell renal cell cancer (1)
- Non-coding RNAs (1)
- Non-diffractive EDOF-IOL (1)
- Non-expert MRI (1)
- Non-falciparum (1)
- Non-invasive brain stimulation (1)
- Non-neuronal cholinergic system (1)
- Non-nucleoside polymerase inhibitors (NNI) (1)
- Non-operative (1)
- Non-perimesencephalic (1)
- Non-responder (1)
- Non-small-cell lung cancer (1)
- Non-steroidal anti-inflammatory drugs (1)
- Non-trauma (1)
- Non-tuberculous mycobacteria (1)
- Non-urothelial (1)
- Non-vitamin K antagonist oral anticoagulants (1)
- Nonaerosolizing treatment (1)
- Noncoding RNA (1)
- Nonfermenter (1)
- Noninferiority (1)
- Nonlinear analysis (1)
- Nonoperative management (1)
- Nonpenetrating (1)
- Nonsteroidal anti-inflammatory drugs (1)
- Nontuberculous mycobacteria (1)
- Nonunion (1)
- Non–small-cell lung cancer (1)
- Noradrenergic (1)
- Nordhrine-Westfalia (1)
- Nordic questionnaire (1)
- Nordrhein-Westfalen (1)
- Norepinephrine (1)
- Normalkollektiv (1)
- Normative modeling (1)
- Notch (1)
- Notch signaling (1)
- Notfallausweis (1)
- Notfallversorgung (1)
- Novel treatment target (1)
- Nox inhibition (1)
- NoxA1 (1)
- Nozizeption (1)
- Npr2 (1)
- Nrf-2 (1)
- Nucleolar protein 14 (1)
- Nucleolus (1)
- Nucleophosmin-1 (1)
- Nucleus pulposus cells (1)
- Nucleus reuniens (1)
- Nukleinsäure-Amplifikations Testung (NAT) (1)
- Nukleinsäure-Amplifikationstechnik (NAT) (1)
- Nukleinsäureamplifikationstest (NAT) (1)
- Nuklid (1)
- Null responder (1)
- Number of platelets (1)
- Nurses (1)
- Nutrition risk stratification (1)
- Nyanja (1)
- Nyanja-Sprache (1)
- Nymphs (1)
- Nyungwe (1)
- O-GlcNAcylation (1)
- OA (1)
- ODEs (1)
- OECD performance standards (1)
- OGR1 (1)
- OGTT (1)
- OHIP-G14 (1)
- OHRQoL (1)
- ONC201 (1)
- OP capacity (1)
- OP-Kapazität (1)
- OPRM1 methylation (1)
- OPS (1)
- OR time (1)
- ORES (1)
- ORIS (1)
- ORL (1)
- ORP (1)
- OSA (1)
- OSF-2 KI-S2 (1)
- OTSC Proctology (1)
- OXA-23 (1)
- OXA-484 (1)
- OXA-58 (1)
- OXPHOS (1)
- Oberarmbruch (1)
- Oberflächenantigen-Mutante (1)
- Object perception (1)
- Object-scene associations (1)
- Objectives (1)
- Objektivität (1)
- Observational studies (1)
- Obsessive-compulsive disorder (1)
- Obstetric care (1)
- Obstetrics (1)
- Obstruktive Bronchitis (1)
- Occlusion (1)
- Occupational Accidents (1)
- Occupational exposure (1)
- Occupational medicine (1)
- Occupational reintegration management (1)
- Occupationally acquired infection (1)
- Oceanic boundlessness (1)
- Ocular findings (1)
- Ocular trauma (1)
- Ocular tuberculosis (1)
- Odorant receptor (1)
- Oesophageal cancer (1)
- Oesophagogastric cancer oxaliplatin (1)
- Off-pump surgery (1)
- Office work (1)
- Ohnr (1)
- Ohrakupunktur (1)
- Ohrenheilkunde (1)
- Ohrenkrankheit (1)
- Okinawa (1)
- Okinawa diet (1)
- Okklusivverband (1)
- Okulist (1)
- Old-old (1)
- Older adult (1)
- Older patient (1)
- Older patients (1)
- Oldest-old (1)
- Olfactory diagnostics (1)
- Olfactory groove meningioma (1)
- Oligodendrogliom (1)
- Oligodendroglioma (1)
- Oligometastatic (1)
- Olive <Anatomie> (1)
- Omega lipids (1)
- Omega-3-Fettsäuren (1)
- Omicron variant BA.1 (1)
- Omics (1)
- Omphalocele (1)
- Omphalozele (1)
- Oncogenes (1)
- Oncologic surgery (1)
- Oncolytic adenovirus (1)
- Oncolytic virus (1)
- Oncoprotein activation (1)
- Oncosomes (1)
- Oncotargets (1)
- One health (1)
- One-leg stand (1)
- Onkogene (1)
- Onkomodulation (1)
- Online Survey (1)
- Online education (1)
- Online-Lehre (1)
- Online-Lernen (1)
- Online-Magazin (1)
- Online-Magazine (1)
- Online-Publikation (1)
- Online-Umfrage (1)
- Opacity (1)
- Open Access (1)
- Open abdomen (1)
- Open pulmonary tuberculosis (1)
- Open source concept (1)
- Open-access data resource (1)
- Operationsvorbereitung (1)
- Ophthalmologie (1)
- Ophthalmoplegia (1)
- Opiatrezeptor (1)
- Opinion (1)
- Opioid system (1)
- Opium (1)
- Oposterior urethral valve (1)
- Oppositional defant disorder (1)
- Oppositional defiant disorder (1)
- Opsoclonus-myoclonus syndrome (1)
- Optic nerve atrophy (1)
- Optical coherence tomography angiography (1)
- Optical lenses (1)
- Optimal wiring (1)
- Optisches Signal (1)
- Oral Health Impact Profile (OHIP) (1)
- Oral and maxillofacial surgery (1)
- Oral and maxillofacial trauma (1)
- Oral cancer (1)
- Oral food challenge (1)
- Oral immunotherapy (OIT) (1)
- Oral implantology (1)
- Oral therapy (1)
- Orale Antikoagulanzien (1)
- Orbital fracture (1)
- Orexin (1)
- Organ allocation (1)
- Organ failure (1)
- Organ injury (1)
- Organ motion (1)
- Organ rinse (1)
- Organ shortage (1)
- Organ support (1)
- Organ-confined (1)
- Organs at Risk (1)
- Orientation preference (1)
- Oroantral communication (1)
- Orphan disease (1)
- Orphan nuclear receptor (1)
- Orthodontic tooth movement (1)
- Orthodontist (1)
- Orthopaedics (1)
- Ortspezifische Mutagenese (1)
- Oryctolagus cuniculus (1)
- Oscillating saws (1)
- Osimertinib (1)
- Osmosensing (1)
- Osmostress (1)
- OspE (1)
- Ossifying fibroma (1)
- Osteoinduction (1)
- Osteonecrosis (1)
- Osteoporose (1)
- Osteoporosis diagnosis (1)
- Oswestry Disability Score (1)
- Otorhinolaryngological (1)
- Otorhinolaryngology (1)
- Outbreak (1)
- Outcome assessment [MeSH] (1)
- Outlier detection (1)
- Ovale (1)
- Ovarian cancer treatment (1)
- Ovarian carcinoma (1)
- Ovarielle Reserve (1)
- Ovartoxizität (1)
- Ovary (1)
- Over-the-scope clip (1)
- Overall survival (1)
- Overweight (1)
- Overwintering (1)
- Oxa1/YidC/Alb3 Membrane Insertases (1)
- Oxaliplatin (1)
- Oxanthrone Glucosyls (1)
- Oxford Nanopore Technologies (1)
- Oxidoreductases (1)
- Oxygen (1)
- Oxygen consumption (1)
- Oxygen extraction fraction (1)
- Oxygen uptake (1)
- Oxygen-derived free radicals (1)
- P-TEFb (1)
- P-gp (1)
- P1NP (1)
- P23/PTGES3 (1)
- P2X3 (1)
- PACS (1)
- PAD-test (1)
- PAD4 (1)
- PAI-1 (1)
- PAM (1)
- PAPR (1)
- PAR (1)
- PARK4 (1)
- PARK6 (1)
- PARK7 (1)
- PATZ1 (1)
- PAX3/FOXO1 (1)
- PBBM (1)
- PBM (1)
- PBMC (peripheral blood mononuclear cells) (1)
- PBPK simulation (1)
- PBSC (1)
- PBX (1)
- PBX1 (1)
- PC12 neuronal differentiation (1)
- PC12APPsw (1)
- PC20 (1)
- PCA (1)
- PCP (1)
- PCSK9 protein (1)
- PCV (1)
- PD-1 inhibitor (1)
- PD20 (1)
- PDCD4 (1)
- PDD - Assessment - Screening (1)
- PDE (1)
- PDE inhibition (1)
- PDE‐5‐inhibitor (1)
- PDI (1)
- PDK1 (1)
- PDPK1 (1)
- PEA-15 (1)
- PEGylated PLGA (PLGA-PEG) (1)
- PEI (1)
- PELICAN (1)
- PEM-technology (1)
- PF-06273340 (1)
- PFL (1)
- PFOA (1)
- PFOS (1)
- PGC-1 alpha (1)
- PGC-1α (1)
- PHGDH (1)
- PHR1 (1)
- PI3K inhibitor (1)
- PI3K/mTor inhibition (1)
- PID prevalence (1)
- PIF pocket (1)
- PIK3CA (1)
- PIM kinases (1)
- PING (1)
- PKA (1)
- PKCδ (1)
- PKCε (1)
- PKD (1)
- PKD/IC (1)
- PLA (1)
- PLAGL1 (1)
- PLGA nanoparticles (1)
- PLK1 (1)
- PLK1 inhibitors (1)
- PLSC (1)
- PLX4032 (1)
- PLX4720 (1)
- PM (1)
- PMA (1)
- PMF (1)
- PMI (1)
- PMMA (1)
- PMNs (1)
- POCT (1)
- POLG (1)
- POR (1)
- PPAR (1)
- PPAR gamma activator (1)
- PPAR-γ (1)
- PPTC7 (1)
- PRG-1 (1)
- PRG5 (1)
- PRIMUM-Studie (1)
- PRLTS3 (1)
- PROM (1)
- PROMISE (1)
- PRRT (1)
- PRRT2 (1)
- PRoMPT (1)
- PSA screening (1)
- PSA-Screening (1)
- PTCH (1)
- PTCH-1 (1)
- PTDM (1)
- PTEN inducible kinase 1 (1)
- PTEN p53 Survivin (1)
- PTK2B (1)
- PTM (1)
- PTP-1B (1)
- PUMA (1)
- PV (1)
- PV loop (1)
- PWI (1)
- PXA (1)
- PYGL (1)
- PacBio SMRT sequencing (1)
- Paediatric Investigation Plan (1)
- Paediatric cancer (1)
- Paediatric oncology (1)
- Paediatric research (1)
- Paediatric trauma patients (1)
- Paediatrics (1)
- Pain behavior (1)
- Pain intensity (1)
- Pain patients (1)
- Pain prevalence (1)
- Pain scale MWA (1)
- Palacos reaction (1)
- Palliative Care [MeSH] (1)
- Palmitoylethanolamid (1)
- Pancreas transplantation (1)
- Pancreatic islet (1)
- Pancreatic neuroendocrine tumor (1)
- Pancreatic surgery (1)
- Pancreatitis (1)
- Pancreatoduodenectomy (1)
- Pandemic Ethics (1)
- Pandemics (1)
- Panel testing (1)
- Panic disorder (1)
- Papillon-Lefèvre syndrome (1)
- Par-4 (1)
- Paracelsus, Asteroid (1)
- Paracetamol (1)
- Parainfluenza (1)
- Parameter estimation (1)
- Paramyxoviridae (1)
- Paraneoplastic neurological syndromes (1)
- Paraneoplastic syndrome (1)
- Parapneumonic pleural effusion (1)
- Parasympathetic (1)
- Parcellation (1)
- Parent support (1)
- Parkinson-Krankheit (1)
- Parkinsonerkrankung (1)
- Parkinsons disease (1)
- Parodontitis (1)
- Parodontitistherapie (1)
- Partial agonist (1)
- Partial least square correlation (1)
- Particle image velocimetry (1)
- Particle load reduction (1)
- Particle number size distribution (1)
- Particle size distribution (1)
- Particle toxicity (1)
- Particles (1)
- Particulates (1)
- Passivrauch (1)
- Patch-Clamp-Methode (1)
- Patch-clamp (1)
- Patellarerkrankungen (1)
- Patellofemoral Joint (1)
- Path dependency (1)
- Pathogen (1)
- Pathogen reduction (1)
- Pathogenicity (1)
- Pathogens (1)
- Pathologic changes (1)
- Pathological complete response (1)
- Pathologists (1)
- Pathology Section (1)
- Pathophysiologie (1)
- Pathophysiology (1)
- Patient Blood Management (PBM) (1)
- Patient Outcome Assessment (1)
- Patient Outcome Assessment [MeSH] (1)
- Patient Reported Outcome Measures [MeSH] (1)
- Patient and public Involvement (1)
- Patient care (1)
- Patient care planning (1)
- Patient education (1)
- Patient information materials (1)
- Patient isolation (1)
- Patient knowledge (1)
- Patient outcome assessment (1)
- Patient participation (1)
- Patient perspective (1)
- Patient portals (1)
- Patient preferences (1)
- Patient reported outcomes (1)
- Patient satisfaction (1)
- Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (1)
- Patient-centered care (1)
- Patient-reported outcomes (1)
- Patienten (1)
- Patientenaufklärung (1)
- Patientenportale (1)
- Patientensicherheit (1)
- Patientenstudie (1)
- Pattern classification (1)
- Pattern recognition receptors (1)
- Pattern separation (1)
- Pause (1)
- Pdgfrβ (1)
- Peanut allergy (1)
- Pedagogue (1)
- Pediatric burn injury (1)
- Pediatric fracture (1)
- Pediatric neuroimaging (1)
- Pediatric oncology (1)
- Pediatric orthopedic (1)
- Pediatric sarcoma (1)
- Pediatric stem cell transplantation (1)
- Pediatric surgery (1)
- Pediatrics [MeSH] (1)
- PedsQL (1)
- Peer Teaching (1)
- Peer review (1)
- Peer teaching (1)
- Peer-feedback (1)
- Peer-teaching (1)
- Peg3 (1)
- Pegylated liposomal doxorubicin (1)
- Pelargonium sidoides questionable hepatotoxicity (1)
- Pelvic (1)
- Penetration (1)
- Penetrationsverstärker (1)
- Penile Neoplasms (1)
- Pentose Pathway (1)
- Peptid-Aptamer (1)
- Peptides (1)
- Peptides and proteins (1)
- Per1−/−-mice (1)
- Perceived stigma (1)
- Perceived vulnerability to disease (1)
- Percutaneous (1)
- Percutaneous endoscopic gastrostomy (1)
- Percutaneous pinning (1)
- Percutaneous ultrasound (1)
- Performance (1)
- Performance Metrics (1)
- Performing Artists (1)
- Peri-implant disease (1)
- Pericardial effusion (1)
- Pericarditis (1)
- Perifolliculitis capitis abscedens et suffodiens (1)
- Perilymph (1)
- Perimesencephalic (1)
- Perinatalzentren (1)
- Periodic (1)
- Periodontal disease (1)
- Periodontal diseases (1)
- Periodontal trauma (1)
- Periodontitis grades B and C (1)
- Peripheral arterial occlusive disease (1)
- Peripheral blood smears (1)
- Peripheral vascular disease (1)
- Periphere arterie (1)
- Periprocedural anticoagulation (1)
- Peritoneal macrophages (1)
- Peritumoural oedema (1)
- Perizyten (1)
- Peri‑implantitis (1)
- Perkutane transluminale Angioplastie (1)
- Permeability (1)
- Peroxidase (1)
- Perrault syndrome (1)
- Persistence SARS-CoV-2 antibodies (1)
- Persistent depressive disorder (1)
- Persistent organic pollutants (1)
- Persistierender Ductus arteriosus (1)
- Personal medicine (1)
- Personal protective equipment (1)
- Personal stigma (1)
- Personalbelastung (1)
- Personalised medicine (1)
- Personality (1)
- Personality disorder (1)
- Personality inventory (1)
- Personalized Medicine (1)
- Personalmangel (1)
- Personnel shortage (1)
- Perspective forum (1)
- Perspektivforum (1)
- Persönlichkeitsfaktor (1)
- Pertussis (1)
- Pessar (1)
- Peutz–Jeghers syndrome (1)
- Peyronie's disease (1)
- Pfannenstiel (1)
- Pflegeeinrichtungen (1)
- Pgrmc1 (1)
- Phage Display (1)
- Phakic (1)
- Phalangeal fractures (1)
- Phantom study (1)
- Phantoms (imaging) (1)
- Pharm-fMRI (1)
- Pharma Management (1)
- Pharmaceutical (1)
- Pharmaco-nutrition (1)
- Pharmacodynamic (1)
- Pharmacodynamics (1)
- Pharmacokinetic Interactions (1)
- Pharmacokinetics (1)
- Pharmacological treatment (1)
- Pharmacometrics (1)
- Pharmacophore (1)
- Pharmacotherapy (1)
- Pharmacovigilance (1)
- Pharmacy setting (1)
- Pharmaka (1)
- Pharmakoepidemiologie (1)
- Pharmazeutische Chemie (1)
- Pharmazeutische Technologie (1)
- Pharmazie (1)
- Pharyngeal reflex (1)
- Phase 2 (1)
- Phase 3 (1)
- Phase 3 trial (1)
- Phase I clinical trial (1)
- Phase I trials (1)
- Phase II trial (1)
- Phase rotors (1)
- Phase-IV research (1)
- Phase-Proteine (1)
- Phase-reset (1)
- Phenazinderivate (1)
- Phenomenology (1)
- Phenotypic plasticity (1)
- Phenprocoumon (1)
- Phenylketonuria (PKU) (1)
- Philadelphia Chromosome (1)
- Philadelphia Chromosome-positive leukemia (1)
- Philadelphia chromosome-positive acute leukemia (1)
- Philemon and Baucis (1)
- Philemon und Baucis (1)
- Philosophie (1)
- Phlyctenule (1)
- Phosphatase (1)
- Phospho-soda (1)
- Phospho-tau (1)
- Phosphodiesterases (1)
- Phospholipasen A2 (1)
- Phosphoproteome (1)
- Phosphopyruvate Hydratase/serum (1)
- Phosphopyruvathydratase/Serum (1)
- Phosphorylierung (1)
- Photodynamische Therapie (1)
- Photodynamische Therapie (PDT) (1)
- Photographie (1)
- Photosensibilisator (1)
- Phraseological games (1)
- Phraseologie (1)
- Phraseologische Spiele (1)
- Phylogeny (1)
- Physical activity intervention (1)
- Physical and chemical properties (1)
- Physical and mental health (1)
- Physical comorbidities (1)
- Physical fitness (1)
- Physical self-perception (1)
- Physical therapist (1)
- Physician report (1)
- Physician-assisted suicide (1)
- Physics of Living Systems (1)
- Physiologie (1)
- Physiotherapie (1)
- Physiotherapy (1)
- Phytochemicals (1)
- Phytopharmakon (1)
- Phänomenologische Soziologie (1)
- Pierre Robin sequence (1)
- Pill Count (1)
- PillCamColon2 (1)
- Pilocytic astrocytoma (1)
- Pilze (1)
- Pilzsinusitis (1)
- Pim-1 (1)
- Pindar, Pythische Ode III (1)
- Pinhole IOL (1)
- Pink esthetic score (1)
- Pink1 (1)
- Pinwheel (1)
- Piriform cortex (1)
- Pittsburgh Sleep Quality Index (1)
- Placental growth factor (1)
- Placental organoids (1)
- Plague (1)
- Planning target volume (1)
- Plantagearbeiter (1)
- Plantation workers (1)
- Plants (1)
- Plaque <Medizin> (1)
- Plasma fibronectin (1)
- Plasma proteins (1)
- Plasma transfusion (1)
- Plasma usage (1)
- Plasmacytoid dendritic cell (1)
- Plasmapheresis (1)
- Plasmapools (1)
- Plasmaprotein analyzer (1)
- Plasmaproteinanalysensysteme (1)
- Plasmaproteinbestimmung im Harn (1)
- Plasmaproteine (1)
- Plasmapräparate (1)
- Plasminogen (1)
- Plastic endoprosthesis (1)
- Plastic pollution (1)
- Plastics (1)
- Plastikstent (1)
- Platelet (1)
- Platelet dysfunction (1)
- Platelet lysate (1)
- Platelet releasate (1)
- Platzierung (1)
- Plausibilität (1)
- Play (1)
- Play sports (1)
- Pleasure (1)
- Plectin (1)
- Plethysmographie (1)
- Pleural empyema (1)
- Plk1 (1)
- Plättchen-Leukozyten-Aggregate (1)
- Plättchenaktivierung (1)
- Pneumococcal conjugate vaccine (1)
- Pneumothorax (1)
- Poe, Der wahre Sachverhalt im Falle Valdemar (1)
- Point of care (1)
- Point-of-Care Testing (POCT) (1)
- Point-of-care wound diagnostics (1)
- Polarisierung (1)
- Polarity index (1)
- Policy implementation (1)
- Poliomyelitis (1)
- Polioviren (1)
- Polizei (1)
- Polo-like kinase 3 (1)
- Poly-Pore (1)
- Polyenfettsäuren (1)
- Polygenic risk score (1)
- Polyhexanide (1)
- Polymerase Chain Reaction (1)
- Polymerase Chain Reaction (PCR) (1)
- Polymerase Kettenreaktion (PCR) (1)
- Polymerase-Kettenreaktion (1)
- Polymerasekettenreaktion (1)
- Polymorphismen (1)
- Polyphenole (1)
- Polyposis (1)
- Polyposis syndrome (1)
- Polyps (1)
- Polysomnography (1)
- Polyunsaturated fatty acid mediators (1)
- Polyunsaturated fatty acids (1)
- Polyzystisches Ovarsyndrom (1)
- Política de Saúde (1)
- Ponatinib (1)
- Pooling (1)
- Poor solubility (1)
- Population dynamics (1)
- Population-based screening (1)
- Porin regulation (1)
- Porphyromonas gingivalis (1)
- Portal (1)
- Porträt (1)
- Portugal (1)
- Portuguese population (1)
- Posaconazole serum level (1)
- Position paper (1)
- Positive mental images (1)
- Positron-emission tomography (1)
- Post mortem examination (1)
- Post mortem interval (1)
- Post surgery pain (1)
- Post treatment (1)
- Post-cesarean (1)
- Post-mortem genetic screening (1)
- Post-offence drinking (1)
- Post-processing (1)
- Post-thaw recovery (1)
- Post-transplant (1)
- Posterior Cerebral (1)
- Posterior cruciate ligament (1)
- Postmortem (1)
- Postmortem interval (1)
- Postoperative Complications (1)
- Postoperative anatomy (1)
- Postoperative infections (1)
- Postoperative nutritional management (1)
- Posttranslational modification (1)
- Postural sway (1)
- Posture (1)
- Postvention (1)
- Potassium channel Kir2.1 (1)
- Potassium iodide (1)
- Powered air-purifying respirator (1)
- Pp (1)
- Ppk (1)
- PrEP (1)
- Practical training (1)
- Practice (1)
- Practice-based Research Network (1)
- Practice-based research network (1)
- Praeklampsie (1)
- Praktische Fertigkeiten (1)
- Praktische Lehre (1)
- Praktisches Jahr (1)
- Pre-economic effects (1)
- Pre-emptive immunotherapy (1)
- Pre-operative radiotherapy (1)
- Pre-treatment drug resistance mutations (1)
- PreS1 deletion (1)
- Precision (1)
- Precision medicine (1)
- Precision oncology (1)
- Preclinical (1)
- Preclinical drug development (1)
- Precompetitive development (1)
- Prediction of locoregional recurrence (1)
- Predictive Modeling (1)
- Predictive medicine (1)
- Predictive model (1)
- Predictive modeling (1)
- Predictive processing (1)
- Predictors (1)
- Prefrontal cortex (1)
- Pregnant smokers (1)
- Premotor cortex (1)
- Prenatal ultrasonographic detection rate (1)
- Preoperative diagnostics (1)
- Preoperative radiochemotherapy (1)
- Prepontine (1)
- Presbyopia (1)
- Preseniline (1)
- Pressure distribution (1)
- Pressure measuring plate (1)
- Pressure pain (1)
- Presynaptic vesicles (1)
- Preußen (1)
- Prevention of Muscle Lesion (1)
- Preventive behavior (1)
- Pre‐Ligand Assembly Domain (PLAD) (1)
- Primary Care Health Centre (1)
- Primary Care Research Network (1)
- Primary breast lymphoma (1)
- Primary health care [MeSH] (1)
- Primary molars (1)
- Primary prophylaxis (1)
- Primary sclerosing cholangitis (1)
- Principal component analysis (1)
- Priorisierung in der Medizin (1)
- Pro.M.D. (1)
- Probenidentifikation (1)
- Procaine (1)
- Procedural Ethics (1)
- Procedural skills (1)
- Process Capability (1)
- Process Performance (1)
- Process Validation (1)
- Process characterization (1)
- Process evaluation (1)
Institute
- Medizin (7494)
- Pharmazie (297)
- Biowissenschaften (271)
- Präsidium (255)
- Biochemie, Chemie und Pharmazie (238)
- Biochemie und Chemie (216)
- Frankfurt Institute for Advanced Studies (FIAS) (155)
- Georg-Speyer-Haus (130)
- Sportwissenschaften (130)
- Psychologie (94)
Inner world and milieu : art, madness, and Brazilian psychiatry in the work of Nise da Silveira
(2024)
This short essay focuses on the work of Brazilian doctor Nise da Silveira, a pioneer in psychiatry who introduced artistic tools to work with psychiatric patients, especially those diagnosed as psychotic. She founded the Museum of Images from the Unconscious in 1952 inside an asylum in Rio de Janeiro to assemble and exhibit the works produced by her patients. As an iconoclast who did not systematize her theory, she engaged with several European psychiatrists, psychoanalysts, and thinkers to produce a very innovative reflection and practical clinical work. Her work resonates in particular with French Institutional Psychotherapy, as well as with Frantz Fanon's psychiatric work in Algeria, but, differently from the former, places art at the core of its clinical method and proposes a radical positioning against every form of medicalized approach.
Background: The Association of the Scientific Medical Societies in Germany (AWMF) clinical practice guideline on cochlear implant (CI) treatment, which was updated in 2020, defined the entire process of CI care for the first time. In the present study, the feasibility and results of very early rehabilitation were examined.
Materials and methods: The intervention group (IG) comprised 54 patients in whom rehabilitation was initiated within 14 (maximally 28) days after implantation. Patients with a significantly longer waiting time were included in the control group (CG, n = 21). In addition to the start and duration of rehabilitation, the speech intelligibility achieved with CI was recorded at different timepoints within a 12-month period. In addition, questionnaires were used to assess the effort of fitting the CI processor and the patients’ satisfaction with the outcome as well as the timing of the start of rehabilitation.
Results: Median waiting time between implantation and start of rehabilitation was 14 days in the IG and 106 days in the CG; 92.6% of IG patients were able to start rehabilitation within 14 days. The effect of rehabilitation in the IG was 35 and in the CG 25 percentage points (Freiburg monosyllabic test). After 6 and 12 months of CI use, both groups showed comparable results in the test condition in quiet (IG/CG 6 months: 70%/70%; 12 months: 70%/60%, Freiburg monosyllabic test) and in noise (IG/CG 6 months: −1.1 dB SNR/–0.85 dB SNR; 12 months: −0.65 dB SNR/+0.3 dB SNR, Oldenburg sentence test). Hearing quality assessment scores collected by SSQ (Speech, Spatial and Qualities of Hearing Scale) questionnaire showed better scores in the IG at 6 months, which converged to CG scores at 12 months. The IG was significantly more satisfied with the timing of the start of rehab than the CG. All other data obtained from questionnaires showed no differences between the two groups.
Conclusion: A very early start of inpatient rehabilitation after cochlear implantation was successfully implemented. The rehabilitation was completed within 7 weeks of CI surgery. Comparison of speech recognition test results before and after rehabilitation showed a significant improvement. A clear rehabilitation effect can therefore be demonstrated. Inclusion of CI rehabilitation in the German catalog of follow-up treatments is thus scientifically justified and therefore strongly recommended.
There has been a growing awareness of the need for scientific research to focus on somatic and mental comorbidities in recent years due to the emerging evidence showing their substantial overlap at numerous levels. In this special issue, initiated by members of the EU-funded PRIME consortium (“Prevention and Remediation of Insulin Multimorbidity in Europe; www.prime-study.eu), the focus is on the comorbidities of metabolic disturbances, especially related to insulin signalling dysregulation and mental and neurological disorders. Thus, while obesity, type 2 diabetes, and metabolic syndrome are commonly known to be insulin-related disorders, the last decades have shown that neurodegenerative disorders, such as Alzheimer’s disease, as well as neurodevelopment disorders, such as obsessive-compulsive disorder (OCD), autism spectrum disorders (ASDs) and attention deficit / hyperactivity disorder (ADHD) also fall into this category. The special issue draws together a series of basic and clinical review articles that describe the current knowledge and future perspectives regarding insulin comorbidities across a multidisciplinary group of experts
The lipid content of skin plays a determinant role in its barrier function with a particularly important role attributed to linoleic acid and its derivatives. Here we explored the consequences of interfering with the soluble epoxide hydrolase (sEH) on skin homeostasis. sEH; which converts fatty acid epoxides generated by cytochrome P450 enzymes to their corresponding diols, was largely restricted to the epidermis which was enriched in sEH-generated diols. Global deletion of the sEH increased levels of epoxides, including the linoleic acid-derived epoxide; 12,13-epoxyoctadecenoic acid (12,13-EpOME), and increased basal keratinocyte proliferation. sEH deletion (sEH-/- mice) resulted in thicker differentiated spinous and corneocyte layers compared to wild-type mice, a hyperkeratosis phenotype that was reproduced in wild-type mice treated with a sEH inhibitor. sEH deletion made the skin sensitive to inflammation and sEH-/- mice developed thicker imiquimod-induced psoriasis plaques than the control group and were more prone to inflammation triggered by mechanical stress with pronounced infiltration and activation of neutrophils as well as vascular leak and increased 12,13-EpOME and leukotriene (LT) B4 levels. Topical treatment of LTB4 antagonist after stripping successfully inhibited inflammation and neutrophil infiltration both in wild type and sEH-/- skin. While 12,13-EpoME had no effect on the trans-endothelial migration of neutrophils, like LTB4, it effectively induced neutrophil adhesion and activation. These observations indicate that while the increased accumulation of neutrophils in sEH-deficient skin could be attributed to the increase in LTB4 levels, both 12,13-EpOME and LTB4 contribute to neutrophil activation. Our observations identify a protective role of the sEH in the skin and should be taken into account when designing future clinical trials with sEH inhibitors.
Highlights
• Deletion of SPPL3 promotes resistance of malignant B cells to NK cell cytotoxicity
• Loss of SPPL3 blocks ligand binding to NK receptors via increased N-glycosylation
• B3GNT2 deletion reduces LacNAc addition and restores SPPL3-KO cell sensitivity to NK cells
• SPPL3-deficient cells are enriched in tetra-antennary N-glycans with LacNAc elongations
Summary
Natural killer (NK) cells are primary defenders against cancer precursors, but cancer cells can persist by evading immune surveillance. To investigate the genetic mechanisms underlying this evasion, we perform a genome-wide CRISPR screen using B lymphoblastoid cells. SPPL3, a peptidase that cleaves glycosyltransferases in the Golgi, emerges as a top hit facilitating evasion from NK cytotoxicity. SPPL3-deleted cells accumulate glycosyltransferases and complex N-glycans, disrupting not only binding of ligands to NK receptors but also binding of rituximab, a CD20 antibody approved for treating B cell cancers. Notably, inhibiting N-glycan maturation restores receptor binding and sensitivity to NK cells. A secondary CRISPR screen in SPPL3-deficient cells identifies B3GNT2, a transferase-mediating poly-LacNAc extension, as crucial for resistance. Mass spectrometry confirms enrichment of N-glycans bearing poly-LacNAc upon SPPL3 loss. Collectively, our study shows the essential role of SPPL3 and poly-LacNAc in cancer immune evasion, suggesting a promising target for cancer treatment.
Biological drug substance (DS) is typically stored frozen to increase stability. However, freezing and thawing (F/T) of DS can impact product quality and therefore F/T processes need to be controlled. Because active F/T systems for DS bottles are lacking, freezing is often performed uncontrolled in conventional freezers, and thawing at ambient temperature or using water baths.
In this study, we evaluated a novel device for F/T of DS in bottles, which can be operated in conventional freezers, generating a directed air stream around bottles. We characterized the F/T geometry and process performance in comparison to passive F/T using temperature mapping and analysis of concentration gradients. The device was able to better control the F/T process by inducing directional bottom-up F/T. As a result, it reduced cryo-concentration during freezing as well as ice mound formation. However, freezing with the device was dependent on freezer performance, i.e. prolonged process times in a highly loaded freezer were accompanied by increased cryo-concentrations. Thawing was faster compared to without the device, but had no impact on concentration gradients and was slower compared to thawing in a water bath.
High-performance freezers might be required to fully exploit the potential of directional freezing with this device and allow F/T process harmonization and scaling across sites.
Wissenschaftsbasierte und verständliche Gesundheitsinformationen sind ein Kernelement der Evidenzbasierten Medizin und von Public Health. Ziel ist es, informierte Entscheidungen zu ermöglichen, die auf realistischen Einschätzungen von Gesundheitsrisiken sowie von Nutzen und Schaden möglicher Interventionen beruhen. In Deutschland wurden während der COVID-19-Pandemie die Standards für eine evidenzbasierte Risikokommunikation wenig beachtet. Häufig war die öffentliche Berichterstattung einseitig, unvollständig und missverständlich. Bedrohungsszenarien haben emotionalen Stress und unnötige Angst ausgelöst. Eine systematische und umfassende Aufarbeitung der Pandemiemaßnahmen ist auch in Deutschland dringlich geboten. Dabei müsste eine kritisch-konstruktive Analyse der medialen Risikokommunikation von Expert*innen, Politiker*innen und Medien ein zentrales Element der Aufarbeitung sein. Die Ergebnisse sollen helfen, aus der vergangenen Pandemie zu lernen, um für künftige Krisen besser vorbereitet zu sein.
Purpose: The IC-8® Apthera™ (AcuFocus Inc.™, Irvine, California, USA) is the first small aperture intraocular lens (IOL) to receive FDA approval for presbyopia correction in the summer of 2022. It is a single-piece hydrophobic acrylic monofocal lens, which is placed in the capsular bag. In its center it carries a black circular mask (FilterRing™) with a diameter of 3.23 mm consisting of polyvinylidene fluoride and carbon black nanoparticles. In the center of this mask sits a 1.36 mm wide aperture. Thanks to this pinhole effect the IC-8® serves as an extended-depth-of-focus (EDOF) IOL and can be used in presbyopia correction.
This report describes the case of a patient with an IC-8® implant who underwent Nd:YAG laser capsulotomy for posterior capsule opacification (PCO). The post laser checkup showed a dark central optical change within the IOL and the patient described optical phenomena as well as blurred central vision, which is why he received IOL exchange. The explanted IC-8® was sent to the Intermountain Ocular Research Center at the University of Utah for further analysis.
Observations: A 56-year-old male underwent cataract surgery with implantation of a non-diffractive EDOF-IOL on the right and the IC-8® small aperture IOL on the left eye. On the left eye, the patient had received penetrating keratoplasty seven years prior to the cataract operation due to posttraumatic corneal scarring. The early checkups after cataract surgery showed a corrected distance visual acuity (CDVA) in the left eye of +0.1 logMAR in the first month. About 5 months after the operation, PCO was first described on the left eye leading to a decrease in visual acuity to +0.4 logMAR (CDVA). Due to PCO, Nd:YAG laser capsulotomy was conducted 5 months after the cataract operation on the left eye. 12 shots were applied at 2.7 mJ. The following appointments showed a continuously reduced visual acuity of +1.3 logMAR (uncorrected) on the left eye and the patient described blurry and ‘swirled’ central vision. By slightly tilting his head and thus not using the center of his optic axis, he would be able to see sharper. Slit lamp examination showed a small optical change inside the IC-8® IOL not resembling a pit but believed to be a small pocket of air. Due to the ongoing symptoms as well as the reduced VA, the seemingly damaged small aperture IOL was exchanged for a three-piece hydrophobic acrylic monofocal lens, which was also placed in the posterior chamber. The explanted IC-8® was sent to the Intermountain Ocular Research Center at the University of Utah for further analysis. Results from gross and light microscopic analysis showed that the change caused by the Nd:YAG laser application consisted of a localized optical area containing carbon black nanoparticles used for the circular mask within the IOL.
Conclusions and importance: When dealing with PCO and performing Nd:YAG laser capsulotomy in eyes with an IC-8® IOL implant, the laser shots should be applied either inside the aperture or outside of the black circular mask of the IOL. Otherwise, the Nd:YAG laser can lead to bursts of carbon nanoparticles within the IOL which may cause optical phenomena as well as decreased visual acuity possibly resulting in an IOL exchange.
Hematopoietic mutations in epigenetic regulators like DNA methyltransferase 3 alpha (DNMT3A), play a pivotal role in driving clonal hematopoiesis of indeterminate potential (CHIP), and are associated with unfavorable outcomes in patients suffering from heart failure (HF). However, the precise interactions between CHIP-mutated cells and other cardiac cell types remain unknown. Here, we identify fibroblasts as potential partners in interactions with CHIP-mutated monocytes. We used combined transcriptomic data derived from peripheral blood mononuclear cells of HF patients, both with and without CHIP, and cardiac tissue. We demonstrate that inactivation of DNMT3A in macrophages intensifies interactions with cardiac fibroblasts and increases cardiac fibrosis. DNMT3A inactivation amplifies the release of heparin-binding epidermal growth factor-like growth factor, thereby facilitating activation of cardiac fibroblasts. These findings identify a potential pathway of DNMT3A CHIP-driver mutations to the initiation and progression of HF and may also provide a compelling basis for the development of innovative anti-fibrotic strategies.
Tight control over transcription factor activity is necessary for a sensible balance between cellular proliferation and differentiation in the embryo and during tissue homeostasis by adult stem cells, but mechanistic details have remained incomplete. The homeodomain transcription factor MEIS2 is an important regulator of neurogenesis in the ventricular–subventricular zone (V-SVZ) adult stem cell niche in mice. We here identify MEIS2 as direct target of the intracellular protease calpain-2 (composed of the catalytic subunit CAPN2 and the regulatory subunit CAPNS1). Phosphorylation at conserved serine and/or threonine residues, or dimerization with PBX1, reduced the sensitivity of MEIS2 towards cleavage by calpain-2. In the adult V-SVZ, calpain-2 activity is high in stem and progenitor cells, but rapidly declines during neuronal differentiation, which is accompanied by increased stability of MEIS2 full-length protein. In accordance with this, blocking calpain-2 activity in stem and progenitor cells, or overexpression of a cleavage-insensitive form of MEIS2, increased the production of neurons, whereas overexpression of a catalytically active CAPN2 reduced it. Collectively, our results support a key role for calpain-2 in controlling the output of adult V-SVZ neural stem and progenitor cells through cleavage of the neuronal fate determinant MEIS2.
Highlights
• Reduced evoked theta activity in the deaf.
• Reduced theta-gamma and alpha-gamma cross-frequency couplings in the deaf.
• Stronger delta-alpha coupling in the deaf.
Abstract
Neurons within a neuronal network can be grouped by bottom-up and top-down influences using synchrony in neuronal oscillations. This creates the representation of perceptual objects from sensory features. Oscillatory activity can be differentiated into stimulus-phase-locked (evoked) and non-phase-locked (induced). The former is mainly determined by sensory input, the latter by higher-level (cortical) processing. Effects of auditory deprivation on cortical oscillations have been studied in congenitally deaf cats (CDCs) using cochlear implant (CI) stimulation. CI-induced alpha, beta, and gamma activity were compromised in the auditory cortex of CDCs. Furthermore, top-down information flow between secondary and primary auditory areas in hearing cats, conveyed by induced alpha oscillations, was lost in CDCs. Here we used the matching pursuit algorithm to assess components of such oscillatory activity in local field potentials recorded in primary field A1. Additionally to the loss of induced alpha oscillations, we also found a loss of evoked theta activity in CDCs. The loss of theta and alpha activity in CDCs can be directly related to reduced high-frequency (gamma-band) activity due to cross-frequency coupling. Here we quantified such cross-frequency coupling in adult 1) hearing-experienced, acoustically stimulated cats (aHCs), 2) hearing-experienced cats following acute pharmacological deafening and subsequent CIs, thus in electrically stimulated cats (eHCs), and 3) electrically stimulated CDCs. We found significant cross-frequency coupling in all animal groups in > 70% of auditory-responsive sites. The predominant coupling in aHCs and eHCs was between theta/alpha phase and gamma power. In CDCs such coupling was lost and replaced by alpha oscillations coupling to delta/theta phase. Thus, alpha/theta oscillations synchronize high-frequency gamma activity only in hearing-experienced cats. The absence of induced alpha and theta oscillations contributes to the loss of induced gamma power in CDCs, thereby signifying impaired local network activity.
The human immune system is determined by the functionality of the human lymph node. With the use of high-throughput techniques in clinical diagnostics, a large number of data is currently collected. The new data on the spatiotemporal organization of cells offers new possibilities to build a mathematical model of the human lymph node - a virtual lymph node. The virtual lymph node can be applied to simulate drug responses and may be used in clinical diagnosis. Here, we review mathematical models of the human lymph node from the viewpoint of cellular processes. Starting with classical methods, such as systems of differential equations, we discuss the values of different levels of abstraction and methods in the range from artificial intelligence techniques formalism.
Hintergrund: Bei der Operation einer ATAD sind Patienten aufgrund multipler komplexer Faktoren gefährdet perioperative permanente neurologische Defizite zu erleiden. Da perioperative PND die Mortalität signifikant steigern, ist die Kenntnis über potentielle Risikofaktoren für ein PND von großem Wert, nicht zuletzt um bestmöglich auf jeden Patientenfall vorbereitet sein zu können und Therapiestrategien zu optimieren.
Diese retrospektive Studie soll prä- und intraoperative Risikofaktoren für die Entstehung eines PND nach der Operation einer ATAD herausfiltern.
Material und Methoden: Patientendaten von Patienten mit ATAD (n=305), die sich im Zeitraum von 2001 – 2017 am Universitätsklinikum Frankfurt in der Abteilung für Herz- und Gefäßchirurgie einer Operation unterzogen haben, wurden retrospektiv mittels univariater Analyse und multivariater logistischer Regression analysiert.
Ergebnisse: Die PND-Rate innerhalb der Studienpopulation betrug 13%. Mit hoher statistischer Signifikanz konnte eine Form der hämodynamischen Instabilität als präoperativer Risikofaktor für die Entstehung eines perioperativen PND identifiziert werden (OR 9,53; p<0.001). Weiterhin konnte gezeigt werden, dass das Vorhandensein einer Karotisstenose das perioperative PND-Risiko ungünstig beeinflusst (OR 2,68, p=0,04). Ein präoperativer Sinusrhythmus kann die perioperative PND-Rate günstig beeinflussen (OR 0,2, p=0,01). Die univariate Analyse konnte signifikant belegen, dass Operationszeiten > 300 Minuten und EKZ-Zeiten > 160 Minuten das PND-Risiko ungünstig beeinflussen. Andere Risikofaktoren wie z.B. die Art der Hirnperfusion oder der Grad des hypothermischen Kreislausstillstandes, die zumindest klinische Signifikanz zu haben scheinen, konnten in dieser Arbeit keine statistische Signifikanz erzielen, was ggf. Ausdruck der Limitationen retrospektiver Arbeiten ist.
Fazit: Eine hämodynamische Instabilität stellt einen präoperativen Risikofaktor für die Entstehung eines PND nach der Operation einer ATAD dar. Zu den identifizierten präoperativen Risikofaktoren, die die PND-Rate ungünstig beeinflussen gehört außerdem das Vorhandensein einer Karotisstenose, während das Vorhandensein eines Sinusrhythmus die PND-Rate günstig beeinflusst.
Das Zeitmanagement bei der Operation einer ATAD ist entscheidend, um peri-operativen PND vorbeugen zu können. Eine Operationszeit > 300 Minuten und eine EKZ-Zeit von > 160 Minuten sind mit wesentlich höheren PND-Raten assoziiert und stellen somit intraoperative Risikofaktorenfür die Entstehung eines PND bei der Operation einer ATAD dar.
Evidence-based and comprehensible health information is a key element of evidence-based medicine and public health. The goal is informed decision-making based on realistic estimations of health risks and accurate expectations about benefits and harms of interventions. In Germany, standards of evidence-based risk information were poorly followed during the COVID-19 pandemic. Frequently, public information was biased, fragmentary and misleading. Pandemic-related threat scenarios induced emotional distress and unnecessary anxiety. A systematic and comprehensive evaluation of the pandemic measures is crucial, but still pending in Germany. A critical analysis of risk communication by experts, politicians and the media during the pandemic should be a key element of the evaluation process. Evaluation of decision making and media reporting during the pandemic should improve preparedness for future crises.
Diese Arbeit hatte das Ziel, die Größe einer DVT-Aufnahme (FOV) mit der Größe der durch die Indikationsstellung definierten Region (ROI) zu vergleichen. Durch eine speziell dafür entwickelte Software sollten Messungen in den Datensätzen ermöglicht werden. Die dazu verwendeten 332 Datensätze wurden zufallsverteilt aus den mit einem Orthophos SL-3D DVT-Gerät der Firma Dentsply Sirona in der Poliklinik für zahnärztliche Chirurgie und Implantologie des ZZMK (Carolinum) in Frankfurt angefertigten Röntgenaufnahmen selektiert.
Es wurde die Auswertungssoftware ExRoi entwickelt, mit der die Werte des axialen Durchmessers, die Höhe (vertikale Dimension) sowie die Distanz der Mittelpunkte von FOV und ROI direkt in den Datensätzen bestimmt werden konnten. Zusätzlich wurde festgehalten, welche rechtfertigenden Indikationen gestellt und welche Auflösungsmodi verwendet wurden.
Die Stichprobe bestand aus Aufnahmen mit einem axialen Durchmesser von 8 cm [VOL 1] (n= 76, entsprechend 46,39%), 5 cm Durchmesser [VOL 2] (n = 102, entsprechend 30,72%) und 11 cm Durchmesser [VOL 3] (n= 154, entsprechend 22,89%). 95,18% der Aufnahmen wurden im HD-Modus mit laut Herstellerangaben vier Mal so vielen Aufnahmen im Vergleich zum SD-Modus angefertigt. Hauptindikationen waren Implantat Planung (45,1%) und Planungen komplizierter Zahn-Extraktionen (25,5%).
Die Messungen zum Vergleich des axialen Durchmessers zeigten, dass bei Verwendung des VOL 2 die ROI im Mittel den größten Anteil der FOV nutzt (78,52 %), den kleinsten Anteil nutzt durchschnittlich VOL 1 (56,04 %). Dazwischen liegt VOL 3 (69,12 %). In der Vertikalen nutzt die ROI von VOL 3 mittelwertig den größten Anteil der FOV (81,87 %), den kleinsten Mittelwert hat VOL 1 (58,76 %). VOL 2 liegt zwischen diesen Werten (64,47 %).
In allen Fällen war das FOV größer als die ROI und die ROI lag im Bereich des gewählten FOV.
Die Mittelpunkte von FOV und ROI lagen im Mittel in der axialen Ebene in Abhängigkeit vom gewählten Volumen um rund 9-13 mm auseinander, in der coronalen und sagittalen Ebene um rund 5-6mm.
Aus diesen Ergebnissen kann für das verwendete Gerät eine gute Trefferquote für die ROI abgeleitet werden. Höhe und Durchmesser des FOV hätten in den meisten Fällen kleiner gewählt werden können, liegen aber angesichts der vorhandenen Auswahl-Optionen des Röntgengeräts zur Dimensionierung der Volumina in einem akzeptablen Bereich.
Der Natrium-abhängige Kaliumkanal Slack (KNa1.1, Slo2.2, KCNT1) nimmt eine Schlüsselrolle in der Regulation neuronaler Erregbarkeit ein, indem er die Ausbildung und Feuerungsfrequenz von Aktionspotentialen kontrolliert. Sowohl in Mäusen als auch in Menschen wird Slack besonders hoch in nicht-peptidergen C-Faser-Neuronen exprimiert. Wissenschaftliche Erkenntnisse der letzten Jahre konnten die Beteiligung von Slack-Kanälen in der Signalverarbeitung neuropathischer Schmerzen, aber auch in verschiedenen Arten von Pruritus, feststellen. Dabei zeigen Slack-defiziente Mäuse ein verstärktes mechanisches Schmerzverhalten nach einer peripheren Nervenverletzung und ein erhöhtes Kratzverhalten in akuten Juckreiz-Modellen. Das als Slack-Aktivator identifizierte trizyklische Neuroleptikum Loxapin zeigt sowohl analgetische als auch antipruritische Effekte in Mäusen, jedoch ist sein klinischer Einsatz auf Grund schwerwiegender antipsychotischer Nebenwirkungen limitiert. Basierend auf Loxapins Leitstruktur wurden daher in dieser Arbeit neue Slack-Aktivatoren mit einem verbesserten pharmakologischen Profil designed und ihr Potential für die Therapie von Schmerzen sowie akutem und chronischem Pruritus in vivo untersucht.
Das Schilddrüsenkarzinom (SK) ist die häufigste bösartige endokrine Tumorerkrankung. Während das nicht-metastasierte und nicht-mutierte papilläre Schilddrüsenkarzinom (PSK) und das follikuläre Schilddrüsenkarzinom (FSK) eine gute Heilungschance aufweisen, zeigen die mutierten und metastasierten Varianten des PSK und FSK sowie das anaplastische Schilddrüsenkarzinom (ASK) weiterhin eine schlechte Prognose. Die Entwicklung von Therapieresistenzen stellen hierbei ein Hauptproblem in der Behandlung des fortgeschrittenen Schilddrüsenkarzinoms dar.
In den letzten Jahren wurden in Studien zunehmend Tumor-initiierende Zellen (TIZ) beschrieben, welche eine kleine Subpopulation von Zellen mit der Fähigkeit zur Selbsterneuerung, Tumorinitiierung und Entwicklung von Therapieresistenzen von Tumoren darstellen. Die Existenz von TIZ wurde auch im SK nachgewiesen. Ein entscheidender Faktor für die Persistenz von TIZ ist die Hypoxie, welche über eine Veränderung des Tumormikromilieus und des Zellmetabolismus zur Entstehung von Therapieresistenzen beiträgt. Ein durch Hypoxie hochreguliertes Enzym ist die Carboanhydrase IX (CAIX). CAIX wird hauptsächlich von Tumorzellen exprimiert und katalysiert die Reaktion von Kohlendioxid zu Bicarbonat und einem Proton und trägt damit zur Säurepufferung der Tumorzelle bei. CAIX stellt somit einen entscheidenden Faktor für das Überleben von Tumorzellen in einem hypoxischen Milieu dar. Des Weiteren ist eine erhöhte Expression von CAIX mit einem schlechten Patienten-Outcome assoziiert, wie z.B. im Brustkrebs. Diese Eigenschaften machen CAIX zu einem attraktiven Angriffspunkt einer zielgerichteten Tumortherapie. Die vorliegende Studie hat zum Ziel, die Expression von CAIX sowie dessen biologische Rolle im Schilddrüsenkarzinom näher zu untersuchen.
Hierzu wurden Proben von 114 SK-Patienten immunhistochemisch auf eine CAIX-Expression untersucht und mit tumorfreiem Schilddrüsengewebe verglichen. Hierbei waren unterschiedliche SK-Subtypen vertreten. Für eine weitere Validierung der Expressionsdaten erfolgte die Auswertung eines Datasets von „The Cancer Genome Atlas“ (TCGA) mithilfe von cBioportal. Da die Hypoxie ein wichtiger Faktor für die Persistenz von TIZ ist, wurde die CAIX-Expression in Tumorsphären, ein in vitro Nachweis von TIZ-Aktivität, mittels der Durchflusszytometrie bestimmt und mit der CAIX-Expression von Monolayern verglichen. Als SK-Zelllinien wurden BCPAP (PSK), FTC 133 (FSK) und 8505 C (ASK) verwendet. Anschließend wurde mithilfe der Polymerasekettenreaktion und Immunofluoreszenzfärbung untersucht, ob eine CAIX-Expression in den Tumorsphären mit der Expression von bereits bekannten Stammzellmarkern, u.a. NANOG, assoziiert ist. Die Unterschiede der CAIX-Expression, nach Inkubation der Monolayer jeweils in Normoxie und Hypoxie, wurden mittels Durchflusszytometrie bestimmt. Mithilfe eines genetischen CAIX-Knockdowns sowie einer pharmakologischen Inhibition mit dem CAIX-Inhibitor Methazolamid (MZM) wurde die Tumorzellproliferation und -Sphärenbildung unter Normoxie und Hypoxie bestimmt. Zusätzlich wurde der Einfluss von MZM auf die Apoptose und den Zellzyklus untersucht.
Immunhistochemische Färbungen der Gewebeproben von SK-Patienten zeigten, dass die CAIX-Expression sowohl im PSK und FSK als auch im ASK im Vergleich zum tumorfreien Schilddrüsengewebe erhöht war. Des Weiteren zeigte die klinisch-pathologische Datenanalyse, dass eine erhöhte CAIX-Expression mit dem Auftreten von Lymphknotenmetastasen im differenzierten SK assoziiert war. Auch die Analyse des TCGA-Datasets bestätigte, dass eine erhöhte Expression der CAIX-mRNA mit einem fortgeschrittenen Tumorstadium, Fernmetastasen und mit einem kürzeren Gesamt-Überleben von SK-Patienten korrelierte. Die weiteren funktionellen in vitro Untersuchungen ergaben, dass die CAIX-Expression in den Tumorsphären im Vergleich zu Monolayern erhöht und mit einer erhöhten Expression von Stammzellmarkern assoziiert war. Ein genetischer CAIX-Knockdown und eine CAIX-Inhibition mit MZM führten über eine Induktion der Apoptose und eines Zellzyklusarrests zu einer verminderten Tumorzellproliferation und Sphärenbildung.
Zusammenfassend deuten die Ergebnisse darauf hin, dass CAIX ein vielversprechendes Zielmolekül für eine gezielte Tumortherapie des fortgeschrittenen SK ist. Um diese Hypothese bestätigen zu können, sind jedoch weitere prospektive Analysen von Patientenproben sowie funktionelle in vivo Untersuchungen am SK nötig.
Memory consolidation tends to be less robust in childhood than adulthood. However, little is known about the corresponding functional differences in the developing brain that may underlie age-related differences in retention of memories over time. This study examined system-level memory consolidation of object-scene associations after learning (immediate delay), one night of sleep (short delay), as well as two weeks (long delay) in 5-to-7-year-old children (n = 49) and in young adults (n = 39), as a reference group with mature consolidation systems. Particularly, we characterized how functional neural activation and reinstatement of neural patterns change over time, assessed by functional magnetic resonance imaging combined with representational similarity analysis (RSA). Our results showed that memory consolidation in children was less robust and strong (i.e., more forgetting) compared to young adults. Contrasting correctly retained remote versus recent memories across time delay, children showed less upregulation in posterior parahippocampal gyrus, lateral occipital cortex, and cerebellum than adults. In addition, both children and adults showed decrease in scene-specific neural reinstatement over time, indicating time-related decay of detailed differentiated memories. At the same time, we observed more generic gist-like neural reinstatement in medial-temporal and prefrontal brain regions uniquely in children, indicating qualitative difference in memory trace in children. Taken together, 5-to-7-year-old children, compared to young adults, show less robust memory consolidation, possibly due to difficulties in engaging in differentiated neural reinstatement in neocortical mnemonic regions during retrieval of remote memories, coupled with relying more on gist-like generic neural reinstatement.
The hepatitis B virus is one of the most common causes of virus-related chronic liver disease and remains a major global health problem affecting 296 million people worldwide. Despite an available and highly effective vaccination, hepatitis B infections lead to an annual mortality rate of approximately 0.8 million people. The global prevalence is heterogeneously distributed and reflects a high infections and chronicity, particularly in low-income countries, due to a lack of vaccination strategies, underdiagnosis and low treatment rates. A complete cure remains undiscovered to this day. Based on their genetic makeup, the virus is categorized into nine genotypes with a genetic difference of more than 8% within the sequence. In addition to their geographical distribution, hepatitis B virus genotypes also differ in terms of their clinical outcome, pathogenesis and treatment response.
The viral protein HBx is known to interact with several cellular signaling pathways and is thereby accounted as the driving force in the development of hepatitis B virus-associated pathogenesis and progression of hepatocellular carcinoma. In particular, HBx interacts with mitochondria and induces profound alterations in the mitochondrial morphology and function with a severe impact on the liver’s physiology and with an emerging role in liver-related disease progression.
This study aims to investigate the genotype-related impact of HBx with regard to their interaction with cellular signaling pathways. A particular focus was placed on mitochondria-dependent interactions and signaling pathways in order to broaden the understanding of the genetic diversity of the genotypes.
Differences between genotypes of HBx were examined and compared through in vitro experiments based on a cell culture-based system. Plasmid DNA encoding the HBx protein of the different genotypes was transiently transfected into Huh7 or HepG2 cells and examined for molecular and protein-biochemical effects on the host cell, usually 72 hours after transfection. This study focused on the most common genotypes A, B, C, D, E and G worldwide.
Based on initial kinome profiling analyses, it was found that HBx differs greatly within their genetic variants and suggests different effects on overall cell function and in particular on mitochondrial kinases. Furthermore, confocal laser scanning microscopy reveals profound HBx-mediated changes in the mitochondrial network structure, however with major differences among the different genotypes. In particular, HBx of genotypes A and G causes enormous fragmentation of mitochondrial structures, accompanied by emergent changes in mitochondrial function. Due to an increased interaction with the voltage-dependent anion channel 3, a significant loss of mitochondrial membrane potential was also observed, together with an increased radial oxygen stress level and an induction of central mitochondria-dependent inflammatory mediators. In contrast, the contribution of HBx-genotype B and E reveals only moderate effects in these regards. Using a pH-sensitive reporter system, HBx genotypes which previously indicated a strong distribution in the mitochondrial morphology and function, also showed an elevated mitophagy through the PINK1/Parkin-mediated pathway. This study provides direct evidence that HBx-mediated changes in host cell signaling pathways, especially in mitochondrial-associated pathways, fundamentally dependent on the different genotypes. In addition, the results also indicate an important role of HBx in the process of genotype-dependent liver pathogenesis and provide insight into the underlying cellular mechanisms and signaling pathways.
Microstates sind kurzzeitig andauernde, wiederkehrende elektrische Potentialfelder über dem Kortex. Ein Großteil der Signalvarianz des
Elektroenzephalogramms (EEG) wird durch vier repräsentative räumliche Potentialverteilungen (Topographien) abgedeckt, welche bereits im Wachzustand und im Schlaf identifiziert wurden und kanonisch als Karten A-D bezeichnet werden. Microstates wurden in den vergangenen Jahren vor allem im Ruhe-Wach-EEG untersucht, über andere Vigilanzzustände hingegen wissen wir bisher wenig. Klassischerweise analysieren wir verschiedene Vigilanzzustände im Elektroenzephalogramm anhand von Frequenzen und Graphoelementen, die Microstate-Analyse hingegen betrachtet in erster Linie die räumliche Verteilung des kortikalen Potentials zu einem jeweiligen Zeitpunkt.
Die vorliegende Studie hatte zum Ziel, die zeitliche Abfolge von Microstates im Wachzustand und im Schlaf zu charakterisieren. Mittels informationstheoretischer Ansätze können die dynamischen Eigenschaften der Microstate-Sequenz direkt mit den frequenzbasierten Eigenschaften des zugrundeliegenden EEG verglichen werden. Es wurden die Ruhe-Wach- und Schlafdaten von 32 gesunden Probanden analysiert. Hierbei fand sich eine Zunahme der mittleren Microstate-Dauer und der Relaxationszeit der Übergangsmatrix, was langsamere Dynamiken im Schlaf anzeigt. Erstaunlicherweise konnte im Tiefschlaf mehr als die Hälfte der Sequenzen nicht von einem simplen Markov-Modell unterschieden werden, was für eine Abnahme der Komplexität der Microstate-Sequenzen spricht. Die Entropierate der untersuchten Sequenzen nahm mit zunehmender Schlaftiefe ab, was weniger
Zufall bzw. eine größere Vorhersagbarkeit innerhalb der Sequenzen bedeutet.
Darüberhinaus konnte gezeigt werden, dass Microstates immer dann periodisch auftreten, wenn das zugrundeliegende EEG eine dominante Grundfrequenz aufweist, sodass oszillatorische Hirnaktivität auch auf der Microstate-Ebene verfolgbar ist. Hierdurch ist es möglich, physiologische Vigilanzzustände quantitativ voneinander zu unterscheiden.
Interpretiert man Microstates als Korrelate neuronaler Netzwerke, scheinen im Schlaf dieselben oder ähnliche Netzwerke aktiviert zu werden wie im Wachzustand, allerdings mit zunehmender Schlaftiefe langsamer und auf eine weniger komplexe Art und Weise.
Molecular concepts for pandemic viruses : membrane fusion assays and targeting of reservoir cells
(2024)
In den letzten Jahren haben verschiedene pandemische Viren zu beträchtlichen Krankheits- und Todesfällen geführt. Um dieser ständigen Bedrohung entgegenzuwirken, ist es wichtig diagnostische Testsysteme und Therapien anzupassen oder neu zu etablieren. Diese Arbeit konzentriert sich auf die pandemischen Viren SARS-CoV-2 und HIV.
Der Zelleintritt von SARS-CoV-2 wird durch das Spike-Protein (S) ausgelöst, welches die Fusion der Virushülle mit der zellulären Membran bewirkt. Erste Studien haben gezeigt, dass das S-Protein eine hohe Fusionsaktivität aufweist. Aus diesem Grund sollten in dieser Arbeit neue Fusionstests etabliert werden, um potenzielle Inhibitoren der Zellfusion zu evaluieren. Im ersten Teil dieser Thesis wird die Etablierung von quantitativen Tests zur Evaluierung der Zell-Zell und Partikel-Zell Fusionsaktivität, welche durch S bewirkt wird, demonstriert.
Trotz jahrelanger Forschung können HIV-Patienten nicht geheilt werden und Virusinfektionen treten weiterhin weltweit auf. Das größte Problem bei der Entwicklung eines Heilmittels ist die frühe Bildung von Reservoirzellen während einer Infektion. Um diese Reservoirzellen zu identifizieren, wurde der Oberflächenmarker CD32a vorgeschlagen. Die Nutzung von Cas9-Nukleasen zur Inaktivierung von HIV ist in vitro erfolgreich, aber der effiziente Transfer in Reservoirzellen bleibt weiterhin herausfordernd. Im zweiten Teil dieser Thesis werden Rezeptor-gerichtete Adeno-assoziierte Vektoren (AAVs) für die HIV-Gentherapie präsentiert, die CD4 und CD32a für den Zelleintritt nutzen.
Zur Charakterisierung der Fusionsaktivität von SARS-CoV-2 wurden drei quantitative Fusionstests etabliert, welche Partikel- und Zell-Zell Fusionen berücksichtigen. Für den Partikel-Zell Fusionstest wurden lentivirale Vektoren (LV) verwendet, welche das S-Protein auf ihrer Oberfläche präsentierten. Die Transduktionseffizienz von S-LV erreichte auf Zellen, die den SARS-CoV-2 Rezeptor ACE2 exprimieren, ein Signal-zu-Hintergrund Verhältnis von über 2000. Durch die Präsentation von S auf leeren LV-Partikeln konnte die Fusion von benachbarten Zellen detektiert und quantifiziert werden („fusion-from-without“ (FFWO)). Für die Quantifizierung wurde ein Reporter-Komplementationstest etabliert. Hierbei wurden die Alpha- und Omega-Fragmente der β-Galaktosidase getrennt in zwei Zielzellpopulationen exprimiert, die beide ACE2 exprimierten. Durch die Zugabe von S-Partikeln kam es zur Fusion der Zielzellen und zur Komplementation der Alpha- und Omega-Fragmente. Die resultierende β-Galaktosidase-Aktivität konnte anschließend quantifiziert werden. Unter optimalen Versuchsbedingungen erreichte dieser Assay ein Signal-zu-Hintergrund Verhältnis von 2,7 Größenordnungen. Anschließend wurde der Komplementationstest für die Messung der Zell-Zell Fusion verwendet. In diesem Test exprimierten Effektorzellen S und das Alpha-Fragment, Zielzellen ACE2 und das Omega-Fragment. Obwohl die S-Expression auf den Effektorzellen sehr gering war, konnte dennoch eine signifikante Fusion nachgewiesen werden. Auch hier konnte unter optimalen Versuchsbedingungen ein hohes Signal-zu-Hintergrund Verhältnis von 2,9 Größenordnungen festgestellt werden. Nach der Etablierung der Testsysteme wurden S-spezifische Inhibitoren verwendet. Im Gegensatz zu Partikel-Zell-Fusionen wurde die Fusionsaktivität von S auf Zellen nur mäßig inhibiert. Dies deutet daraufhin, dass das Eindringen von Partikeln in Zellen wirksamer verhindert werden kann als die Ausbreitung durch Zell-Zell Fusionen.
Um AAVs spezifisch an HIV-Reservoirzellen zu binden, wurden CD4- und CD32a-spezifische DARPins („designed ankyrin repeat proteins“) in Rezeptor-verblindete AAVs eingebaut. Ebenso wurden beide DARPins gleichzeitig auf dem Kapsid präsentiert, um eine höhere Spezifität für doppelt-positive Zellen zu erreichen. Wenn diese Partikel einer Zellmischung aus CD4-, CD32a- und CD4/CD32a-exprimierenden Zellen zugesetzt wurden, transduzierten die bispezifischen Vektoren vorzugsweise doppelt-positive Zellen. Diese Präferenz war am höchsten in Zellkulturen, die stark unterrepräsentierte CD4/CD32a-exprimierende Zellen enthielten. Unter diesen Voraussetzungen erreichten bispezifische Vektoren eine bis zu 66-fach höhere Transduktionseffizienz auf CD4/CD32a-positive Zellen im Vergleich zu CD32a-exprimierenden Zellen. Darüber hinaus zeigten bispezifische AAV eine präferentielle Bindung und Transduktion von isolierten Primärzellen und Zellen in Vollblut. Selbst nach systemischer Injektion in humanisierte Mäuse wurden doppelt-positive Zellen effizienter von bispezifischen als von monospezifischen AAVs transduziert. Schließlich zeigten die generierten Vektoren, welche die Cas9 Nuklease transferierten, eine effiziente Inhibition der HIV-Replikation.
Die E3-Ubiquitinligase TRIM25 ist in verschiedenen humanen Tumoren verstärkt exprimiert, was häufig mit einer schlechten Prognose der betroffenen Patienten sowie dem Auftreten von Therapieresistenzen korreliert. Unsere Arbeitsgruppe konnte TRIM25 zuvor als Caspase-2 und -7 mRNA-bindendes Protein und negativen Regulator beider Caspasen in humanen Kolonkarzinomzellen identifizieren. Ein transienter TRIM25 Knockdown führt in Abhängigkeit der erhöhten Expression der jeweiligen Caspasen zur Sensitivierung der Kolonkarzinomzellen gegenüber Chemotherapeutika-induzierter Apoptose. Ein Ziel dieser Arbeit war, die Übertragbarkeit dieser Erkenntnisse auf einen loss-of-function-Ansatz mit stabilen TRIM25 Knockdown Zellen zu überprüfen. Die stabilen Knockdown Zellen sollten der späteren Etablierung eines Xenograftmodells dienen. Da zahlreiche TRIM Proteine bekannterweise eine vielseitige Rolle bei der Regulation sowohl onkogener als auch tumorsuppressiver Prozesse einnehmen, wurde als weitere maßgebliche Fragestellung dieser Arbeit der Einfluss von TRIM25 auf wichtige tumorigene Eigenschaften wie Proliferation, Migration, Zellzyklus und Inflammation untersucht. TRIM25-abhängige Effekte auf das Migrationsver halten von RKO-Zellen wurden im in vitro-Wundheilungsassay mit stabilen TRIM25 Knock down Zellen analysiert. Aufgrund hoher interexperimenteller Unterschiede im Migrations verhalten derselben Zellklone konnte hinsichtlich einer TRIM25-abhängigen Regulation der Migration jedoch keine eindeutige Aussage getroffen werden. Dagegen belegten die gezeigten Proliferationsassays eine signifikant vermehrte Proliferation von RKO-Zellen nach stabilem TRIM25 Knockdown. Dies legt eine tumorsuppressive Rolle von TRIM25 nahe. Durch flusszytometrische Analysen stabiler TRIM25 Knockdown und Kontrollzellen zeigten hinge gen keinen konsistenten Einfluss von TRIM25 auf den Zellzyklus von RKO-Zellen. Eine Sensitivierung von Kolonkarzinomzellen gegenüber Chemotherapeutika-induzierter Apoptose konnte auch in stabilen TRIM25 Knockdown Zellen nachgewiesen werden, während die für transiente Ansätze bekannte, TRIM25 Knockdown-abhängige Hochregulation von Caspase 2 und -7 dagegen deutlich geringer ausgeprägt war. Dies lässt vermuten, dass die Tumorzellen einer Hochregulation Zelltod-induzierender Proteine bei einem konstitutiven TRIM25Knockdown gegenregulieren. Aufgrund der aber nach wie vor nachweisbaren Sensitivierung der TRIM25 Knockdown Zellen gegenüber Apoptose, können zusätzliche, bisher noch nicht bekannte Mechanismen postuliert werden, welche zur Sensitivierung dieser Zellen gegenüber Apoptose beitragen. Die daraus abgeleitete, TRIM25-abhängige Apoptosehemmung spricht für einen „Überlebensmechanismus“, welcher maßgeblich zur Chemotherapieresis tenz von Kolonkarzinomzellen beitragen kann. Hinsichtlich eines Einflusses von TRIM25 auf entzündliche Prozesse wurden RKO-Zellen mit klassischen Aktivatoren des NLRP3-Inflammasoms stimuliert und ausgewählte Marker mittels Western Blot-Analysen nachgewiesen. TRIM25 Knockdown-abhängig war eine verminderte Spaltung der Apoptosemarker Caspase-3, -7 und PARP-1 nachweisbar. Caspase-7 und PARP-1 spielen bekanntermaßen auch im Rahmen Inflammasom-induzierter Signalprozesse eine wichtige Rolle, während die Spaltung von Caspase-3 durch das NLRP3-Inflammasom induziert werden kann und v.a. für apoptotische oder pyroptotische Prozesse verantwortlich gemacht wird. Daher kann postuliert werden, dass der stabile TRIM25 Knockdown zur Hemmung von Inflammasom-induzierten Signalprozessen führt und darüber Kolonkarzinomzellen vor Apoptose/Pyroptose geschützt werden. Umgekehrt deutet dies auf eine Aktivierung von Inflammasom-vermittelten Signalprozessen durch TRIM25 hin.
Aufgrund der hohen Inzidenz und Mortalität, der schlechten Prognose und der Entwicklung von Therapieresistenzen besteht ein dringender Bedarf in der Entwicklung neuer, verbesserter Therapien des kolorektalen Karzinoms sowie der Resensibilisierung der Krebszellen gegenüber gängigen, bereits bestehenden Therapieoptionen. Im Rahmen dieser Arbeit konnte ein onkogener Einfluss von TRIM25 auf Kolonkarzinomzellen durch Hemmung Chemotherapeutika-induzierter Apoptose nachgewiesen werden, während eine mögliche tumorigene Rolle von TRIM25 durch zusätzliche Aktivierung Inflammasom-induzierter Signalprozesse weiterer Untersuchungen bedarf. Zusammenfassend kann TRIM25 als vielversprechender therapeutischer Angriffspunkt für die Entwicklung von sowohl neuen antientzündlichen als auch tumorsuppressiven Therapien betrachtet werden.
Magnetoencephalography (MEG) and Electroencephalography (EEG) provide direct electrophysiological measures at an excellent temporal resolution, but the spatial resolution of source-reconstructed current activity is limited to several millimetres. Here we show, using simulations of MEG signals and Bayesian model comparison, that non-invasive myelin estimates from high-resolution quantitative magnetic resonance imaging (MRI) can enhance MEG/EEG source reconstruction. Our approach assumes that MEG/EEG signals primarily arise from the synchronised activity of pyramidal cells, and since most of the myelin in the cortical sheet originates from these cells, myelin density can predict the strength of cortical sources measured by MEG/EEG. Leveraging recent advances in quantitative MRI, we exploit this structure-function relationship and scale the leadfields of the forward model according to the local myelin density estimates from in vivo quantitative MRI to inform MEG/EEG source reconstruction. Using Bayesian model comparison and dipole localisation errors (DLEs), we demonstrate that adapting local forward fields to reflect increased local myelination at the site of a simulated source explains the simulated data better than models without such leadfield scaling. Our model comparison framework proves sensitive to myelin changes in simulations with exact coregistration and moderate-to-high sensor-level signal-to-noise ratios (≥10 dB) for the multiple sparse priors (MSP) and empirical Bayesian beamformer (EBB) approaches. Furthermore, we sought to infer the microstructure giving rise to specific functional activation patterns by comparing the myelin-informed model which was used to generate the activation with a set of test forward models incorporating different myelination patterns. We found that the direction of myelin changes, however not their magnitude, can be inferred by Bayesian model comparison. Finally, we apply myelin-informed forward models to MEG data from a visuo-motor experiment. We demonstrate improved source reconstruction accuracy using myelin estimates from a quantitative longitudinal relaxation (R1) map and discuss the limitations of our approach.
Highlights
We use quantitative MRI to implement myelin-informed forward models for M/EEG
Local myelin density was modelled by adapting the local leadfields
Myelin-informed forward models can improve source reconstruction accuracy
We can infer the directionality of myelination patterns, but not their strength
We apply our approach to MEG data from a visuo-motor experiment
Mnemonic but not contextual feedback signals defy dedifferentiation in the aging early visual cortex
(2024)
Perception is an intricate interplay between feedforward visual input and internally generated feedback signals that comprise concurrent contextual and time-distant mnemonic (episodic and semantic) information. Yet, an unresolved question is how the composition of feedback signals changes across the lifespan and to what extent feedback signals undergo age-related dedifferentiation, that is, a decline in neural specificity. Previous research on this topic has focused on feedforward perceptual representation and episodic memory reinstatement, suggesting reduced fidelity of neural representations at the item and category levels. In this fMRI study, we combined an occlusion paradigm that filters feedforward input to the visual cortex and multivariate analysis techniques to investigate the information content in cortical feedback, focusing on age-related differences in its composition. We further asked to what extent differentiation in feedback signals (in the occluded region) is correlated to differentiation in feedforward signals. Comparing younger (18–30 years) and older female and male adults (65–75 years), we found that contextual but not mnemonic feedback was prone to age-related dedifferentiation. Semantic feedback signals were even better differentiated in older adults, highlighting the growing importance of generalized knowledge across ages. We also found that differentiation in feedforward signals was correlated with differentiation in episodic but not semantic feedback signals. Our results provide evidence for age-related adjustments in the composition of feedback signals and underscore the importance of examining dedifferentiation in aging for both feedforward and feedback processing.
Childhood is a period when memory consolidation and knowledge base undergo rapid changes. The present study examined short-delay (overnight) and long-delay (after a 2-week period) consolidation of new information either congruent or incongruent with prior knowledge in typically developing 6- to 8-year-old children (n = 32), 9- to 11-year-old children (n = 33), and 18- to 30-year-old young adults (YA; n = 39). Both memory accessibility (cued recall of objects) and precision (precision of object placement) of initially well-learned object–scene pairs were measured. Our results showed that overnight, memory accessibility declined similarly in all age groups; memory precision improved more in younger children (YC) compared to older children (OC) and even declined in YA. After a 2-week period, both memory accessibility and precision became worse. Specifically, while age groups showed similar decline in memory accessibility, precision decline was less in YC than in OC and YA. The accessibility and precision of congruent and incongruent information changed similarly with consolidation in all age groups. Taken together, our results showed that, for initially well-learned information, YC have robust memory consolidation, despite their overall lower mnemonic performance compared to OC and YA, which is potentially crucial for stable and precise knowledge accumulation early on in development.
Inflammation is a regulated reaction of the body to control a threat such as infection or injury. An efficient resolution of inflammation is critical to prevent the development of chronic inflammation and to restore tissue homeostasis. Macrophages (Mf) play a crucial role in the onset, but also in the resolution of inflammation, because they phagocytose and eliminate pathogens and tissue debris. Efficient efferocytosis, i.e. the engulfment of apoptotic cells, represents an important trigger for the onset of the resolution response and contributes to the pro-resolving reprogramming of Mf. Despite the importance of post- transcriptional modes of regulation during the resolution phase and translational control as a key node modulating gene expression in immune cells, relevant translational alterations remain largely elusive.
In the present study, I aimed to identify translationally regulated targets in inflammatory primary murine Mf upon resolution-promoting efferocytosis. To this end, I used total RNA-sequencing as well as de novo proteomics analyses to determine global transcriptional and translational changes. Sequencing data confirmed that efferocytosis induced a pro-resolution signature in inflammatory Mf and pointed towards translational regulation because the related integrated stress response was enriched upon efferocytosis. While changes of gene expression between efferocytic and non-efferocytic Mf appeared rather small at the transcriptional level, I observed considerable differences at the level of de novo synthesized proteins. This finding suggests a regulation at the level of translation. Furthermore, the tight connection between translational and metabolic changes was confirmed by enriched metabolism-associated terms of targets upregulated by efferocytosis at both RNA and de novo protein level. Interestingly, analysis of translationally regulated targets in response to inflammatory stimulation showed reduced translation for most targets, with only little impact of efferocytosis. Among those targets, I identified pro-resolving matrix metallopeptidase 12 (Mmp12) as a novel candidate, which showed translational repression during early inflammation and translational increase during the resolution phase. Noteworthy, a first indicator for a potential translation regulatory component of Mmp12 were the extremely high mRNA levels and not overly high de novo protein levels. Validation experiments recapitulated a slight elevation of Mmp12 mRNA expression and a significant downregulation of MMP12 intracellular protein levels in inflammatory Mf, as observed in the RNA-seq and de novo proteomics datasets. To investigate whether the discrepancy in mRNA and protein expression were due to changes in translation, I applied polysomal fractionation analysis to determine the translational status of Mmp12. Inflammatory Mf displayed a significantly lower relative Mmp12 mRNA abundance in the late polysomes compared to naïve Mf, suggesting reduced translational efficiency upon inflammatory stimulation. Consequently, extracellular MMP12 levels in the supernatant of inflammatory Mf decreased, although with a slight delay.
The functional impact of attenuated Mmp12 translation upon inflammatory stimulation was assessed in migration assays. While siRNA-mediated knockdown of Mmp12 did not alter Mf migration on uncoated plates, it increased migration 3-fold on matrigel/elastin-coated plates. Importantly, the increase in migrated distance driven by siMmp12 could be lowered by the addition of exogenous recombinant MMP12 protein. In line with reduced Mmp12 translation and MMP12 protein in inflammatory Mf, I observed a significant increase in cell migration on matrigel/elastin-coated plates, while it remained unaltered on uncoated plates. Consequently, Mf elastase MMP12 degrades elastin, thereby cell migration along elastin fibers is diminished. In inflammatory Mf, Mmp12 is translationally downregulated, thereby enhancing the migratory capacity.
In summary, the present study identifies a substantial contribution of translational regulation in the course of inflammation shown by high changes between inflammatory naïve and efferocytic Mf at the de novo proteomic level. Specifically, I was able to determine the translational regulation of pro-resolving Mmp12, which is repressed during early inflammation and recovers during the resolution phase. Functionally, translational control of MMP12 emerged as a strategy to alter the migratory properties of Mf, enabling enhanced, matrix- dependent migration of Mf during the early inflammatory phase, while restricting migration during the resolution phase.
Background: A good physician should be empathic and altruistic, among other qualities. Therefore, the levels of socially undesirable personality traits (Dark Triad) as well as implicit motives of achievement, affiliation and power (Multi-Motive Grid) among medical students as future physicians were analyzed at two different points in their medical training.
Methods: This study includes 380 medical students in their first year and 217 in their third year in Germany. All participants completed the Dirty Dozen (DD) and Multi-Motive Grid (MMG) questionnaires at the end of two different classes as paper-and-pencil tests. Relevant differences of the Dark Triad traits between the medical students and reference sample and the two different cohorts, as well as their implicit motives, the associations of Dark Triad traits and MMG components and gender differences of the Dark Triad traits were calculated.
Results: There were no significant group differences between year one and year three medical students in narcissism, psychopathy and Machiavellianism (Dark Triad). There were no significant differences between the medical students and reference sample except in psychopathy. Male students scored significantly higher in the Dark Triad traits than female students. In the MMG, first-year students scored significantly higher levels in Fear of Rejection, and lower levels in Hope of Success and Hope of Power than the third-year students. Some associations were found between narcissism and Machiavelliansim with Hope of Success, Hope of Power and Fear of power.
Conclusions: Dark Triad traits already appear to exist before the commencement of medical studies. These traits do not differ significantly between the medical students and reference sample; only a few MMG components seem to differ at different stages of their studies. This lack of differences between the medical students and validation cohort indicates that tests based on (undesirable) personality traits are not suitable criteria for the admission selection of medical students.
Human feline leukaemia virus subgroup C receptor-related proteins 1 and 2 (FLVCR1 and FLVCR2) are members of the major facilitator superfamily1. Their dysfunction is linked to several clinical disorders, including PCARP, HSAN and Fowler syndrome2,3,4,5,6,7. Earlier studies concluded that FLVCR1 may function as a haem exporter8,9,10,11,12, whereas FLVCR2 was suggested to act as a haem importer13, yet conclusive biochemical and detailed molecular evidence remained elusive for the function of both transporters14,15,16. Here, we show that FLVCR1 and FLVCR2 facilitate the transport of choline and ethanolamine across the plasma membrane, using a concentration-driven substrate translocation process. Through structural and computational analyses, we have identified distinct conformational states of FLVCRs and unravelled the coordination chemistry underlying their substrate interactions. Fully conserved tryptophan and tyrosine residues form the binding pocket of both transporters and confer selectivity for choline and ethanolamine through cation–π interactions. Our findings clarify the mechanisms of choline and ethanolamine transport by FLVCR1 and FLVCR2, enhance our comprehension of disease-associated mutations that interfere with these vital processes and shed light on the conformational dynamics of these major facilitator superfamily proteins during the transport cycle.
Die vorliegende Arbeit behandelt den Vergleich zweier Geräte - „Endotrust MiFusion TLS 2“ und „Medtronic LigaSure Maryland System“ - zur endoskopischen Entnahme der Arteria radialis (RA) zur Verwendung als Bypass-Gefäß in der Herzchirurgie.
Grundsätzlich kommen in der Bypass-Chirurgie zur Herstellung eines Free-Grafts am Herzen neben der Verwendung der Thoraxarterien die Vena Saphena Magna (VSM) sowie die RA in Frage. In den aktuellen europäischen Leitlinien zur Behandlung von hochgradigen Stenosen wird die Verwendung der RA empfohlen („Class 1 Level B“-Empfehlung).
Die Frage, ob die RA für den Einsatz als Bypass-Gefäß offen oder endoskopisch entnommen werden sollte, ist in der Literatur weiterhin umstritten. In den aktuellen Leitlinien zur Behandlung von koronaren Herzkrankheiten wird aufgrund dieser insoweit uneindeutigen Studienlage keine Empfehlung ausgesprochen. Trotzdem ist die endoskopische Entnahme der RA im klinischen Alltag mittlerweile etabliert. Im Kontext dieser uneindeutigen Studienlage einerseits und der praktischen Bedeutung endoskopischer Entnahme andererseits ist es Zielsetzung der vorliegenden Arbeit, durch einen Gerätevergleich einen Beitrag zur Optimierung der endoskopischen Operationstechnik zu leisten. Es soll zudem aufgezeigt werden, inwieweit die endoskopische Entnahme der RA ein sicheres und effizientes Verfahren darstellt.
In der Literatur zum Vergleich von Operationstechniken zur Entnahme von Bypass-Gefäßen werden häufig histologische Untersuchungen angewendet. Diese ermöglichen eine zeitnahe Beurteilung der Qualität des entnommenen Grafts. Das ist auch in dieser Arbeit der wesentliche Grund dafür, dass die histologische Beurteilung der Qualität der RA als primärer Endpunkt angewendet wird. In Anlehnung an die Literatur wurde die strukturelle Integrität des Endothels und der Elastica interna beurteilt. Die histologische Beurteilung erfolgte nach Immunfluoreszenz-Bearbeitung der Proben.
Im Einklang mit der bestehenden Literatur zur Frage, ob die RA offen oder endoskopisch entnommen werden sollte, wurde in dieser Studie als sekundäre Endpunkte Kriterien bezüglich der Sicherheit und Effizienz der Entnahme verwendet. Dies betrifft das Auftreten von intra- und postoperativen Komplikationen, insbesondere im Hinblick auf neurologische Beeinträchtigungen am operierten Arm, sowie die Entnahmedauer und den operativen Aufwand zur Blutstillung.
Die in dieser Arbeit behandelte Studie wurde als prospektive, 1:1 randomisierte Studie mit zwei Gruppen mit jeweils 50 Patienten durchgeführt. Alle Operationen erfolgten im Zeitraum Januar 2017 bis Juli 2017 im Herzzentrum der Kerckhoff-Klinik Bad Nauheim.
Bezüglich der Resultate des Gerätevergleichs zeigte sich ein eindeutiges Ergebnis. Sämtliche Beurteilungskriterien, bei denen signifikante Unterschiede zwischen den beiden Gruppen aufgetreten sind, u.a. Integrität der Elastica interna, Entnahmedauer, Vorkommen von Residualblutungen, Auftreten von sensorischen Störungen fallen zugunsten des LigaSure-Systems aus.
Dabei ist unserer Meinung nach der wichtigste Einzelaspekt, dass die histologisch ermittelte Integrität der Elastica interna als Indikator für die Qualität des entnommen Grafts in der LigaSure-Gruppe signifikant besser war als in der MiFusion-Gruppe. Dagegen konnten aus der histologischen Untersuchung des Endothels keine klaren Rückschlüsse gezogen werden. Insofern besteht Unsicherheit, ob die Schädigung der Endothelschicht durch die Entnahme selbst oder durch die anschließende Präparierung der entnommenen Proben verursacht wurde.
Bezüglich der sekundären Endpunkte zeigten sich für die Mifusion-Patientengruppe im Vergleich zu anderen Studien zur endoskopischen Entnahme der RA zufriedenstellende bis gute und für die LigaSure Gruppe gute bis sehr gute Ergebnisse. Unabhängig vom verwendeten Gerät kann diese Studie deshalb als eine Bestätigung bisheriger Studien zur Vorteilhaftigkeit der endoskopischen RA-Entnahme angesehen werden. Letztlich fehlt jedoch weiterhin der Nachweis, dass eine endoskopische Entnahme unbedenklich im Hinblick auf den langfristigen kardiologischen Outcome ist. Dies bleibt zukünftiger Forschung vorbehalten.
Darüber hinaus trägt die Studie dazu bei, das klinische Erfahrungswissen über operationstechnische Details bei der Entnahme der Radialarterie zu erweitern und somit die Akzeptanz für die Verwendung der Radialarterie als Bypass-Gefäß in der koronaren Herzchirurgie zu verbessern.
Highlights
• It is important to distinguish acute provoked seizures due to autoimmune encephalitis from chronic unprovoked seizures due to autoimmune-associated epilepsy.
• Currently it is hardly possible in an individual AIE/ALE/RE patient to separate acute provoked seizures from chronic unprovoked seizures due to limitations in determining seizure outcomes, unclear time courses, potential causal interactions between both seizure origins, compartmentalized immune-inflammation, and a lack of licensed drugs to reliably resolve immune-inflammation in the brain parenchyma.
• This makes it hard to decide when to terminate ASMs and to counsel the individual patient regarding driving abilities and other behavioral restrictions and recommendations.
• Studies are urgently needed to define clinical and paraclinical biomarkers in a hypothesis-free, data-driven approach reliably predicting (or not) the development of AAE and the cognitive and behavioral outcome in the due course of an individual patient´s disease.
• These studies should be experimentally validated in suitable animal models.
Abstract
The current International League Against Epilepsy (ILAE) definition and classification guidelines for the first time introduced the category of immune-mediated focal epilepsy in addition to structural, genetic, infectious, and metabolic aetiologies. Moreover, the ILAE Autoimmunity and Inflammation Taskforce recently provided a conceptual framework for the distinction between acute “provoked” seizures in the acute phase of autoimmune encephalitis from chronic “unprovoked” seizures due to autoimmune-associated epilepsy. The first category predominately applies to those autoimmune encephalitis patients with autoantibodies against cell surface neural antigens, in whom autoantibodies are assumed to exert a direct ictogenic effect without overt structural damage. These patients do not exhibit enduring predisposition to seizures after the “acute phase” encephalitis, and thus do not fulfil the definition of epilepsy. The second category applies to those autoimmune encephalitis patients with autoantibodies against intracellular neural antigens and Rasmussen's encephalitis, in whom T cells are assumed to cause epileptogenic effects through immune-inflammation and overt structural damage. These patients do exhibit enduring predisposition to seizures after the “acute phase” of encephalitis and thus fulfil the definition of epilepsy. AAE may result from both, ongoing brain autoimmunity and associated structural brain damage according to the current ILAE definition and classification guideline. We here discuss the shortcomings and defaults of this concept and suggest an unbiased translationally validated and data-driven approach to predict in an individual encephalitis patient the propensity to develop (or not) AAE and the cognitive and behavioural outcome.
Hintergrund: Mit der im Jahr 2020 aktualisierten AWMF-Leitlinie zur Versorgung mit einem Cochleaimplantat (CI) wurde erstmals der gesamte Prozess einer CI-Versorgung definiert. In der vorliegenden Studie wurden die Machbarkeit und die Ergebnisse einer sehr frühen Rehabilitationsmaßnahme (Reha) untersucht.
Methodik: Es wurden 54 Patienten in die Interventionsgruppe (IG) eingeschlossen, bei der die Reha innerhalb von 14 (maximal 28) Tagen nach der Implantation eingeleitet wurde. In eine Kontrollgruppe (KG, n = 21) wurden Patienten mit deutlich längerer Wartezeit eingeschlossen. Neben dem Beginn und der Dauer der Reha wurde das mit CI erreichte Sprachverstehen zu verschiedenen Zeitpunkten innerhalb von 12 Monaten erfasst. Zusätzlich wurde mit Fragebögen der Aufwand der Anpassung des CI-Prozessors und die Zufriedenheit der Patienten mit dem Ergebnis sowie dem Zeitpunkt des Beginns der Reha ermittelt.
Ergebnisse: Die Wartezeit zwischen Implantation und Beginn der Reha lag in der IG bei 14 Tagen und in der KG bei 106 Tagen (Mediane). Es konnten 92,6 % der Patienten der IG die Reha innerhalb von 14 Tagen antreten. Der Effekt der Reha lag in der IG bei 35 und in der KG bei 25 Prozentpunkten (Freiburger Einsilbertest). Nach 6 und 12 Monaten (M) CI-Nutzung zeigten beide Gruppen sowohl in der Testbedingung in Ruhe (IG/KG 6M: 70 %/70 %; 12M: 70 %/60 %, Freiburger Einsilbertest) als auch im Störgeräusch (IG/KG 6M: −1,1 dB SNR/–0,85 dB SNR; 12M: −0,65 dB SNR/+0,3 dB SNR, Oldenburger Satztest) vergleichbare Ergebnisse. Die mittels des Fragebogens Speech, Spatial and Qualities of Hearing Scale (SSQ) erfassten Ergebnisse für die Einschätzung der Hörqualität zeigten nach 6 Monaten eine bessere Bewertung in der IG, die sich nach 12 Monaten an die Ergebnisse der KG anglich. Die IG war mit dem Zeitpunkt des Beginns der Reha deutlich zufriedener als die KG. Alle anderen aus Fragebögen ermittelten Daten zeigten keine Unterschiede zwischen den beiden Gruppen.
Schlussfolgerung: Der sehr frühe Beginn einer stationären Reha nach Cochleaimplantation ist erfolgreich umsetzbar. Die Reha konnte innerhalb von 7 Wochen nach der Implantation abgeschlossen werden. Der Vergleich der Ergebnisse der Tests des Sprachverstehens vor und nach der Reha zeigte eine deutliche Steigerung. Somit ist ein deutlicher Reha-Effekt nachweisbar. Die Aufnahme der CI-Rehabilitation in den Katalog der Anschlussheilbehandlungen ist somit wissenschaftlich begründet und damit dringend zu empfehlen.
Neurodevelopmental psychiatric disorders (NPDs) like attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and schizophrenia, affect millions of people worldwide. Despite recent progress in NPD research, much remains to be discovered about their underpinnings, therapeutic targets, effects of biological sex and age. Risk factors influencing brain development and signalling include prenatal inflammation and genetic variation. This dissertation aimed to build upon these findings by combining behavioural, molecular, and neuromorphological investigations in mouse models of such risk factors, i.e. maternal immune activation (MIA), neuron-specific overexpression (OE) of the cytoplasmatic isoforms of the RNA-binding protein RBFOX1, and neuronal deletion of the small Ras GTPase DIRAS2.
Maternal infections during pregnancy pose an increased risk for NPDs in the offspring. While viral-like MIA has been previously established elsewhere, this study was the first in our institution to implement the model. I validated NPD-relevant deficits in anxiety- and depression-like behaviours, as well as dose- and sex-specific social deficits in mouse offspring following MIA in early gestation. Proteomic analyses in embryonic and adult hippocampal (HPC) synaptoneurosomes highlighted novel and known targets affected by MIA. Analysis of the embryonic dataset implicated neurodevelopmental disruptions of the lipid, polysaccharide, and glycoprotein metabolism, important for proper membrane function, signalling, and myelination, for NPD-pertinent sequelae. In adulthood, the observed changes encompassed transmembrane trafficking and intracellular signalling, apoptosis, and cytoskeletal organisation pathways. Importantly, 50 proteins altered by MIA in embryonic and adult HPC were enriched in the NPD-relevant synaptic vesicle cycle. A persistently upregulated protein cluster formed a functional network involved in presynaptic signalling and proteins downregulated in embryos but upregulated in adults by MIA were correlated with observed social deficits. 49/50 genes encoding these proteins were significantly associated with NPD- and comorbidity-relevant traits in human phenome-wise association study data for psychiatric phenotypes. These findings highlight NPD-relevant targets for future study and early intervention in at-risk individuals. MIA-evoked changes in the neuroarchitecture of the NPD-relevant HPC and prefrontal cortex (PFC) of male and female mice highlighted sex- and region-specific alterations in dendritic and spine morphology, possibly underlining behavioural phenotypes.
To further investigate genetic risk factors of NPDs, I performed a study based on the implications of RBFOX1’s pleiotropic role in neuropsychiatric disorders and previous preclinical findings. Cytoplasmatic OE of RBFOX1, which affects the stability and translation of thousands of targets, was used to disseminate its role in morphology and behaviour. RBFOX1 OE affected dendritic length and branching in the male PFC and led to spine alterations in both PFC and HPC. Due to previously observed ASD-like endophenotypes in our Rbfox1 KO mice and the importance of gene × environment effects on NPD susceptibility, I probed the interaction of cytoplasmatic OE and a low-dose MIA on offspring. Both RBFOX1 OE alone and with MIA led to increased offspring loss during the perinatal period. Preliminary data suggested that RBFOX1 OE × MIA might increase anxiety- and anhedonia-like behaviours. Morphological changes in the adult male OE HPC and PFC suggested increased spine density and reduced dendritic complexity. A small post-mortem study in human dorsolateral PFC of older adults did not reveal significant effects of a common risk variant on RBFOX1 abundance.
To expand upon NPD genetic risks, I evaluated the effects of a homo- (KO) or heterozygous (HET) Diras2 deletion in a novel, neuron-specific mouse model. DIRAS2’s function is largely unknown, but it has been associated with ADHD in humans and neurodevelopment in vitro. In adult mice, there were subtle sex-specific effects on behaviour, i.e. more pronounced NPD-relevant deficits in males, in keeping with human data. KO mice had subtly improved cognitive performance, while HET mice exhibited behaviours in line with core ADHD symptoms, e.g. earning difficulties (females), response inhibition deficits and hyperactivity (males), suggesting Diras2 dose-sensitivity and sex-specificity. The morphological findings revealed multiple aberrations in dendritic and spine morphology in the adult PFC, HPC, and amygdala of HET males. KOs changes in spine and dendritic morphology were exclusively in the PFC and largely opposite to those in HETs and NPD-like phenotypes. Region- and genotype-specific expression changes in Diras2 and Diras1 were observed in six relevant brain regions of adult HET and KO females, also revealing differences in the survival and morphology regulator mTOR, which might underlie observed differences.
In conclusion, the effects of MIA and partial Diras2 knockdown resembled each other in core, NPD-associated behavioural and morphological phenotypes, while cytoplasmatic RBFOX1 OE and full Diras2 KO differed from those. My findings suggest complex dose- and sex-dependent relationships between these prenatal and genetic interventions, whose NPD-relevant influences might converge onto neurodevelopmental molecular pathways. An assessment of such putative overlap, based on available data from the MIA proteomic analyses of embryonic and adult HPC, suggested the three models might be linked via downstream targets, interactions, and upstream regulators. Future studies should disseminate both distinct and shared aspects of MIA, RBFOX1, and DIRAS2 relevant to NPDs and build upon these findings.
Die Appendizitis stellt mit einer Inzidenz von 115 pro 100000 Einwohnern in Deutschland eine der häufigsten Ursachen für ein akutes Abdomen dar. Bakterielle Infektionen sind ein wesentlicher Faktor für die postoperative Morbidität nach Appendektomie.
Ziel dieser prospektiven Studie war es, das Keimspektrum und insbesondere die Prävalenz resistenter Keime bei der akuten Appendizitis zu bestimmen und die Auswirkungen resistenter Keime auf das Auftreten infektiöser Komplikationen zu analysieren. Alle erwachsenen Patient*innen mit akuter Appendizitis, die zwischen April 2022 und Juli 2023 am Universitätsklinikum Frankfurt operativ behandelt wurden, wurden prospektiv eingeschlossen. Das Keimspektrum der Appendix und die Häufigkeit von MRE in Rektalabstrichen wurden analysiert. Die klinischen Daten wurden extrahiert, um die Korrelation des Keimspektrums mit dem Auftreten von postoperativen Komplikationen, Dauer und Art der Antibiotikatherapie und dem postoperativen Verlauf zu evaluieren. 30 Tage nach der Operation wurde ein Follow-up durchgeführt. Insgesamt wurden 105 Patient*innen in die Studie eingeschlossen.
In den Appendixabstrichen gelang ein Erregernachweis bei 67,6 % aller Fälle. Hierbei betrug die Prävalenz von Keimen mit Antibiotikaresistenz 43,8 %, Multipler-Antibiotikaresistenz (MAR) 27,6 % und bei 5,7 % der Fälle gelang ein MRE-Nachweis nach CDC im Appendixabstrich. Beim MRE-Screening konnten im Rektalabstrich bei 11,4 % der Patient*innen ein MRE nachgewiesen werden. In vier Fällen zeigte sich eine Übereinstimmung zwischen rektalen und appendikulären Abstrich, somit betrug die Sensitivität des MRE-Screenings für einen Nachweis multiresistenter Keime in der Appendix lediglich 33,3 % bei einer Spezifität von 86,7 %. In einer univariaten Analyse konnte das Vorliegen eines Diabetes mellitus als Risikofaktor für das Auftreten von Keimen mit Cefuroxim- Resistenz, Multipler-Antibiotikaresistenz (MAR) und MRE identifiziert werden.
Insgesamt erhielten 47,6 % aller Patient*innen postoperativ eine Antibiotikatherapie, von denen erfolgte bei 46 % eine Umstellung der empirischen Antibiose auf eine antibiogramm-gerechte Therapie nach Erhalt des mikrobiologischen Befundes. Insbesondere Patient*innen mit komplizierter Appendizitis erhielten postoperativ eine Antibiotikatherapie, wobei 28 % eine Antibiotikaeskalation benötigten.
Patient*innen, deren Appendixabstriche eine Resistenz gegen maximal ein Antibiotikum aufwiesen, wurden als nicht multiple Resistenz (Nicht-MAR) definiert und mit Patient*innen verglichen, deren Keime mit multipler Antibiotikaresistenz (MAR) waren. Die MAR-Gruppe zeigte im Vergleich zur Nicht-MAR-Gruppe eine höhere Inzidenz postoperativer Komplikationen, insbesondere eine erhöhte Inzidenz von Clavien-Dindo Grad 3 Komplikationen sowie von tiefen postoperativen Wundinfektionen (CDC Grad A3). Weiterhin benötigten Patient*innen der MAR-Gruppe häufiger eine postoperative Antibiotikatherapie und es erfolgte häufiger eine Eskalation der antibiotischen Therapie. Dies ging auch mit einem signifikant verlängerten Krankenhausaufenthalt einher.
Zusammenfassend kann festgestellt werden, dass eine bakterielle Infektion mit Multipler Antibiotikaresistenz bei der akuten Appendizitis häufig auftritt und die Morbidität nach Appendektomie beeinflusst. Die mikrobiologische Untersuchung mittels Appendixabstrich bei operativ behandelten Fällen von akuter komplizierter Appendizitis, die eine postoperative Antibiotikatherapie erfordern, könnte somit eine gezielte und kürzere Antibiotikatherapie ermöglichen. Dies könnte dazu beitragen, längere Krankenhausaufenthalte zu vermeiden, den unnötigen Einsatz unwirksamer Antibiotika zu reduzieren und die Kosten im Gesundheitswesen zu senken.
Einleitung: Die Zentrale Notaufnahme (ZNA) stellt eine Schnittstelle zwischen prä- und innerklinischer Versorgung dar. Das Spektrum der Krankheitsbilder erstreckt sich über jegliche Fachrichtungen und variiert von harmlosen Banalitäten bis zu akuten Notfällen. Eine sichere und suffiziente Primärversorgung ist die Basis eines qualitativ-hochwertigen Gesundheitssystems.2 Verspätete oder falsche Diagnosen in der ZNA sind mit 10-30 % keine Seltenheit.
Dies ist nicht nur für den individuellen Patienten belastend, es bedeutet auch einen zusätzlichen Ressourcenverbrauch und eine finanzielle Belastung für das Gesundheitssystem. Clinical Decision Support Systems (CDSS) haben das Potenzial, sowohl professionelle Anwender als auch Laien bei ihrer Diagnosefindung zu unterstützen. Fragestellung: Ziel der Arbeit ist es herauszufinden, welchen Einfluss der Diagnosezeitpunkt auf das Outcome von Patienten mit Abdominalschmerzen in der ZNA hat und inwiefern ein CDSS das Potenzial hat, die genannten Punkte zu beeinflussen.
Methoden: Es handelte sich um eine prospektive, doppelt verblindete Beobachtungsstudie. Patienten, die sich mit Abdominalschmerzen in der Notaufnahme vorstellten, gaben ihre Symptome in die Ada-App ein. Sowohl die Diagnosevorschläge der App als auch die Verdachtsdiagnosen des behandelnden Arztes wurden dokumentiert und verglichen. Weitere erhobene Parameter waren die Verwendung von apparativer Diagnostik, die vergangene Zeit bis zur endgültigen Diagnosestellung, das Auftreten von Komplikationen, die Komorbidität und Mortalität sowie die Länge des Krankenhausaufenthalts. Das Follow-Up erfolgte zu verschiedenen Zeitpunkten bis zu Tag 90. Für die Analyse wurden die 450 Patienten anhand des Zeitpunkts ihrer Diagnosestellung in Gruppen "früh" (Tag 0) und "spät" (Tag 1-24) eingeteilt.
Ergebnisse: Im Vergleich zur „frühen“ Gruppe, hatte die Gruppe der „spät“ diagnostizierten Patienten einen höheren Anteil von Männern (45.2% (n=168/372) versus 60.3 % (n=47/78); p=0.018), im Schnitt einen höheren Charlson Comorbidity Index (0.7 versus 1.1; p=0.045) und im Schnitt einen höheren RAI-C Score (8.06 versus 9.9; p<0.001) am Tag ihrer Vorstellung. Bei den „spät“ diagnostizierten blieben weniger Patienten komplikationsfrei (57.0 % 49 (n=212/372) versus 17.9% (n=14/78); p<0.001), es traten mehr Major-Komplikationen auf (8.9% (n=33/372) versus 17.9% (n=14/78); p=0.024), analog dazu war der Comprehensive Complication Index höher (13.1 versus 25.6; p<0.001) und sie verweilten länger im Krankenhaus (2.6 Tage versus 6.7 Tage; p<0.001). Zudem nahmen sie signifikant mehr apparative Diagnostik in Anspruch.
Die behandelnden Ärzte konnten in 82.6% der Fälle (n=372/450) am Tag der Vorstellung die korrekte Diagnose stellen. Die Ada-App konnte in insgesamt 52% der Fälle (n=234/450) die korrekte Diagnose unter ihren Diagnoseverschlägen nennen.
Schlussfolgerung: Multimorbide Patienten scheinen anfälliger zu sein für falsche und verspätete Diagnosen. Ein später Diagnosezeitpunkt korreliert mit der vermehrten Nutzung apparativer Diagnostik, einem komplikationsreicheren Verlauf, einer höheren Komorbidität und einem längeren Krankenhausaufenthalt.
Die Ada-App ist den Ärzten zwar unterlegen, dennoch ist Potenzial vorhanden.
Für Ärzte kann die Ada-App eine Unterstützung im Rahmen der Diagnosefindung darstellen. Neben der Ressourcenentlastung kann sie vor Fehlannahmen und frühzeitigen Schlussfolgerungen schützen und auf weitere mögliche Differentialdiagnosen hinweisen. Die Ada-App stellt für Laien mit Sicherheit eine Weiterentwicklung gegenüber der simplen Symptomsuche über das Internet dar, dennoch sollten weitere Studien den Nutzen und die Sicherheit der App überprüfen.
Polygene Risikoscores (PRS) integrieren zahlreiche Einzelnukleotid-Polymorphismen (SNP) von meist geringer Effektstärke, um Auskunft über das Erkrankungsrisiko bestimmter Krankheiten zu geben. In dieser Arbeit wurde der PRS zur genetisch generalisierten Epilepsie (GGE) von Leu et al. aus dem Jahr 2019 untersucht, um festzustellen, ob über das Erkrankungsrisiko hinaus noch Korrelationen mit weiteren phänotypischen Eigenschaften von Patienten bestehen. Der Nachweis solcher Zusammenhänge würde eine Prädiktionsfähigkeit des GGE-PRS demonstrieren, die perspektivisch ein Potential für dessen klinische Anwendbarkeit, beispielsweise im Sinne der personalisierten Medizin, aufzeigen könnte.
Die Identifizierung neuer Korrelationen sollte durch Vergleich der Phänotypen von zwei Gruppen von GGE-Patienten mit extrem hohen, beziehungsweise extrem niedrigen PRS-Werten erfolgen. Hierfür wurden von 2256 Patienten aus der Datenbank von Epi25, einem internationalen Forschungskollaborativ zur Erforschung der Relevanz genetischer Faktoren bei der Entwicklung von Epilepsie, die Patienten mit den höchsten (n=59) und den niedrigsten (n=49) GGE-PRS-Werten ausgewählt. Für diese 108 Patienten wurden retrospektive klinische Daten von den jeweiligen Behandlungszentren akquiriert. Hierzu wurde den Studienleitern der Zentren ein Questionnaire mit Fragen zu zahlreichen phänotypischen Parametern der Patienten übermittelt. Die Rücklaufrate war mit 54% gut.
Die so eingeholten Patientendaten wurden anschließend mittels Exaktem Test nach Fisher und Wilcoxon-Rangsummentest statistisch analysiert, um Unterschiede zwischen den Phänotypen beider Gruppen nachzuweisen. Im Falle der Pharmakoresistenz zeichneten sich hierbei zunächst signifikante Unterschiede ab, die ein selteneres Auftreten dieser Eigenschaft für Patienten mit hohen GGE-PRS-Werten implizierten. Diese Ergebnisse waren jedoch nach einer Bonferroni-Korrektur und bei Validierung in einer größeren Kohorte (n=825) nicht mehr signifikant. Für die anderen untersuchten Parameter waren ebenfalls keine signifikanten Unterschiede nachweisbar.
Das Ergebnis, dass für keinen der untersuchten Parameter signifikante Differenzen bestanden, obwohl zwei Kohorten mit extrem gegensätzlichen PRS-Werten untersucht wurden, spricht gegen eine Verwendung des aktuell verfügbaren GGE-PRS als prädiktiver Biomarker über das Erkrankungsrisiko hinaus und somit gegen dessen klinische Anwendbarkeit. Jedoch können die nicht-signifikanten Korrelationen im Falle der Pharmakoresistenz als Hinweis verstanden werden, dass im Bereich der Pharmakotherapie Zusammenhänge zwischen Score und Phänotyp bestehen könnten, die weiterer Untersuchungen in zukünftigen Studien bedürfen. Bei Verwendung eines verbesserten GGE-PRS mit zusätzlichen risikoassoziierten SNP und verfeinerter Wichtung der Effektstärken sowie größerer Kohorten könnten in diesem Bereich möglicherweise auch signifikante Zusammenhänge nachweisbar werden.
In Deutschland leidet ca. jeder zehnte Mensch über 40 Jahren an einer chronischen Einschränkung seiner Nierenfunktion. Nicht wenige davon sind im Laufe der Erkrankung auf eine Nierenersatztherapie angewiesen. Die Ursachen für eine Nierenschädigung sind vielfältig. Als neuartiger und vielversprechender Therapieansatz werden aktuell Mesenchymale Stamm-/Stromazellen (MSC) als Therapeutikum für diverse Nierenerkrankungen getestet. Erste Ergebnisse klinischer Phase-I-Studien zeigen, dass MSC sicher als Immunsuppressivum nach Nierentransplantation angewendet werden können. Auch für weitere Erkrankungen der Niere sind erste klinische Studien am Laufen. MSC gelten als regenerativ, immunsupprimierend und antientzündlich. Dennoch gibt es noch einige Limitationen. Nach der Transplantation der Zellen ist das Wachstum der Zellen oft eingeschränkt und es kommt zur vermehrten Apoptose. Auch wird immer wieder ein paradoxes und entzündungsförderndes Verhalten der MSC am Wirkort beobachtet. Ein wichtiger Lösungsansatz ist eine in vitro Vorbehandlung der MSC zur Modulierung der zellulären Eigenschaften. In dieser Arbeit wurden drei Substanzen und Arzneimittel auf ihre Fähigkeit untersucht, die entzündungshemmenden Eigenschaften der MSC zu verbessern und die entzündungsfördernden zu unterdrücken. Der Fokus lag hierbei auf dem Arzneimittel Niclosamid und den beiden bisher noch nicht zugelassenen Substanzen Berberin und Gedunin, die alle in vitro und in vivo bereits erste vielversprechende antientzündliche Wirkungen bewiesen haben. Für diese Arbeit wurden MSC aus Fettgewebe isoliert (ASC) und mit LPS oder einem Cytokin-Mix (Mischung aus TNF-α, IFN-γ und IL-1β) sowie den drei Substanzen stimuliert. Untersucht wurden im Anschluss die mRNA-Expressionen der gängigsten proinflammatorischen (TNF-α, IL-6, TLR-4, ICAM-1, HLA-DR) und antiinflammatorischen Marker (IDO, IL-10), sowie mittels ELISA die Protein-Freisetzung von IL-6 und IL-8. Die vielversprechendsten Ergebnisse ließen sich durch Berberin hervorrufen. Hier zeigte sich eine deutliche Senkung der IL-8-Konzentration im ELISA. Die Anwendung des Gedunin hatte keine signifikante Wirkung auf die ASC. Niclosamid hingegen scheint widererwarten sogar entzündungsfördernd zu wirken, in dem es die IL-6-, ICAM-1-mRNA-Expression steigerte und die IDO-mRNA-Expression absenkte. Unter den drei getesteten Subtanzen hat Berberin die beste Wirkung bewiesen. Nach weiterer Testung könnte eine Anwendung mit Berberin als in vitro Präkonditionierung von MSC vielversprechend sein. Die Verwendung von Niclosamid hingegen sollte vermieden werden, die Wirkung von Gedunin müsste genauer untersucht werden.
Hidradenitis suppurativa ist eine multifaktoriell-bedingte chronisch entzündliche Hauterkrankung, die durch eine Okklusion der Talgdrüseneinheit des Haarfollikels entsteht. Aus der anschließend mit Entzündung einhergehenden Ruptur des Haarfollikels entwickeln sich entzündliche Knoten, Abszesse und Fistelgänge. (39–41) In der weiteren Progression der Erkrankung kommt es zur Störung der Hautarchitektur und fibrotischen Narbenbildungen. (52) Durch Untersuchungen des entzündlichen Infiltrates konnte bereits die Beteiligung einer Reihe von Immunzellen und Entzündungsmediatoren identifiziert werden. Hierzu zählen Makrophagen, neutrophile Granulozyten, Dendritische Zellen, Lymphozyten, IL-1β sowie TNF-α. (41,45,46,51,53) Da die genaue Pathophysiologie der Hidradenitis suppurativa bislang unzureichend aufgeklärt ist, gibt es aktuell keine kausale Therapiemöglichkeit für die Betroffenen. (52) Die Wahl der Therapie wird anhand der Bewertung des Schweregrades nach Hurley getroffen. (25) Obwohl meisten Patientinnen und Patienten von der milden bis mittelschweren Form der Hidradenitis suppurativa (Hurley I und Hurley II) betroffen sind (98), werden die meisten Arzneimittel für die Behandlung von Hurley II und Hurley III von den Leitlinien empfohlen. Zu den empfohlenen Medikamenten gehören u. a. Rifampicin, meist in Kombination mit Clindamycin, sowie der TNF-α-Inhibitor Adalimumab (18,85), welche effektiv und systemisch wirken. Durch die entstehenden Nebenwirkungen wäre die Behandlung der milden bis mittelschweren Hidradenitis suppurativa mit diesen Medikamenten allerdings unverhältnismäßig. Um jedoch den im Verlauf der Krankheit entstehenden Hautdestruktionen vorbeugen zu können, müssten die Medikamente möglichst früh eingesetzt werden. (228) Vor diesem Hintergrund sollte in Kooperation mit dem Institut für Pharmazeutische Technologie der Goethe Universität Frankfurt eine Rifampicin-Nanoformulierung zur Behandlung milder bis mittelschwerer Hidradenitis suppurativa entwickelt und im Labor der dermatologischen Klinik präklinisch validiert werden.
Daher wurde im ersten Teil der vorliegenden Arbeit ein Epidermismodell aus der Haut betroffener Patientinnen und Patienten generiert, um die Rifampicin-Nanoformulierung validieren zu können. Dieses wies eine mehrschichtige Epidermis mit allen wichtigen Differenzierungsmarkern ähnlich der läsionalen Hidradenitis suppurativa auf und schüttete die proinflammatorischen Zytokine IL-1β und TNF-α aus. Als weiteres Modell wurden ex vivo Explantate aus läsionaler Hidradenitis suppurativa Haut etabliert. Für die Bewertung der Validität der Explantatkulturen wurde die Morphologie und Integrität der Epidermis mittels Hämatoxylin-Eosin sowie der Proliferationsmarker Ki-67 näher beleuchtet. Im zweiten Teil dieser Arbeit wurden Untersuchungen für die Festlegung eines Konzentrationsbereichs, unter Verwendung von Rifampicin in DMSO gelöst als in vitro Behandlung, durchgeführt.
Hierbei wurde gezeigt, dass die eingesetzten Konzentrationen keine negativen Effekte bezüglich Proliferationsfähigkeit der Keratinozyten oder Apoptoseinduktion ausüben. Die Behandlung von nicht entzündlichen Epidermismodellen sowie Explantatkulturen mit der Rifampicin-Nanoformulierung mit einem Wirkstoffgehalt von 0,3 % führte ebenfalls zu keinen Proliferationsverlusten, induzierte keine Apoptose oder Zytotoxizität und hatte keinen Einfluss auf die Differenzierung der Keratinozyten. Im letzten Teil der Arbeit sollte die Wirksamkeit der Rifampicin-Nanoformulierung näher beleuchtet werden. Als Antibiotikum inhibiert Rifampicin die DNA-abhängige RNA-Polymerase von Bakterien (107,108), weshalb es bei der Behandlung der Tuberkulose eingesetzt wird. (111–113) Die Hidradenitis suppurativa ist aber primär keine Infektionskrankheit, sondern eine von Bakterien getriggerte, entzündliche Erkrankung. (19,52,82) Aus diesem Grund ist der positive Effekt der systemischen Rifampicintherapie vermutlich vielmehr auf eine antiphlogistische Wirkung zurückzuführen. Diese Überlegung wird durch mehrere Artikel gestützt, die zeigten, dass Rifampicin die Ausschüttung von IL-1β und TNF-α in unterschiedlichen in vitro und in vivo Modellen hemmt. (89–91,96,97) Die anschließenden Untersuchungen zur Wirksamkeit einer in vitro Rifampicinbehandlung bestätigten die antientzündliche Wirkung in den Explantatkulturen indem es die Sekretion von IL-1β, IL-6, IL-8, IL-10 und TNF-α verminderte. Ebenso senkte die Rifampicin-Nanoformulierung die Ausschüttung von IL-1β in den ex vivo Explantaten, was somit die in der klinischen Praxis beobachteten antiinflammatorischen Wirkung von Rifampicin belegt. Des Weiteren stellte sich in Untersuchungen heraus, dass Rifampicin zu einer reduzierten Zahl CD4(+)-T-Zellen führte, aber auf die CD3(+)-T-Zellen keine Auswirkungen hatte, was auf eine Veränderung des T-Zell Phänotyps hinweist.
Aufgrund der vorliegenden Ergebnisse zur Validierung der Rifampicin-Nanoformulierung, spricht nichts gegen die Testung der Rifampicin-Nanoformulierung in einem individuellen Heilversuch am Menschen.
Although, during the past decades, substantial advances emerged in identifying major local and systemic factors contributing to initiation and progression of osteoarthritis (OA), some neuroendocrine mechanisms are still not understood or even neglected when thinking about novel therapeutic options. One of which is the sympathetic nervous system that exhibits various OA-promoting effects in different tissues of the joint. Interestingly, the β2-adrenoceptor (AR) mediates the majority of these effects as demonstrated by several in vitro, in vivo as well as in clinical studies. This review article does not only summarize studies of the past two decades demonstrating that the β2-AR plays an OA-promoting role in different tissues of the joint but also aims to encourage the reader to think about next-level research to discover novel and innovative preventive and/or therapeutic strategies targeting the β2-AR in OA.
Highlights
• TAM polarization induces CP RNA.
• CP RNA expression is regulated by HIF-2 and STAT1.
• CP RNA is transferred from TAMs to HT1080 cells.
• CP RNA is translated by HT1080 cells and protects from ferroptosis.
• Co-cultured HT1080 cells decrease iron and lipid peroxidation.
Abstract
Solid tumors are characterized by hypoxic areas, which are prone for macrophage infiltration. Once infiltrated, macrophages polarize to tumor associated macrophages (TAM) to support tumor progression. Therefore, the crosstalk between TAMs and tumor cells is of current interest for the development of novel therapeutic strategies. These may comprise induction of an iron- and lipid peroxidation-dependent form of cell death, known as ferroptosis. To study the macrophage - tumor cell crosstalk we polarized primary human macrophages towards a TAM-like phenotype, co-cultured them with HT1080 fibrosarcoma cells, and analyzed the tumor cell response to ferroptosis induction. In TAMs the expression of ceruloplasmin mRNA increased, which was driven by hypoxia inducible factor 2 and signal transducer and activator of transcription 1. Subsequently, ceruloplasmin mRNA was transferred from TAMs to HT1080 cells via extracellular vesicles. In tumor cells, mRNA was translated into protein to protect HT1080 cells from RSL3-induced ferroptosis. Mechanistically this was based on reduced iron abundance and lipid peroxidation. Interestingly, in naïve macrophages also hypoxia induced ceruloplasmin under hypoxia and a co-culture of HT1080 cells with hypoxic macrophages recapitulated the protective effect observed in TAM co-cultures. In conclusion, TAMs provoke tumor cells to release iron and thereby protect them from lipid peroxidation/ferroptosis.
Highlights
• Piriform cortex and amgydala can be separated based on their distinct structural connectivity.
• Similar to histological findings, the connectivity of the piriform cortex suggests posterior frontal and temporal subregions.
• Subregions of the piriform cortex have distinct connectivity profiles.
• Anterior PC extended into ventrotemporal PC posteriorly, which has not been described before, requiring further investigation.
• All parcellations were made publicly available.
Abstract
The anatomy of the human piriform cortex (PC) is poorly understood. We used a bimodal connectivity-based-parcellation approach to investigate subregions of the PC and its connectional differentiation from the amygdala.
One hundred (55 % female) genetically unrelated subjects from the Human Connectome Project were included. A region of interest (ROI) was delineated bilaterally covering PC and amygdala, and functional and structural connectivity of this ROI with the whole gray matter was computed. Spectral clustering was performed to obtain bilateral parcellations at granularities of k = 2–10 clusters and combined bimodal parcellations were computed. Validity of parcellations was assessed via their mean individual-to-group similarity per adjusted rand index (ARI).
Individual-to-group similarity was higher than chance in both modalities and in all clustering solutions. The amygdala was clearly distinguished from PC in structural parcellations, and olfactory amygdala was connectionally more similar to amygdala than to PC. At higher granularities, an anterior and ventrotemporal and a posterior frontal cluster emerged within PC, as well as an additional temporal cluster at their boundary. Functional parcellations also showed a frontal piriform cluster, and similar temporal clusters were observed with less consistency. Results from bimodal parcellations were similar to the structural parcellations. Consistent results were obtained in a validation cohort.
Distinction of the human PC from the amygdala, including its olfactory subregions, is possible based on its structural connectivity alone. The canonical fronto-temporal boundary within PC was reproduced in both modalities and with consistency. All obtained parcellations are freely available.
Hintergrund: Die NEC ist eine sehr häufige Erkrankung von Frühgeborenen und Kindern mit geringem Geburtsgewicht innerhalb der ersten zwei Lebenswochen. Mit einer Inzidenz von bis zu 11% bei Frühgeborenen7 und einer Letalität von 15-30%, stellt diese einen ernstzunehmenden Notfall auf neonatalen Intensivstationen dar. Die Pathophysiologie und Ätiologie sind bis heute nicht endgültig geklärt. Es besteht jedoch der allgemeine Konsens über eine multifaktorielle Genese. Im Vordergrund steht dabei die Unreife des Frühgeborenendarms. Hinzu kommen eine abnorme bakterielle Kolonisation des Darms und Hypoxien im Splanchnikusgebiet. In der aktuellen Literatur gibt es unterschiedliche Aussagen über einen möglichen Zusammenhang zwischen den histopathologischen Befunden der Resektionspräparate und dem postoperativen Verlauf. Teilweise wird von einem Zusammenhang zwischen dem Ausmaß der Nekrose im Resektionsrand mit einer bakteriellen Besiedlung und dem Outcome berichtet. Das Ziel unserer Studie war es, diesen Zusammenhang weiter zu untersuchen und einen möglichen Unterschied zwischen den Resektionsrändern und den zentralen Segmenten zu beschreiben.
Material und Methoden: In dieser Studie wurden die Operationspräparate von Frühgeborenen, die zwischen 2010 und 2019 in der kinderchirurgischen Abteilung des Universitätsklinikums der Goethe-Universität in Frankfurt am Main mit dem Verdacht auf eine NEC operiert wurden, retrospektiv und doppelt verblindet histologisch untersucht und befundet. Die Befundung der zentralen Segmente und Resektionsränder der Operationspräparate erfolgte von drei Untersucher:innen unabhängig. Der postoperative Verlauf wurde retrospektiv mithilfe der klinikinternen Dokumentationssoftware ermittelt und die Patient:innen wurden in drei Gruppen eingeteilt: komplikationsfrei, Komplikationen und Exitus letalis. Anschließend erfolgte sowohl eine uni- als auch eine multivariate Zusammenhangsanalyse zwischen dem Befund und dem postoperativen Verlauf. Die Durchführung der Studie wurde von dem Ethikkomitee des Universitätsklinikums der Goethe-Universität genehmigt.
Ergebnisse:
Es wurden die Präparate von insgesamt 59 Kindern mit Verdacht auf NEC untersucht. Bei 49 Kindern bestätigte sich der initiale Verdacht. Bei 10 Kindern lagen andere Darmerkrankungen wie eine FIP, ein Volvulus oder ein Mekonium-Ileus vor. 29 der 59 Kinder (49%) blieben postoperativ frei von Komplikationen, 25 (42%) zeigten im Verlauf Komplikationen im Sinne einer gravierenden Allgemeinzustandsverschlechterung, eines Ileus oder einer erneuten NEC und fünf Kinder (9%) verstarben.
Diese Studie zeigte einen signifikanten Zusammenhang zwischen dem Vorliegen einer Einblutung in das Gewebe des Resektionsrandes und dem postoperativen, klinischen Verlauf (p = 0,032). Lag eine Einblutung in die Resektionsränder vor, kam es häufiger zu Komplikationen oder einem Exitus letalis. Dem entgegen konnte kein weiterer Zusammenhang zwischen der Vitalität der Tunica Mucosa oder der Tunica Muscularis im Resektionsrand und dem klinischen Verlauf gefunden werden. Außerdem konnte kein Zusammenhang zwischen den histopathologischen Befunden in den zentralen Anteilen des resezierten Präparates und dem klinischen Verlauf nachgewiesen werden.
Schlussfolgerung: Mit dieser Studie ermittelten wir einen statistisch signifikanten Zusammenhang zwischen dem Vorliegen einer frischen Hämorrhagie in den Resektionsrand und dem postoperativen klinischen Verlauf. Vergleicht man die Ergebnisse mit der aktuellen Literatur, besteht Einigkeit darüber, dass die histologische Vitalität der Resektionsränder alleine für das Outcome nicht maßgeblich zu sein scheint.
Den Kinderchirurg:innen kann an Hand dieser Studie bei gleichbleibender Wahl der Resektionsränder eine möglichst atraumatische Operationstechnik mit Ausräumung makroskopisch sichtbarer Hämatome empfohlen werden. Die Schnellschnittuntersuchung der Resektionsränder im Hinblick auf die Vitalität des Gewebes ist nicht nötig.
Key Teaching Points
• Wearables such as smartwatches can monitor beyond heart rate and heart rhythm.
• Specific smartwatches provide reliable measurements of electrocardiographic intervals (eg, QT interval).
• Correct analysis and interpretation of the QT interval in an individual with previously unknown long QT syndrome facilitated the diagnosis.
Highlights:
• Assessment of body composition parameters in a large cohort of patients with HCC undergoing TACE.
• Fully automated artificial intelligence-based quantitative 3D volumetry of abdominal cavity tissue composition.
• Skeletal muscle volume and related parameters were independent prognostic factors in patients with HCC undergoing TACE.
Background & Aims: Body composition assessment (BCA) parameters have recently been identified as relevant prognostic factors for patients with hepatocellular carcinoma (HCC). Herein, we aimed to investigate the role of BCA parameters for prognosis prediction in patients with HCC undergoing transarterial chemoembolization (TACE).
Methods: This retrospective multicenter study included a total of 754 treatment-naïve patients with HCC who underwent TACE at six tertiary care centers between 2010–2020. Fully automated artificial intelligence-based quantitative 3D volumetry of abdominal cavity tissue composition was performed to assess skeletal muscle volume (SM), total adipose tissue (TAT), intra- and intermuscular adipose tissue, visceral adipose tissue, and subcutaneous adipose tissue (SAT) on pre-intervention computed tomography scans. BCA parameters were normalized to the slice number of the abdominal cavity. We assessed the influence of BCA parameters on median overall survival and performed multivariate analysis including established estimates of survival.
Results: Univariate survival analysis revealed that impaired median overall survival was predicted by low SM (p <0.001), high TAT volume (p = 0.013), and high SAT volume (p = 0.006). In multivariate survival analysis, SM remained an independent prognostic factor (p = 0.039), while TAT and SAT volumes no longer showed predictive ability. This predictive role of SM was confirmed in a subgroup analysis of patients with BCLC stage B.
Conclusions: SM is an independent prognostic factor for survival prediction. Thus, the integration of SM into novel scoring systems could potentially improve survival prediction and clinical decision-making. Fully automated approaches are needed to foster the implementation of this imaging biomarker into daily routine.
Impact and implications: Body composition assessment parameters, especially skeletal muscle volume, have been identified as relevant prognostic factors for many diseases and treatments. In this study, skeletal muscle volume has been identified as an independent prognostic factor for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Therefore, skeletal muscle volume as a metaparameter could play a role as an opportunistic biomarker in holistic patient assessment and be integrated into decision support systems. Workflow integration with artificial intelligence is essential for automated, quantitative body composition assessment, enabling broad availability in multidisciplinary case discussions.
Ziel: Nebennierenraumforderungen können sonographisch mit guter Sensitivität und Spezifität erkannt werden. Ziel der vorliegenden Studie war es, die Wertig-keit der Kontrastmittel-Sonographie (CEUS = contrast enhanced ultrasound) unter Verwendung von Zeit-Intensitäts-Kurven für die Charakterisierung von Nebennierenraumforderungen zu bewerten.
Material und Methoden: 108 Patienten mit 116 Raumforderungen der Neben-niere erhielten einen Ultraschall der Nebenniere, inklusive einer Kontrastmittel-Sonographie mit dem Kontrastmittel SonoVue®. Die Kontrastmitteldynamik wurde mittels Zeit-Intensitätskurven aufgezeichnet. Anhand der Kontrastmittel-anflutungszeit wurden folgende vier Kontrastmittelanreicherungsmuster ver-wendet, welche in einer Pilotstudie1 entwickelt wurden: Anreicherungsmuster I = früh arterielle Kontrastmittelanreicherung, Anreicherungsmuster II = arterielle Kontrastmittelanreicherung, Anreicherungsmuster III = späte Kontrastmittelan-reicherung, Anreicherungsmuster IV = keine Kontrastmittelanreicherung. Zu-sätzlich erhielten alle Patienten eine Beurteilung der Nebenniere durch ein zweite Bildgebendes Verfahren (Computertomographie (CT) oder Magnetresonanztomographie (MRT)) sowie eine laborchemische Hormondiagnostik. In Fällen mit malignitätsverdächtigem Befund erfolgte eine Biopsie oder Adrenalektomie.
Ergebnisse: CEUS- Anreicherungsmuster I und II konnten bei allen Patienten mit primärem oder sekundärem Malignom der Nebenniere (n = 16) nachgewie-sen werden. Die Sensitivität der CEUS für die Diagnose einer malignen Neben-nierenraumforderung betrug 100% (95% CI [75; 100]) und die Spezifität 67% (95% CI [56; 75]). Bei 40 Nebennierenraumforderungen war die Histologie die Referenzmethode. In 68% dieser Nebennierenraumforderungen waren MRT/CT und CEUS kongruent in der Beurteilung der Dignität. Schlussfolgerung: Die Kontrastmittel-Sonographie ist eine nützliche ergän-zende Methode in der Aufarbeitung von Nebennierenraumforderungen mit exzellenter Sensitivität für die Diagnose eines Malignoms.